The BAR domain proteins: Molding membranes in fission, fusion, and phagy by Ren, G. et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, Mar. 2006, p. 37–120 Vol. 70, No. 1
1092-2172/06/$08.000 doi:10.1128/MMBR.70.1.37–120.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
The BAR Domain Proteins: Molding Membranes
in Fission, Fusion, and Phagy
Gang Ren,1,4 Parimala Vajjhala,1 Janet S. Lee,1 Barbara Winsor,4 and Alan L. Munn1,2,3*
Institute for Molecular Bioscience,1 ARC Special Research Centre for Functional and Applied Genomics,2 and School of
Biomedical Sciences,3 University of Queensland, St. Lucia, Queensland 4072, Australia, and UMR7156,
Centre National Recherche Scientifique, Universite´ Louis Pasteur, Strasbourg 67084, France4
INTRODUCTION .........................................................................................................................................................39
BUDDING YEAST Rvs PROTEINS...........................................................................................................................40
Nutrient Availability and the Control of Cell Proliferation ...............................................................................40
Rvs161p and Rvs167p Proteins and Their Common BAR Domain...................................................................40
BAR Domains of Rvs161p and Rvs167p Assemble into Heterodimers .............................................................40
Loss of Rvs161p or Rvs167p Causes a Similar and Diverse Spectrum of Phenotypes ..................................42
Reduced viability upon starvation (Rvs).........................................................................................................42
Growth sensitivity to salt (especially Na) .......................................................................................................42
Growth sensitivity to cytotoxic compounds .......................................................................................................42
Growth sensitivity to elevated temperature.......................................................................................................43
Growth on nonfermentable carbon sources ......................................................................................................43
Meiosis and sporulation ......................................................................................................................................43
Heterogeneous cell size and morphology upon starvation or exposure to Na ..........................................43
Loss of actin cytoskeleton polarization to sites of polarized growth.............................................................43
Delocalized cell wall chitin deposition....................................................................................................44
Loss of bipolar bud site selection.......................................................................................................................44
Defective fluid-phase and receptor-mediated endocytosis...............................................................................44
Inefficient cell-cell fusion during mating...........................................................................................................44
Rvs161p and Rvs167p Structure-Function Relationships...................................................................................45
Rvs Proteins Localize to the Cortical Actin Cytoskeleton ..................................................................................45
Subcellular localization of Rvs161p and Rvs167p............................................................................................45
Interactions between Rvs167p and actin patch proteins.................................................................................47
Roles of Rvs161p and Rvs167p in Endocytosis ....................................................................................................49
Rvs161p and Rvs167p in receptor-mediated internalization of -factor ......................................................49
Role for Rvs161p and Rvs167p in postinternalization trafficking through endosomes?............................57
Roles of Rvs161p and Rvs167p in the Secretory Pathway ..................................................................................58
Rvs161p and Rvs167p are not essential for all secretory membrane traffic ................................................58
Rvs proteins may be required for polarized secretion during cell division .................................................58
Rvs proteins and post-Golgi apparatus traffic .................................................................................................58
Rvs proteins and ER-to-Golgi apparatus traffic...............................................................................................59
Rvs proteins and mating......................................................................................................................................59
rvs Mutations Interact with Actin and Myosin Mutations .................................................................................63
Rvs phenotypes are associated with mutations affecting other actin cytoskeleton proteins ...................63
Genetic interactions between Rvs proteins and actin......................................................................................67
Genetic interactions between Rvs proteins and yeast myosins ......................................................................67
Rvs Proteins and Membranes.................................................................................................................................68
Association of cortical actin cytoskeleton with membranes............................................................................68
Fractionation of Rvs proteins with membranes ...............................................................................................68
Rvs proteins and lipid rafts ................................................................................................................................68
Suppression of Rvs phenotypes by mutations affecting glycosphingolipid biosynthesis ..........................69
Regulation of Rvs167p by Phosphorylation ..........................................................................................................72
Regulation of Rvs167p by Ubiquitination .............................................................................................................73
Genomic and Proteomic Approaches and the Diverse Network of Rvs Interactions......................................74
Large-scale two-hybrid screens for Rvs161p- and Rvs167p-interacting proteins ........................................74
Identification of Rvs167p SH3 domain-interacting proteins by phage display............................................74
Identification of Rvs161p- and Rvs167p-interacting proteins by high-throughput proteomics.................74
Mapping the genetic interactions of Rvs161p and Rvs167p by synthetic genetic array.............................74
Rvs161p and Rvs167p physical and genetic interactions suggest multiple functions in vivo....................74
* Corresponding author. Mailing address: Institute for Molecular
Bioscience, University of Queensland, St. Lucia, Queensland 4072,
Australia. Phone: 61-7-3346 2017. Fax: 61-7-3346 2101. E-mail: a.munn
@imb.uq.edu.au.
37
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
m
br.asm
.org/
D
ow
nloaded from
 
FISSION YEAST BAR DOMAIN PROTEINS Hob1p AND Hob3p......................................................................75
Hob3p, Fission Yeast Ortholog of Rvs161p ..........................................................................................................75
Hob3p has a domain structure similar to that of Rvs161p............................................................................75
Hob3p functions in polarization of the cortical actin cytoskeleton but not endocytosis............................75
Functional conservation between Hob3p, Rvs161p, and human Bin3.....................................................................75
Hob1p, Fission Yeast Ortholog of Rvs167p ..........................................................................................................75
Hob1p has a domain structure similar to that of Rvs167p............................................................................75
Hob1p is not required for polarization of the cortical actin cytoskeleton or endocytosis .........................75
Hob1p interacts with actin assembly proteins and protein kinases that regulate cell polarity ................76
Hob1p functions in regulating cell cycle progression in response to nutrient availability........................76
Functional Conservation of Hob1p and Bin1 and Divergence of Rvs167p ......................................................76
Hob1p functions in regulation of cell cycle progression in response to DNA damage...............................76
Hob1p functions in a cell stress signal transduction pathway upstream of Hob3p ...................................77
VERTEBRATE BAR DOMAIN PROTEIN AMPHIPHYSIN 1 ..............................................................................77
Endocytic Recycling of Synaptic Vesicles ..............................................................................................................77
Role of dynamin 1 in synaptic vesicle recycling ...............................................................................................77
Discovery of Amphiphysin 1 in Chicken Brain ....................................................................................................77
Chicken amphiphysin 1 has a domain structure similar to that of budding yeast Rvs167p.....................77
Chicken amphiphysin 1 is expressed in neurons .............................................................................................77
Minor pool of chicken amphiphysin 1 is tightly associated with synaptic vesicles.....................................78
Discovery of Human Amphiphysin 1......................................................................................................................78
Human amphiphysin 1 is the autoantigen in stiff-man syndrome with breast cancer ...............................78
Human amphiphysin 1 has a domain structure similar to that of yeast Rvs167p .....................................78
Mammalian amphiphysin 1 is highly expressed in the brain but is also expressed in other tissues ......78
Amphiphysin 1 interacts with the endocytic proteins dynamin 1 and synaptojanin 1...............................78
Amphiphysin 1 Interacts with Clathrin and the AP-2 Adaptor .........................................................................80
Regulation of Amphiphysin 1 Interactions by Phosphorylation ........................................................................80
Amphiphysin 1 Subcellular Localization in Presynaptic Terminals .................................................................80
Amphiphysin 1 localizes to endocytic intermediates .......................................................................................80
Amphiphysin 1 also localizes to the actin-rich cytomatrix .............................................................................81
Amphiphysin 1 functions in polarized growth..................................................................................................81
Amphiphysin 1 Functions in Endocytosis .............................................................................................................81
Amphiphysin 1 interaction with dynamin 1 is essential for endocytosis in neurons..................................81
Amphiphysin interaction with dynamin is also essential for endocytosis in nonneuronal cells ...............83
Amphiphysin 1 interacts with clathrin and AP-2................................................................................................83
Appendage domain of -adaptin mediates interaction with amphiphysin 1 ...............................................84
Amphiphysin 1 interaction with clathrin and AP-2 is essential for endocytosis.........................................84
Amphiphysin 1 interacts with endophilin A1/SH3p4/SH3GL2 .................................................................................84
Amphiphysin 1 forms homodimers ....................................................................................................................84
Regulation of amphiphysin 1 complex formation by phosphorylation and dephosphorylation ................84
Protein phosphatase 2B/calcineurin is responsible for dephosphorylation of amphiphysin 1,
dynamin 1, and synaptojanin 1 upon nerve stimulation.............................................................................85
Proline-rich central insert domain of amphiphysin 1 is phosphorylated by Cdk5/p35 in vivo.................85
Amphiphysin 1 Knockout Mice...............................................................................................................................86
Amphiphysin 1 is important but not essential for synaptic vesicle recycling in vivo .................................86
Essential role for amphiphysin 1 in learning ...................................................................................................87
Amphiphysin 1 and Molding of Membranes ........................................................................................................87
Dynamin 1 binds membranes and evaginates tubules in vitro ......................................................................87
Amphiphysin 1 binds membranes and evaginates tubules in vitro ...............................................................89
Amphiphysin 1 binding to membranes is dependent on lipid composition .................................................89
Amphiphysin 1 and dynamin 1 coassemble into rings on membrane tubules.............................................89
Amphiphysin 1 stimulates assembly of dynamin 1 into thick rings in solution..........................................89
Amphiphysin 1 coordinates clathrin bud and dynamin 1 tubule formation................................................89
Amphiphysin 1 stimulates the activity of dynamin 1 in membrane tubule fission .....................................89
In vivo role for amphiphysin 1 in membrane tubule formation ....................................................................90
Membrane curvature and amphiphysin 1 binding...........................................................................................90
Amphiphysin 1 tubulation of membranes is dependent on lipid composition.............................................90
Domains of amphiphysin 1 required for membrane tubulation ....................................................................90
Domains of amphiphysin 1 required for coassembly with dynamin 1 into rings in solution....................91
SECOND ISOFORM OF AMPHIPHYSIN, Bin1.....................................................................................................91
Discovery of Bin1 ......................................................................................................................................................91
Bin16a1213/Amphiphysin 2/Amphiphysin II/BRAMP2 in the Brain.......................................................93
Distribution of Bin11213 in the brain.........................................................................................................93
Localization of Bin16a12 on purified plasma membranes .......................................................................93
Association of Bin1 with membranes.................................................................................................................93
38 REN ET AL. MICROBIOL. MOL. BIOL. REV.
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
m
br.asm
.org/
D
ow
nloaded from
 
Recruitment of Bin16a12 to the plasma membrane..................................................................................94
Interaction of Bin112 with Other Brain Proteins.............................................................................................94
Bin112 (with or lacking exons 6a and 13) interacts with dynamin 1 and synaptojanin 1 in
the brain.............................................................................................................................................................94
Bin112 (with or lacking exons 6a and 13) interacts with the -adaptin subunit of AP-2
in the brain ........................................................................................................................................................94
Bin112 (with or lacking exons 6a and 13) interacts with clathrin heavy chain in the brain.................94
Interaction of Bin112 with endophilin A1/SH3p4/SH3GL2 in the brain...................................................94
Bin16a12 forms homodimers and heterodimers in the brain..................................................................95
Interaction of amphiphysin 1/Bin16a12 heterodimers with dynamin 1 in the brain ...........................95
Bin16a12 is regulated by phosphorylation and dephosphorylation ........................................................95
Bin16a12 functions in synaptic vesicle recycling/endocytosis ..................................................................95
Bin112 may function in postinternalization transport through endosomes .............................................96
Bin11013/Bin1.....................................................................................................................................................96
Identification of Bin11013/Bin1....................................................................................................................96
Domain structure of Bin11013..................................................................................................................................96
Interaction of Bin11013 with c-Myc ............................................................................................................97
Bin11013 is a tumor suppressor ..................................................................................................................97
Bin11013 induces apoptosis specifically in tumor cells............................................................................98
Subcellular localization of Bin11013 ...........................................................................................................98
Stability of Bin11013 in vivo.........................................................................................................................99
Phosphorylation of Bin11013........................................................................................................................99
Role for Bin11013 in muscle differentiation...............................................................................................99
Bin11013 localization in adult skeletal muscle........................................................................................100
Bin11013 and T-tubule formation in muscle............................................................................................100
Bin11013 and lipid rafts..............................................................................................................................101
Bin11013 binds and tubulates liposomes in vitro ...................................................................................101
Bin1101213/SH3p9 ........................................................................................................................................101
Bin1101213/ALP1/Amphiphysin IIm ..........................................................................................................101
Bin1101213 in regulation of the actin cytoskeleton .............................................................................102
Bin1101213 functions in phagocytosis in macrophages ......................................................................102
AMPHIPHYSIN-RELATED PROTEIN Bin2..........................................................................................................103
AMPHIPHYSIN-RELATED PROTEIN Bin3..........................................................................................................104
ENDOPHILIN FAMILY OF PROTEINS................................................................................................................104
Identification of Endophilin A1/SH3p4/SH3GL2 ...............................................................................................104
Endophilin A and B Family Proteins Bind and Tubulate Membranes ..........................................................105
Endophilin A Family Proteins Function in Receptor-Mediated Endocytosis ................................................106
OTHER BAR DOMAIN PROTEINS .......................................................................................................................107
Rich-1/Nadrin 1.......................................................................................................................................................107
SNX1.........................................................................................................................................................................107
Other BAR Domain Proteins ................................................................................................................................107
CRYSTAL STRUCTURE OF THE AMPHIPHYSIN BAR DOMAIN .................................................................107
Structure of the BAR Domain...............................................................................................................................107
Coupling of the BAR Domain with Additional Lipid-Binding Sequences ......................................................109
Membrane Binding and GTPase Binding of BAR Domains: Independent or Associated?..........................109
BAR Domain and IMD Structure ........................................................................................................................109
MEMBRANE TUBULATION AND BAR DOMAIN PROTEIN FUNCTION IN VIVO ...................................109
CONCLUSIONS AND FUTURE PERSPECTIVES...............................................................................................112
ACKNOWLEDGMENTS ...........................................................................................................................................112
REFERENCES ............................................................................................................................................................112
INTRODUCTION
The BAR domain proteins form a rapidly expanding protein
family defined by the presence of a homologous -helical do-
main of 250 to 280 amino acids named after the founding
members of this family: Bin1, Amphiphysin, and Rvs167 (BAR)
(278, 298). BAR domain proteins have been implicated in an
extraordinary diversity of cellular processes, including fission
of synaptic vesicles, cell polarity, endocytosis, regulation of the
actin cytoskeleton, transcriptional repression, cell-cell fusion,
signal transduction, apoptosis, secretory vesicle fusion, excita-
tion-contraction coupling, learning/memory, tissue differentia-
tion, ion flux across membranes, and tumor suppression. The
conserved features of the BAR domain suggest there may exist
an underlying common molecular mechanism that is provided
by the BAR domain and that has been adapted for use in these
different physiological processes.
Insight into what this common molecular mechanism may be
has come from recent key discoveries. The first discovery was
that BAR domains bind liposomes in vitro and convert low-
curvature spheres to high-curvature tubules (316). The second
discovery was that the BAR domain is itself curved (banana-
shaped) and is therefore exquisitely designed both to sense
membrane curvature and to actively influence membrane cur-
vature (237). Furthermore, subsequent structure comparisons
revealed that many proteins that bind GTPases do so through
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a similar protein fold (109). These discoveries have created
great excitement, since it may now be possible to explain the
diverse cellular roles of BAR domain proteins in terms of
sensing membrane curvature, binding GTPases, and actively
molding cellular membranes.
BAR domain proteins are encoded by most, if not all, eu-
karyotic genomes. They are found in organisms from lower
unicellular eukaryotes such as budding yeast and fission yeast
to insects, plants, and vertebrates. The phylogeny of BAR
domain proteins has been the subject of an excellent recent
review (109). Database homology searches with known BAR
domains have not yet identified an obvious BAR domain en-
coded by the genome of any prokaryote. Sequence homology
between known BAR domains is, however, relatively modest.
The sequence features that confer folding of a polypeptide into
a structure that can bind and bend membranes are still not fully
understood. It is possible that proteins with similar properties
exist also in prokaryotes but that low sequence homology has
made them difficult to recognize. The apparent origin of BAR
domain proteins in eukaryotes suggests a function(s) unique to
eukaryotes. Some of the roles of BAR domain proteins (e.g., in
membrane traffic) would be relevant only in eukaryotic cells.
Hence, the evolution of BAR domain proteins may parallel the
evolution of cellular compartmentation and complexity.
This article will first review the physiological roles and in-
teractions of the BAR domain proteins, focusing primarily on
the amphiphysins (including the Bin1-3 proteins) and the en-
dophilins. Other BAR domain proteins, such as the sorting
nexins (SNXs), will be discussed only briefly. In particular, this
article focuses on the roles of BAR domain proteins in yeasts
(budding yeast and fission yeast) and in mammals (with occa-
sional reference to their roles in flies). This article then reviews
the three-dimensional structure of the BAR domain. The ar-
ticle concludes with a somewhat speculative attempt to explain
the known physiological roles of BAR domain proteins in
yeasts and in mammals in terms of binding membranes and
generating membrane tubules in vivo.
BUDDING YEAST Rvs PROTEINS
Nutrient Availability and the Control of Cell Proliferation
Yeasts as free-living unicellular organisms are at the mercy of
their environment and experience a variety of stresses, including
changes in osmolarity, temperature, pH, redox potential, and
nutrient deprivation. Therefore, yeast cells must continuously
monitor their extracellular environment and respond to changes
in ways that ensure survival. A common response of yeast cells
when confronted by stress is to arrest progression through the cell
division cycle and become quiescent. For example, when starved
of essential nutrients, dividing yeast cells arrest uniformly in late
G1 of the cell division cycle prior to initiation of chromosome
replication and formation of a daughter cell (bud) (185, 186). This
arrest point in yeast is analogous to the “restriction point” in
mammalian cells. Following cell division cycle arrest the starved
yeast cells enter a quiescent phase (G0) (135). Yeast cells quies-
cent in G0 survive for long periods and are resistant to stress
(247). However, if yeast cells cannot enter this quiescent state,
their futile attempts to transit the cell division cycle without an
adequate nutrient supply have dire consequences and the cells
perish. Hence, the ability to stop dividing and become quiescent
is vital for yeast cells to survive under adverse environmental
conditions.
To identify genes important for cell cycle arrest in response
to starvation, Michel Aigle and colleagues screened a random
collection of UV-induced mutants for those specifically defec-
tive in their ability to adapt to starvation conditions. Mutants
that were fully viable in the presence of nutrients but that lost
viability more rapidly than wild-type cells when starved of
glucose (carbon), ammonium (nitrogen), or sulfate (sulfur)
were retained. Two mutants found to exhibit a Reduced Via-
bility upon Starvation (Rvs) phenotype and to carry mu-
tations in distinct genes were named rvs161 and rvs167 the
corresponding wild-type genes are RVS161 and RVS167, re-
spectively). In cell cycle terminology, the proteins Rvs161p and
Rvs167p are negative cell cycle regulators that link nutrient
availability to cell cycle progression (12, 42).
Rvs161p and Rvs167p Proteins and Their
Common BAR Domain
Comparison of Saccharomyces cerevisiae Rvs161p and
Rvs167p revealed strong amino acid sequence homology be-
tween the two proteins (Fig. 1). The homology extended over
the total length (265 residues) of Rvs161p and over the N-
terminal 281 residues of Rvs167p. Over this region the two
proteins exhibit 27% amino acid sequence identity and 52%
amino acid sequence similarity. The homologous domain was
predicted to contain two regions with predominantly -helical
structure (12, 47, 220, 298). The N-terminal homologous do-
main was initially named the Rvs domain (299). Because ver-
tebrate amphiphysin 1 and Bin1 (see below) also feature a
homologous domain, Sakamuro et al. renamed the Rvs domain
the Bin1/Amphiphysin/Rvs167 (BAR) domain (Fig. 1) (278).
The designation BAR domain is now commonly used to de-
scribe this homologous domain in both yeast and nonyeast
proteins. More recently, this domain has been subdivided into
a short N-terminal amphipathic -helix (40 to 45 residues)
and the BAR domain itself, as some BAR domain proteins
lack the N-terminal amphipathic -helix (Fig. 1).
Rvs167p has two additional C-terminal domains that are not
present in Rvs161p. Following the BAR domain is the glycine-,
proline-, and alanine-rich (GPA-rich) region which contains no
charged amino acids, includes a hydrophobic sequence, and is
not predicted to adopt a defined secondary structure (Fig. 1).
The GPA-rich region is followed by a Src Homology 3 (SH3)
domain (Fig. 1) (12). SH3 domains are short, 50- to 70-amino-
acid modules found in a diverse range of signal transduction
and actin cytoskeletal proteins (234). They mediate protein-
protein interactions by binding primarily (but not exclusively)
to short linear proline-rich target motifs (261, 382).
BAR Domains of Rvs161p and Rvs167p Assemble
into Heterodimers
Secondary-structure prediction identified two regions of
high -helical potential in both the Rvs161p BAR domain
(residues 22 to 65 and 127 to 183) and the Rvs167p BAR
domain (residues 30 to 57 and 144 to 191) (47, 220). Moreover,
the COILS algorithm revealed that the BAR domain -helices
are amphipathic and have a propensity to form coiled-coil
40 REN ET AL. MICROBIOL. MOL. BIOL. REV.
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FIG. 1. Domain structure of yeast and human amphiphysin family proteins. Schematic representation of the domain organization of the
budding yeast amphiphysin family proteins Rvs161p and Rvs167p, the fission yeast amphiphysin family proteins Hob1 and Hob3, and the human
amphiphysin family proteins amphiphysin 1, Bin1/amphiphysin 2 (several tissue-specific and ubiquitous splice variants), Bin2, and Bin3, and
endophilins A1, A2, A3, B1, and B2.
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structures that may mediate interaction of the BAR domain
with other coiled-coil proteins. Two-hybrid analysis revealed
that Rvs167p and Rvs161p interact and that the interaction is
mediated by their BAR domains. In this study, neither
Rvs161p nor Rvs167p interacted with itself, suggesting that the
Rvs proteins form obligate heterodimers. The in vivo associa-
tion of Rvs161p with Rvs167p was confirmed by coimmuno-
precipitation of Rvs161p with Rvs167p from yeast lysates in
vitro (220).
Subsequently, no fewer than eight other two-hybrid studies
have analyzed interactions between Rvs161p and Rvs167p
and each protein with itself (18, 38, 59, 84a, 97, 136, 180,
339). All these studies confirmed interaction between Rvs161p
and Rvs167p via the respective BAR domains. In contrast to
the initial study (220), two of these later studies found that
Rvs167p also forms homodimers via the BAR domain (38,
180). Furthermore, two-hybrid interaction of Rvs167p with
itself persists when RVS161 is deleted, indicating that Rvs167p-
Rvs167p interaction is either direct or mediated by a protein
other than Rvs161p (180). Two later studies, however, con-
cluded that Rvs167p does not form homodimers in vegetatively
growing cells (i.e., it only forms heterodimers) (84a, 97). In-
terestingly, in cells lacking Rvs161p the steady-state level of
Rvs167p is considerably reduced due to accelerated proteolysis
and vice versa (180). These results represent strong evidence
that in vivo Rvs161p and Rvs167p form heterodimers and
function in concert.
Loss of Rvs161p and Loss of Rvs167p Cause Similar and
Diverse Spectra of Phenotypes
The yeast rvs161 and rvs167 mutations are highly pleiotropic
and the reported phenotypes are summarized below. For many of
the phenotypes tested, rvs161 and rvs167 mutants have identical
phenotypes and the rvs161 rvs167 double mutant is not more
severely affected than either single mutant. A recent genome-
wide analysis of genetic interactions of Rvs161p and Rvs167p
revealed that loss of each protein is lethal in pairwise combination
with loss of the same set of 49 other yeast proteins. This indicates
that the roles of Rvs161p and Rvs167p in vegetative growth are
identical. The rvs161-1 and rvs167-1 mutations identified in the
initial mutant screen appear to be complete loss-of-function al-
leles because deletion or disruption of the RVS161 gene (rvs161)
or the RVS167 gene (rvs167) in almost every case reveals a
phenotype identical to that with the original mutant allele (12, 42,
53, 84a).
Reduced viability upon starvation (Rvs). As introduced
above, rvs161 and rvs167 mutants were originally isolated based
on their inability to maintain viability when starved of a source
of nitrogen, carbon, or sulfur. For example, rvs161 cells grown
to stationary phase in glucose-limited or nitrogen-limited me-
dium and then left in the depleted medium for 60 h exhibit only
20 and 65% viability, respectively. In contrast, wild-type cells
subjected in the same way to either glucose or nitrogen star-
vation maintain close to 100% viability. A similar loss of via-
bility under starvation conditions has been shown for rvs167
cells. In nitrogen- or glucose-limited minimal medium, 90 to
100% of wild-type cells arrest without buds after 50 h. In
contrast, under each condition 20% of rvs161 cells still ex-
hibit a bud. Again, a similar defect in starvation-induced cell
cycle arrest was found for rvs167 cells. Hence, under starvation
conditions rvs mutants still attempt to transit the cell cycle and
likely die as a consequence of their failure to arrest (12, 42).
Small GTPases of the Ras family regulate response to star-
vation in yeast. They do this by regulating adenylyl cyclase
activity and production of the second messenger cyclic AMP
(282). Yeast mutants with constitutively activated Ras exhibit
reduced viability upon starvation and an inability to mount a
normal physiological response to nutrient deprivation similar
to rvs mutants. Wild-type yeast cells accumulate the storage
carbohydrate glycogen when starved (177). One characteristic
of the constitutively activated ras phenotype is the failure to
accumulate glycogen upon glucose starvation (185, 325, 329).
Can rvs mutant cells accumulate glycogen when nutrients be-
come limiting, e.g., when cultures reach stationary phase and
the cells cease growth? When they reach stationary phase both
rvs161 and rvs167 mutant cells do indeed accumulate glycogen
normally (12, 42, 53). This suggests the defect in rvs mutant
cells is distinct from that in hyperactivated ras mutants or
mutants in which adenylyl cyclase activity is constitutive. The
molecular basis of the defect in response to starvation in rvs
mutants is not yet known.
Growth sensitivity to salt (especially Na). rvs mutants are
not only sensitive to starvation. They are also more sensitive to
a range of other stresses that include the presence of high
concentrations of various salts (e.g., NaCl, KCl, MgCl2, and
Na2SO4) in the medium. This sensitivity is to salt rather than to
osmotic strength, because rvs mutants are not sensitive to sor-
bitol at high osmotic strength. Moreover, there is selectivity for
certain cations. For example, rvs161 mutants exhibit morpho-
logical defects at fivefold lower concentrations of NaCl (0.25
M) than of KCl (1.2 M) while wild-type cells are unaffected by
either salt. Furthermore, rvs161 mutants are no more sensitive
to LiCl than wild-type cells (although both are sensitive) (42).
In this review the rvs salt sensitivity will be referred to as Na
sensitivity to reflect this. The molecular basis of the enhanced
sensitivity of rvs mutants to Na is not known.
Growth sensitivity to cytotoxic compounds. The growth of
both rvs161 and rvs167 mutants is hypersensitive to the pres-
ence of various cytotoxic compounds, including 3-amino-1,2,4-
triazole (3-AT) and canavanine (12, 42). 3-AT is a histidine
biosynthesis inhibitor that induces an artificial starvation re-
sponse when added to cells. Canavanine is an arginine analog
that can be incorporated into proteins in place of arginine and
produce nonfunctional proteins. Yeast mutants defective in
ubiquitin-mediated proteolysis are especially sensitive to cana-
vanine and overexpression of ubiquitin confers canavanine re-
sistance (32, 115). In addition, rvs161 cells have been reported
to be hypersensitive to the effects of sinefungin, which com-
pletely blocks growth of rvs161 cells at 0.1 M (rvs167 cells
were not tested) (42). Sinefungin is a toxic analog of S-adenosyl-
methionine that inhibits methylation reactions. In yeast, sine-
fungin has recently been shown to inhibit methylation of
guanosine to form m7GpppN, which is used to cap the 5 end
of mRNAs. Capping of mRNAs is in turn important for
mRNA stability and efficient translation (36). Whether hyper-
sensitivity to these compounds is specific or reflects a general
hypersensitivity of rvs161 and rvs167 cells to all cytotoxic com-
pounds is not known.
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Growth sensitivity to elevated temperature. The standard
growth temperature for budding yeast is 30°C. Elevated tem-
perature presents a stress to yeast cells and while wild-type
cells continue to grow well at 37°C they stop dividing at 42°C.
Yeast mutants with constitutively activated ras mutations ex-
hibit not only reduced viability upon starvation, but also an
inability to grow at normal temperature after a short heat
shock at 55°C. In contrast, rvs161 and rvs167 mutant cells both
survive heat shock at 55°C. In two reports, rvs161 cells did not
exhibit defects in growth at low (e.g., 15°C) or normal (28°C)
temperature and neither rvs161 nor rvs167 cells exhibit defects
in growth at elevated (e.g., 36°C) temperature (12, 42).
The ability of rvs161 and rvs167 cells to grow at elevated
temperature may be dependent on genetic background or the
accumulation of second-site suppressor mutations. In a some-
what different genetic background rvs161 and rvs167 cells did
not grow at 37°C (215). Exposure to elevated temperature
causes induction of heat shock proteins (HSP) which aid in the
refolding of damaged proteins. However, HSP induction upon
exposure to elevated temperature was found to be normal in
rvs167 mutant cells (12). rvs mutants are not sensitive to all
environmental stresses, e.g., rvs161 and wild-type yeast cells
are equally resistant to extremes of pH (12, 42).
Growth on nonfermentable carbon sources. Both rvs161 and
rvs167 mutants grow well on a range of fermentable carbon
sources (e.g., glucose, galactose, mannose, and sucrose), but
are unable to grow on nonfermentable carbon sources (e.g.,
glycerol, lactate, or acetate) (12, 42). An inability to utilize
nonfermentable carbon sources suggests a possible mitochon-
drial defect. These carbon sources are metabolized in mito-
chondria (370). rvs161 mutant cells possess a normal spectrum
of mitochondrial cytochromes, but respire threefold more
slowly than wild-type cells as measured by oxygen consump-
tion. It is not clear, however, whether this level of respiratory
defect is sufficient to fully account for the observed failure to
utilize nonfermentable carbon sources. Defects in glycerol uti-
lization are a common phenotype of mutations that affect the
actin cytoskeleton, but the molecular basis for the defect is still
unclear. Mitochondrial defects alone cannot account for the
Rvs phenotype since deletions in the mitochondrial genome
([rho]) that abolish growth on nonfermentable carbon
sources do not give rise to the other Rvs phenotypes such as
reduced viability upon starvation (12, 42).
Meiosis and sporulation. In the laboratory, budding yeast
cells can be maintained as either stable diploids or stable
haploids. Diploid yeast cells can be induced to undergo sporu-
lation (meiosis) by nitrogen starvation on nonfermentable car-
bon sources. Sporulation has been well studied in yeast be-
cause it represents a cellular differentiation process that can be
studied in budding yeast and that may have molecular mech-
anisms in common with more complex cellular differentiation
pathways used in vertebrate development. Sporulation involves
switching off the expression of blocks of genes required for
vegetative growth and initiating a developmental program in
which spore-specific genes are expressed in a highly regulated
pattern. In addition to meiosis, sporulation also involves de
novo bilayer membrane biogenesis to form the plasma mem-
brane of the resultant haploid cell and also cell wall biogenesis
to form the spore wall.
Desfarge et al. reported that homozygous rvs161/rvs161 dip-
loid cells do not sporulate upon nitrogen starvation (53). Sub-
sequently, Colwill et al. showed that rvs167/rvs167 homozygous
diploid cells, although not entirely compromised for sporula-
tion, form spores with only 10% the frequency of wild-type
diploids (38). rvs/rvs homozygous diploids may not sporulate
because they are unable to utilize the nonfermentable carbon
source provided or because they lose viability upon nitrogen
starvation. The sporulation defect in these mutants could be
indirect. However, genetic interaction studies have suggested
that the Rvs proteins play a direct role in sporulation (53)
(discussed below). The molecular mechanisms that underlie
this defect have yet to be elucidated.
Heterogeneous cell size and morphology upon starvation or
exposure to Na. Although rvs161 and rvs167 mutant cells
exhibit the relatively uniform size and ellipsoid shape of wild-
type cells under optimal growth conditions, when starved or
exposed to Na (or the cytotoxic compounds referred to
above) cultures of both rvs161 and rvs167 cells accumulate a
high proportion of cells that are either grossly enlarged with
swollen vacuoles or abnormally tiny. Some mother cells also
have multiple buds. Each bud has a nucleus but is apparently
unable to complete cytokinesis and separate from the mother cell
(12, 42). In wild-type yeast, there is a minimum cell size that is
required at Start for commitment to a new cell division cycle
(137). The rvs mutations appear to compromise this cell cycle
regulation with under-sized mother cells continuing to divide.
Loss of actin cytoskeleton polarization to sites of polarized
growth. Yeast cells possess an actin cytoskeleton comprising
filamentous actin (F-actin) and a diverse set of actin-associated
proteins (71, 213, 371). Yeasts express orthologs of many,
although not all, vertebrate actin-associated proteins, including
the Arp2/3 complex and its activators, both conventional (fil-
ament forming) and unconventional myosins, profilin, tropo-
myosin, fimbrin, capping protein, and cofilin. When yeast cells
are stained with fluorophore-conjugated phalloidin (an F-
actin-specific reagent) several distinct structures are visible.
Actin patches are small highly motile spots located at or near
the cortex. Actin cables are long thick fibers comprising bun-
dled actin filaments that extend through the cortical cytoplasm.
Although individual actin patches and actin cables turn over,
patches and cables are visible throughout the cell cycle.
Dividing yeast cells display a third F-actin structure known as
the contractile actomyosin ring (16, 178). This ring structure lo-
calizes at the neck between the mother cell and bud. Contraction
of the actomyosin ring occurs during cytokinesis and is accompa-
nied by deposition of new cell wall material (septum). Septum
deposition eventually separates the cytoplasm of the mother cell
and bud and cleavage of the septum allows cell separation.
During the cell division cycle, the distribution of actin patches
and actin cables changes. Immediately prior to bud emergence,
cables align with their tips focused at the nascent bud site and
patches concentrate at this site. When the bud starts to emerge,
the cables align with their tips inside the growing bud and the
patches localize at the bud tip. In G2 the actin patches remain
polarized to the bud but switch from a polarized to an isotropic
distribution within the bud. After the switch the bud expands
laterally as well as at the tip. During mitosis actin is recruited to
the actomyosin ring, cables become randomly oriented, and
patches distribute randomly throughout the mother cell and bud.
Finally, upon exit from mitosis the patches in the mother cell and
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bud repolarize to either side of the bud neck and cables in the
mother cell and bud realign with their tips focused to the bud
neck. At this stage of the cell cycle the actomyosin ring contracts
to a dot, septum is deposited and cleaved, and the cells divide.
The newly divided mother and daughter cells transiently retain
polarized actin patches and cables, and then polarity is lost until
a new bud site is selected (16, 178, 371).
When rvs161 and rvs167 mutant cells were first stained to
visualize F-actin it was apparent that the actin cytoskeleton in
these cells was abnormal. Actin patches were not as polarized
at nascent bud sites and growing buds. Actin cables were more
difficult to visualize and appeared less well aligned than those
in wild-type cells. When rvs161 or rvs167 mutant cells were
exposed to high levels of salt (e.g., NaCl) or starved, the loss of
actin cytoskeleton polarity became complete. Under both
stress conditions actin cables disappeared completely and actin
patches depolarized fully (12, 298).
Delocalized cell wall chitin deposition. In wild-type yeast
cells the cell wall polysaccharide chitin is specifically depos-
ited at the site of bud formation during both bud emergence
and bud growth, and to seal the scar after separation of the
mother cell and the bud. In rvs167 mutant cells, however,
staining of chitin with Calcofluor and microscopic examina-
tion reveal that chitin is not restricted to sites of active bud
formation and at scars from previous budding events. There
appears to be an accumulation of chitin distributed evenly
throughout the cell wall and this defect is exacerbated by the
presence of a sublethal concentration of Na in the growth
medium (12, 84a).
Loss of bipolar bud site selection. Yeast cells do not bud
randomly. After a bud has emerged from a mother cell, a
scar made of chitin is left on the surface of both mother (bud
scar) and daughter (birth scar). These scars are permanent
and can be visualized by use of the fluoresent stain Cal-
cofluor. Bud scars on mother cells accurately record all sites
where previous buds have emerged. In wild-type haploid
cells, the bud sites are visualized as a cluster at one pole of
the cell in an “axial” pattern, which is generated when bud-
ding occurs in new mothers at a site adjacent to the birth
scar and in old mothers at a site adjacent to the previous bud
scar. In diploid cells the bud sites form clusters at both poles
of the cell in a “bipolar” pattern, which is generated when
budding occurs in new mothers at a site on the opposite pole
to the birth scar and in old mothers at a site that alternates
between opposite cell poles.
Mutant studies have shown that the requirements for axial
and bipolar bud site selection are distinct. Mutations in the
genes BUD1, BUD2, and BUD5 cause haploid cells to bud at
random sites, while mutations in BUD3 and BUD4 cause hap-
loid cells to bud in a bipolar pattern (29, 30). So some genes
are required for axial budding and some for all patterns of
budding. Interestingly, RVS161 and RVS167 were among the
first genes discovered that are specifically required for bipolar
bud site selection. Haploid rvs161 and rvs167 mutant cells bud
in an axial pattern like wild-type cells. However, rvs161/rvs161
and rvs167/rvs167 homozygous mutant diploids bud at random
sites (12, 53, 65, 298). The defect is not specific to diploid cells,
but to the process of bipolar bud site selection. When haploid
cells are induced to undergo bipolar budding (e.g., by mutation
of BUD3 or BUD4) additional mutation of RVS161 or RVS167
results in random budding (65).
It is possible that spatial landmarks at the cell poles are not
formed properly in rvs161 or rvs167 mutant cells. This would
mean that when the next division ensues the cell can no longer
“remember” where the previous bud formed to place the next
bud site appropriately. Alternatively, spatial landmarks may be
formed in rvs mutant cells, but not recognized or interpreted
correctly. Subsequently, a close correlation has been estab-
lished between those mutations that affect actin patch polar-
ization and those that abolish bipolar bud site selection (375).
Defective fluid-phase and receptor-mediated endocytosis.
Endocytosis is the process by which cells internalize plasma
membrane material as well as ligands, particles, and fluid from
the extracellular environment via invagination of the plasma
membrane and formation of endocytic vesicles. To identify
genes important for endocytosis, Riezman and colleagues con-
ducted a screen for yeast mutants unable to internalize plasma
membrane receptor-ligand complexes. A bank of random yeast
mutants was screened using an assay for receptor-mediated
internalization of -factor, the peptide ligand secreted by hap-
loid yeasts of the  mating type. One of several mutants re-
covered from this screen carried a mutation in ENDocytosis-
defective 6 (END6). Isolation and characterization of the
END6 gene showed that END6 is identical to RVS161 and that
the end6 mutation affects polarization of the actin cytoskeleton
as observed for rvs161. A previously isolated rvs167 mutant
was also blocked in internalization of -factor. Hence, efficient
receptor-mediated endocytosis in budding yeast requires both
Rvs161p and Rvs167p. Uptake and accumulation in the vacu-
ole of the membrane-impermeant fluid-phase endocytic dye
lucifer yellow are also blocked in both rvs161 and rvs167 mu-
tant cells (215).
Inefficient cell-cell fusion during mating. Haploid budding
yeast cells exist in two mating types, a (MATa) and  (MAT),
that have an identical physical appearance. MATa cells se-
crete a peptide pheromone known as a-factor that binds to
the a-factor receptor (a G-protein-coupled receptor called
Ste3p) expressed only by MAT cells. Conversely, MAT
cells secrete a peptide pheromone known as -factor that
binds to the -factor receptor (a G-protein-coupled recep-
tor called Ste2p) expressed only by MATa cells. Binding of
each pheromone to its receptor activates a mitogen-acti-
vated protein kinase signal transduction cascade that has
two main readouts. First, cell cycle progression is arrested in
G1 to ensure that each mating cell has a normal 1C DNA
content in preparation for nuclear fusion. Second, expression
of various proteins specifically required for mating is induced,
e.g., proteins that promote cell-cell adhesion and fusion (41,
365).
During mating, each haploid cell chooses a mate from the
surrounding cells based on the level of pheromone each cell
secretes. Yeast cells are able to detect gradients of phero-
mone with extraordinary sensitivity and form a tube-like
projection at their surface known as a mating projection or
shmoo. This projection grows up the gradient to the source
of pheromone, i.e., towards the cell that produces the high-
est level. When mating yeast cells are treated with synthetic
mating pheromone they mate at random with cells of the
opposite mating type even if those cells produce no phero-
mone. This behavior, known as “default” mating, is approx-
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imately 10-fold less efficient than normal pheromone gradi-
ent mating. Supersensitive 2 (sst2) mutants are hypersensitive
to endogenous pheromone and are consequently unable to
accurately detect subtle pheromone gradients. They mate by
default with random partners even in the presence of endog-
enous pheromone gradients (56).
In a search for mutants defective in default mating, candi-
date mutants were tested for their ability to mate with a
“pheromoneless” partner in the presence of synthetic phero-
mone. One of the mutants tested was rvs161. Earlier work
had shown rvs161 sst2 double mutants (which mate by default
due to sst2) mate extremely inefficiently. Indeed, the rvs161
mutant was specifically defective in default mating since
rvs161 and wild-type cells mated with efficiency similar to that
of wild-type cells of the opposite mating type (56).
In an independent study, a screen was performed for mu-
tants defective in mating (using endogenous pheromone) but
only when both parents carry the mutation (i.e., bilateral mat-
ing defect) (158). One such mutation blocked mating at the
stage of cell-cell fusion and was named fusion 7 (fus7) (91).
Further work showed fus7 is a mutation in RVS161 (21). The
mating defect of rvs161 cells was not apparent in the study of
Dorer et al. (56) because only mating of rvs161 cells to wild-
type cells was tested (which only detects unilateral mating
defects). Interestingly, rvs167 cells do not exhibit a mating
defect in either test, one case where rvs161 and rvs167 cells
differ in phenotype.
Rvs161p and Rvs167p Structure-Function Relationships
The diverse range of phenotypes displayed by rvs161 and
rvs167 mutants suggested that Rvs161p and Rvs167p are mul-
tifunctional proteins. In the case of Rvs167p, which comprises
three distinct domains, each domain may confer different bio-
logical activities. Two studies investigated structure-function
relationships in Rvs167p (38, 299). In the first study the ability
of various truncated Rvs167p constructs, each lacking one or
more Rvs167p domains, to complement the phenotypes of
rvs167 was examined, i.e., viability upon glucose starvation,
growth in the presence of Na or 3-AT, and utilization of a
nonfermentable carbon source. The BAR domain alone was
sufficient to rescue each phenotype tested, although less effi-
ciently than full-length Rvs167p. In contrast, a fragment com-
prising only the GPA-rich and SH3 domains did not rescue any
of the phenotypes (299).
The ability of the various truncated Rvs167p fragments to
rescue the loss of actin cables and depolarization of actin
patches in rvs167 mutant cells exposed to a sublethal concen-
tration of Na was also examined. In general, the same
Rvs167p fragments that were functional in growth assays were
also able to rescue the actin cytoskeleton defects, i.e., the BAR
domain alone was able to correct the actin cytoskeleton de-
fects, but rescue by the BAR domain was not as complete as
rescue by full-lengthRvs167p. The fragment comprising the
GPA-rich and SH3 domains was not able to correct the actin
cytoskeleton defects. Expression of the BAR domain alone
restored bipolar bud site selection in 75% of rvs167/rvs167
homozygous diploid cells but full rescue of bipolar budding
required full-lengthRvs167p. The GPA-rich and SH3 domain
fragment did not rescue bipolar bud site selection (299).
In a later study, various Rvs167p constructs were tested for
their ability to restore growth in the presence of Na, bipolar
bud site selection, fluid-phase endocytosis, and sporulation to
cells lacking Rvs167p (rvs167). In addition to a truncated
Rvs167p construct lacking an SH3 domain (BAR-GPA), this
study also employed a full-length Rvs167p construct featuring
a P473L substitution in the SH3 domain that abolishes binding
to proline-rich motifs. Unlike the BAR-GPA fragment, the
full-length P473L mutant construct was expressed at the same
steady-state level as full-length Rvs167p and fully rescued all
rvs167 defects. This study concluded that Rvs167p is fully
functional without a functional SH3 domain if expressed at
normal levels.
Do the GPA-rich and SH3 domains contribute to Rvs167p
function? The GPA-rich and SH3 fragment (GPA-SH3) did
not rescue growth in the presence of Na, bipolar bud site
selection, or endocytosis, but unexpectedly was able to fully
rescue the sporulation defect of rvs167. The SH3 domain
alone was also able to rescue the sporulation defect, showing
that the SH3 domain was sufficient for this function (38).
The BAR domains of Rvs161p and Rvs167p are highly
homologous. Sivadon et al. tested the effect of swapping the
BAR domains. The Rvs167p GPA-rich and SH3 domains were
fused to Rvs161p to create an artificial Rvs167p-like protein
(Rvs161p-GPA-SH3). The fragment of Rvs167p comprising
the BAR domain only was used as the corresponding Rvs161p-
like protein (Rvs167p-BAR). Rvs161p-GPA-SH3 retained full
ability to rescue the growth, actin cytoskeleton, and bud site
selection defects of rvs161, but did not rescue these defects in
rvs167 cells. Rvs167p-BAR was partially functional in rescuing
the phenotypes of rvs167 cells, but it lacked the ability to rescue
the defects of rvs161 cells. Nor could Rvs167p-BAR and
Rvs161p-GPA-SH3 when coexpressed rescue the growth, actin
cytoskeleton, or bud site selection defects in rvs161 rvs167
double mutant cells (299). Clearly, the two BAR domains have
important differences.
Enforced overexpression of Rvs167p from a strong pro-
moter induces lethality at normal growth temperature. In con-
trast, overexpression of the GPA-SH3 construct does not affect
growth. However, the SH3 domain is important for the over-
expression phenotype of full-length Rvs167p. Overexpression
of the full-length P473L mutant has milder deleterious effects
than wild-type Rvs167p and these only become apparent at
elevated temperature (38). The mechanism by which Rvs167p
overexpression inhibits growth is not known. Consistent with
an important function for the Rvs167p SH3 domain, a recent
study identified conditions under which the Rvs167p SH3 do-
main becomes important for growth (84a).
Rvs Proteins Localize to the Cortical Actin Cytoskeleton
Subcellular localization of Rvs161p and Rvs167p. Where do
Rvs161p and Rvs167p localize in the cell? Rvs161p and
Rvs167p interact with each other and there is compelling
evidence that these two proteins function as a heterodimer
in most, if not all, of their various cellular functions (18, 38,
97, 180, 220). Indeed, as discussed above, in the absence of
either Rvs protein the other is unstable and is degraded
(180). Paradoxically, Rvs161p and Rvs167p appear to ex-
hibit somewhat distinct subcellular localizations in live cells
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FIG. 2. Subcellular localization of Rvs161p in growing and mating yeast cells. A. Shown are budding yeast cells that express fusion proteins that
comprise full-length Rvs161p fused to the fluorescent reporter Aequoria victoria green fluorescent protein (GFP). The same fields of cells were
viewed by fluorescence optics (left) to visualize GFP and by differential interference contrast optics (right) to visualize the cell profiles. In panels
A to J, M, and N the cells express Rvs161p-GFP with the reporter fused at the Rvs161pC terminus. In panels K and L the cells express
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when fused to the green fluorescent protein (GFP) for vi-
sualization by fluorescent imaging. It should be noted, how-
ever, that fusion to GFP alters the subcellular distribution of
some proteins, so differences may reflect differences in the
ability of Rvs161p and Rvs167p to tolerate fusion to GFP
without perturbing their subcellular localization rather than
differences between Rvs161p and Rvs167p in subcellular
localization per se.
In growing cells a fusion protein comprising Rvs161p and
GFP (Rvs161p-GFP) was reported to exhibit a predominantly
diffuse cytoplasmic distribution in cells without buds (Fig. 2A).
In cells with small buds Rvs161p-GFP localized to patches at
the bud neck, but these patches were no longer apparent in
large buds. Expression of Rvs161p-GFP fully rescued the cell
fusion defect of an rvs161 mutant (see below), suggesting this
fusion protein is functional (at least in cell fusion). This study
focused on the role of Rvs161p in cell fusion during mating, so
the ability of this fusion protein to rescue other rvs161 defects
was not tested. Both N- and C-terminal Rvs161p fusions to
GFP exhibited the same subcellular distribution (21). A more
recent report demonstrated localization of a similar Rvs161p-
GFP fusion protein to numerous small cortical patches (Fig.
2B). These patches exhibited polarization to nascent bud sites
and small buds during bud emergence and to the bud neck in
dividing cells. However, this particular Rvs161p-GFP fusion
protein was not able to rescue the defects of an rvs161 mu-
tant, so it is nonfunctional (10).
A very recent report described the subcellular localization
of an apparently fully functional Rvs161p-GFP fusion pro-
tein (144). This Rvs161p-GFP fusion localized to cortical
actin patches but also exhibited a strong diffuse cytoplasmic
distribution. Cortical actin patches are larger and less nu-
merous than the patches to which the nonfunctional
Rvs161p-GFP fusion used by Balguerie et al. localizes (10).
Localization of Rvs161p-GFP to cortical actin patches is
F-actin dependent, since localization to patches is abolished
by depolymerization of all F-actin by treatment with latrun-
culin A (144). Confirmation of the subcellular distribution
of native (untagged) Rvs161p by immunofluorescence stain-
ing with Rvs161p-specific antisera has not yet been reported.
This may be due to the extreme sensitivity of Rvs161p an-
tigenicity and/or subcellular localization to chemical fixation
(our unpublished data).
An Rvs167p-GFP fusion protein localizes in vegetatively
growing cells to cortical actin patches (Fig. 3). The Rvs167p-
GFP fusion protein was able to fully rescue the various defects
of rvs167 cells and hence appears to be functional (11). This
gives one confidence that this fusion protein displays an au-
thentic Rvs167p subcellular localization. Double labeling of
F-actin and Rvs167p-GFP shows that most patches that con-
tain F-actin also contain Rvs167p-GFP and vice versa, al-
though the relative signal intensity of the two proteins varies
from one patch to another (11). This difference may reflect the
age of the patch, since a number of studies have shown that the
protein composition of an individual patch can vary during its
lifetime (132, 139, 143, 144).
The distribution of Rvs167p-GFP patches changes as cells
progress through the cell cycle exactly as for actin patches.
Rvs167p-GFP specifically associates with actin patches and has
not been observed to localize to other F-actin structures such
as actin cables. Localization of Rvs167p is predominantly in-
dependent of F-actin, as disassembly of all F-actin in cells by
treatment with the actin polymerization inhibitor latrunculin A
does not abolish Rvs167p localization to cortical patches (11).
A recent study reported, however, that loss of F-actin appears
to cause a partial redistribution of Rvs167p from cortical
patches, as there is an apparent increase in diffuse cytoplasmic
Rvs167p after latrunculin A treatment (144).
Interactions between Rvs167p and actin patch proteins.
How does Rvs167p localize to actin patches? As loss of
Rvs161p does not perturb actin patch localization of Rvs167p,
it seems unlikely that interaction with Rvs161p mediates actin
patch localization of Rvs167p (11).
Does Rvs167p associate with actin? In one study a two-
hybrid screen was performed to identify actin-interacting
proteins and a fragment encoding the Rvs167p SH3 domain
was recovered. Hence, there is some evidence Rvs167p as-
sociates with actin. The Rvs167p-actin interaction requires
the Rvs167p SH3 domain since deletion of the SH3 domain-
encoding sequence abolishes the two-hybrid interaction (4).
SH3 domains interact with short proline-rich motifs (e.g.,
PXXP) (331). The actin sequence contains only a single
motif (PMNP) that might mediate SH3 domain interaction.
Subsequently, it was proposed that the Rvs167p-actin inter-
action is indirect (38, 176, 180). A third protein might bind
actin directly and contain proline-rich motifs that then bind
the Rvs167p SH3 domain.
Systematic “charged-to-alanine” scanning mutagenesis of the
yeast ACTin gene (ACT1) has been performed (363). Charged
residues predicted to be surface exposed and potentially able to
engage in interactions with other proteins were replaced singly
and in clusters with uncharged alanine residues and a collection
of 35 act1 mutations was generated. These act1 mutants vary in
phenotype (e.g., some are inviable and others are without obvious
GFP-Rvs161p with the reporter fused at the Rvs161pN terminus. Panels A to F show vegetatively growing cells, panels G and H show cells arrested
in G1 and forming mating projections after pheromone treatment, and panels I to N show mating cells. In pheromone-treated cells Rvs161p-GFP
concentrates at the tip of the mating projection (shmoo) and in mating cells Rvs161p-GFP and GFP-Rvs161p concentrate at the site of cell-cell
fusion. In vegetatively growing cells Rvs161p-GFP exhibits a diffuse cytoplasmic distribution and is excluded from the vacuole (large indentation
apparent in the cell profiles). (Reproduced from reference 21 by copyright permission of The Rockefeller University Press.) B. Shown are
vegetatively growing budding yeast cells that express a fusion protein (Rvs161p-GFP) that comprises full-length Rvs161p with GFP fused at the
Rvs161pC terminus. The same fields of cells were viewed by fluorescence optics (center and right columns) to visualize GFP and by differential
interference contrast (left column) to visualize the cell profiles. For each field of cells two focal planes were viewed by fluorescence optics: an
equatorial view (center column) and a top view (right column). A, an unbudded cell; B, a cell at an early stage of bud emergence; C, cells
undergoing cell division (cytokinesis). This Rvs161p-GFP fusion protein localizes to numerous small cortical patches. (Reprinted with permission
from reference 10.)
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phenotype). Two-hybrid analysis using these 35 mutant act1 genes
and a panel of actin-interacting proteins revealed that different
interactions are affected by different act1 mutations. Unexpectedly,
all those act1 mutations that abolish interaction with Rvs167p also
abolish interaction with another actin-binding protein, profilin.
Conversely, the act1 mutations that do not affect interaction with
profilin do not affect interaction with Rvs167p (4). So either
Rvs167p binds to actin in the same way as profilin (i.e., makes the
same contacts) or Rvs167p binds to profilin and the Rvs167p-actin
interaction is indirect and mediated by profilin. To date, interaction
between Rvs167p and profilin has not been demonstrated.
One actin patch component that has been proposed to mediate
actin-Rvs167p interaction is Abp1p, encoded by the Actin Binding
Protein 1 (ABP1) gene. Abp1p was first identified biochemically
as a protein that binds with high affinity to F-actin in vitro (60).
The Rvs167p SH3 domain recognizes Abp1p in a Far-Western
blot and in two-hybrid screens. Consistent with a model that
Abp1p contributes to Rvs167p function in vivo, loss of Abp1p
results in defects in sporulation, growth in the presence of Na,
and growth on nonfermentable carbon sources, similar to but
weaker than defects associated with loss of Rvs167p. Abp1p and
Rvs167p also exhibit functional redundancy with the same set of
proteins (i.e., with Sla1p, Sla2p, and Sac6p). Moreover, loss of
Rvs167p reduces the deleterious effect of Abp1p overexpression
on growth and cell morphology, which suggests that the deleteri-
ous effect of Abp1p overexpression requires an intact Rvs167p-
Abp1p complex (38, 176). A recent study identified conditions
under which Rvs167p-Abp1p interaction becomes important for
vegetative growth (84a).
Despite the appeal of models in which Abp1p recruits
Rvs167p into actin patches via interaction with the Rvs167p
SH3 domain, experimental evidence suggests other mecha-
nisms must also exist: deletion of ABP1 (abp1) does not affect
Rvs167p localization to actin patches (11), two-hybrid interac-
FIG. 3. Subcellular localization of Rvs167p in growing and mating yeast cells. Shown are budding yeast cells that express a fusion protein
(Rvs167p-GFP) that comprises full-length Rvs167p with GFP inserted between the BAR and GPA-rich domains of Rvs167p. The same fields of
cells were viewed by fluorescence optics (right) to visualize GFP and by differential interference contrast (left) to visualize the cell profiles. A,
unbudded cell; B, cell at an early stage of bud emergence; C, cell with small bud; D, cell with large bud; E, cells undergoing division (cytokinesis);
F, cells arrested in G1 and forming a mating projection (shmoo) after pheromone treatment (only one cell expressing Rvs167p-GFP is depicted
in this panel). In vegetatively growing cells Rvs167p-GFP localizes to large cortical patches that polarize to nascent bud sites, small buds, and the
bud neck during cell division (cytokinesis). In mating cells Rvs167p-GFP concentrates at the tip of the mating projection (shmoo). (Reprinted from
reference 11 with permission of the Company of Biologists Ltd.)
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tion between the Rvs167p SH3 domain and actin does not
require Abp1p (180), the act1 two-hybrid data suggest that
Rvs167p interaction with actin is mediated by a protein that
binds monomeric actin (e.g., profilin) while Abp1p is an F-
actin binding protein, localization of Rvs167p to cortical
patches does not require F-actin, the SH3 domain of Rvs167p
alone does not associate with actin patches in vivo, and the
SH3 domain of Rvs167p is not essential for localization to actin
patches (11, 38). Abp1p may function in Rvs167p localization
to actin patches, but its role may be redundant with that of
other proteins (see Table 1 for a list of other cortical actin
patch proteins known to interact with Rvs167p).
There is evidence that the BAR and SH3 domains of
Rvs167p both contribute to its actin patch localization. For
example, a fragment comprising only the Rvs167p BAR do-
main localizes poorly to cortical actin patches, while the
Rvs167p SH3 domain shows no localization to actin patches. In
contrast, the full-length protein containing the BAR and SH3
domains localizes efficiently to actin patches (11). Perhaps
other actin patch components mediate recruitment of Rvs167p
to actin patches via interactions with the BAR domain. Possi-
ble candidates are the products of three genes, synthetic lethal
with abp1 1 (SLA1) and SLA2 and suppressor of ras Val19 2
(SRV2), which localize to actin patches and have functions
redundant with that of Abp1p (126, 176).
Sla1p associates with Rvs167p in vivo and directly binds via
multiple domains to recombinant Rvs167p in vitro, but the
Rvs167p domain that mediates these interactions is not yet
known (59, 123, 307). Interestingly, Sla2p possesses a coiled-
coil domain (coil1) that has been reported to interact with the
Rvs167p BAR domain. Furthermore, the Sla2p coil1 domain
has a function important for growth, actin patch polarization,
and endocytosis. Intriguingly, however, this function of coil1 is
fully redundant with a function mediated by Abp1p (or Srv2p),
i.e., the Sla2p coil1 mutant phenotypes only become apparent
in cells that lack Abp1p (or Srv2p) (364). Interactions of the
Rvs167p BAR domain with Sla2p coil1 and the Rvs167p SH3
domain with Abp1p may work in concert to facilitate Rvs167p
localization to actin patches.
The Rvs167p SH3 domain may also recruit actin monomers
to patches via interaction with other actin patch components
such as Local Anaesthetic Sensitive 17 (Las17p, also known
as Bee1p) and Very Rich in Proline 1 (Vrp1p, also known as
End5p or verprolin) (Table 1). Las17p is the yeast ortholog of
human Wiskott-Aldrich syndrome protein (WASp) that is mu-
tated in patients with the inherited immunodeficiency (8). Both
WASp in mammals and Las17p in yeast are implicated in de
novo assembly of actin monomers into actin filaments by a
highly conserved seven-subunit complex known as the Arp2/3p
complex (119, 372). Vrp1p is the yeast ortholog of human
WASp-interacting protein (WIP), a protein identified by two-
hybrid screens with WASp. Vrp1p and Las17p in yeast interact
analogous to WASp and WIP in mammals (181, 219).
Consistent with a possible role for Vrp1p in recruitment of
Rvs167p to actin patches, loss of VRP1 (vrp1) displays exactly
the same pattern of negative genetic interactions with the yeast
myosins (Myo1p-Myo5p) as loss of Rvs167p (see below) (19,
275). However, Rvs167p must retain significant function in
cells lacking Vrp1p even if its localization to actin patches is
affected, since additional loss of Rvs167p (rvs167) dramati-
cally affects the growth of vrp1 mutants (las17 was not
tested). Interestingly, additional loss of Rvs161p (rvs161) did
not have any obvious effect on the growth of vrp1 cells
(las17 was not tested) (275). Hence, Vrp1p may be required
for all cellular functions of Rvs161p, which would be consistent
with a possible role in Rvs161p localization to actin patches.
Interestingly, in the fission yeast Schizosaccharomyces pombe
there is recent evidence that the Las17p ortholog (Wsp1p) is
required for actin patch localization of the Rvs167p ortholog
(Hob1p) (131).
An interesting possibility that has not yet been explored is
that Vrp1p and/or Las17p mediates the two-hybrid interaction
of Rvs167p with actin (4). Rvs167p interacts with both Las17p
and Vrp1p via its C-terminal SH3 domain (38, 181, 331; our
unpublished data). Both Vrp1p and Las17p possess actin
monomer binding WASP Homology 2 (WH2) domains. Al-
though the contacts that WH2 domains make with actin are
not yet known, they may resemble the contacts that profilin
makes with actin, since both WH2 domains and profilin bind
specifically to actin monomers. If correct, this would account
for the observation that actin mutations that perturb profilin
binding also perturb Rvs167p binding (4).
Roles of Rvs161p and Rvs167p in Endocytosis
Rvs161p and Rvs167p in receptor-mediated internalization
of -factor. In vertebrates, receptor endocytosis occurs at spe-
cific sites on the plasma membrane that bear a cytoplasmic
protein coat. This coat comprises the coat protein clathrin
(comprising heavy and light chains) and the clathrin coat as-
sembly factor known as the clathrin Associated (or Assembly)
Protein 2 (AP-2) adaptor. The assembly of clathrin coats on
the cytoplasmic face of the plasma membrane by the AP-2
adaptor generates clathrin-coated endocytic pits. Binding of
the AP-2 adaptor to the cytoplasmic tails of plasma membrane
receptors to be endocytosed concentrates the receptors in the
forming clathrin-coated pits. The conversion of an invaginated
clathrin-coated pit into a clathrin-coated vesicle is mediated by
the GTPase dynamin. Dynamin assembles into rings at the
neck of invaginated clathrin-coated pits, and hydrolysis of GTP
is accompanied by fission of the neck of the pit and the release
of a clathrin-coated vesicle into the cytoplasm. In vertebrates,
the Rvs161p and Rvs167p homolog amphiphysin has been
shown to function in endocytosis via recruitment of dynamin
from the cytoplasm to plasma membrane clathrin-coated pits.
Could rvs161 and rvs167 mutants perturb the recruitment of a
yeast dynamin to clathrin-coated pits?
In yeast cells, in contrast to vertebrates, receptor endocy-
tosis is predominantly independent of clathrin. Yeast cells in
which the single genes encoding clathrin heavy chain or
clathrin light chain are deleted continue to internalize -fac-
tor, although at a reduced rate (37, 235). A temperature-
sensitive clathrin mutant (chc1-ts) was constructed that can
be inactivated by a shift to elevated temperature. This mu-
tant was used to examine the acute effects of clathrin inac-
tivation on -factor endocytosis. Even in this study, only a
slower kinetics of -factor internalization and not a complete
block was observed (318). Furthermore, single and combined
deletions of the various genes encoding the subunits of the puta-
tive yeast equivalent of the AP-2 adaptor and related proteins
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TABLE 1. Comprehensive list of Rvs161p and Rvs167p interactors in budding yeasta
Group Gene Encoded protein Type(s) of interaction(reference[s])b Experimental evidence
Cytoskeleton
and polarity
ABP1c Actin Binding Protein involved in actin cytoskeleton
assembly and cell polarity establishmentc
7 (38, 59, 160, 176) Two-hybrid, peptide scanning
ACF2/PCA1 Actin Assembly Complementing Factor, intracellular
-1,3-endoglucanase
7 (59, 97, 160, 331) Two-hybrid, peptide scanning
ACF4 Actin Assembly Complementing Factor, molecular
function unknown
7 (59, 160, 331) Two-hybrid, peptide scanning
ACT1 Yeast ACT in 1 (19, 215), 7 (4, 19, 59, 180) Two-hybrid, synthetic lethal,
nonallelic noncomplementation
APP1 Actin Patch Protein, molecular function unknown 1 (18), 7 (18, 59, 160, 331) Two-hybrid, peptide scanning
ARP2 Actin-Related Protein, essential component of the
Arp2/3 complex
1 (332), 7 (160, 332) Two-hybrid, synthetic lethal (rvs161),
synthetic sick (rvs167)
BBC1 Protein possibly involved in assembly of actin patches;
interacts with actin assembly factor Las17p and with
the SH3 domains of type 1 myosins Myo3p and
Myo5p
1 (332), 7 (332) Synthetic sick
BSP1 Binding protein of Synaptojanin Polyphosphoinositide
phosphatase domain, adaptor that links synaptojanins
Inp52p (Sjl2p) and Inp53p (Sjl3p) to the cortical
actin cytoskeleton
7 (59, 160, 331) Two-hybrid, peptide scanning
CAP1 CAPping protein, binds to barbed ends of actin
filaments, preventing further polymerization
1 (332), 7 (332) Synthetic lethal
CAP2 CAPping protein, binds to barbed ends of actin
filaments, preventing further polymerization
1 (332), 7 (332) Synthetic lethal
CDC24 Cell Division Cycle, guanine nucleotide exchange factor
for Cdc42p
1 (136) Two-hybrid
CLA4 Protein serine/threonine kinase, homologous to Ste20p 1 (332), 7 (332) Synthetic sick
END3 ENDocytosis defect, EH domain-containing protein
involved in endocytosis, actin cytoskeletal
organization, and cell wall morphogenesis
1 (332), 7 (85, 332) Synthetic sick
EXO70 EXOcyst, 70-kDa subunit of exocyst complex 7 (18) Two-hybrid
GIM3 Gene Involved in Microtubule biogenesis, subunit of the
heterohexameric cochaperone prefoldin complex
1 (332), 7 (332) Synthetic sick
GIM4 Gene Involved in Microtubule biogenesis, subunit of the
heterohexameric cochaperone prefoldin complex
1 (332), 7 (332) Synthetic sick
GIM5 Gene Involved in Microtubule biogenesis, subunit of the
heterohexameric cochaperone prefoldin complex
1 (332), 7 (332) Synthetic lethal
LAS17 Yeast mutant that is Local Anesthetic Sensitive, yeast
WASp
1 (123), 7 (18, 38, 59, 97, 123,
136, 160, 181, 331)
Two-hybrid, peptide scanning,
ELISA, complex isolation, and
mass spectrometry
MYO1 Yeast type II MYOsin 1 (19), 7 (19) Synthetic lethal
MYO2 Yeast type V MYOsin 1 (19), 7 (19) Synthetic sick
MYO3 Yeast type I MYOsin 7 (331) Two-hybrid
MYO5 Yeast type I MYOsin 1 (332), 7 (331, 332) Two-hybrid, synthetic sick
PAC10 Protein required in the Absence of Cin8p, part of
heteromeric cochaperone GimC/prefoldin complex,
also called GIM2
1 (332), 7 (332) Synthetic lethal
RVS161 Reduced Viability upon Starvation 7 (18, 38, 59, 97, 123, 136, 180,
220, 339)
Two-hybrid, affinity purification,
complex isolation, and mass
spectrometry
Continued on facing page
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TABLE 1—Continued
Group Gene Encoded protein Type(s) of interaction(reference[s])b Experimental evidence
RVS167 Reduced Viability upon Starvation 1 (18, 38, 59, 97, 123, 136, 180,
220, 339), 7 (18, 180)
Two-hybrid, affinity purification,
complex isolation, and mass
spectrometry
SAC6 Suppressor of ACtin mutations, yeast fimbrin 1 (97), 7 (97, 176) Two-hybrid, synthetic lethal
SEC8 SECretory, essential 121-kDa subunit of the exocyst
complex
7 (18) Two-hybrid
SLA1 Synthetic Lethal with ABP1, protein required for
assembly of the cortical actin cytoskeleton
1 (123, 332), 7 (59, 85, 97, 123,
176, 307, 332)
Two-hybrid, Co-IP, affinity
purification, synthetic lethal,
complex isolation, and mass
spectrometry
SLA2 Synthetic Lethal with ABP1, protein required for
assembly of the cortical actin cytoskeleton
1 (97), 7 (59, 97, 176, 364) Two-hybrid, synthetic lethal
SUR7 SUppressor of Rvs167 1 (300, 381), 7 (300, 381) Genetic suppression
VRP1 Very Rich in Proline, yeast WASp-interacting protein 1 (123), 7 (123, 275, 331) Two-hybrid, synthetic sick, complex
isolation, and mass spectrometry
YKE2 Yeast nuclear gene encoding a protein showing
homology to mouse KE2 and containing a putative
leucine zipper motif
1 (332), 7 (332) Synthetic sick
YSC84 SH3 domain-containing protein with function unknown,
also called LSB4 (LaS17p-Binding)
7 (59) Two-hybrid
Transcription
and
signaling
BCK1 Bypass of C Kinase, mitogen-activated protein kinase
kinase kinase
1 (332), 7 (332) Synthetic sick
CTI6 Cyc8-Tup1-Interacting protein, transcription factor
binding protein
7 (18) Two-hybrid
EAP1 EIF4E-Associated Protein, implicated in TOR signaling 1 (332), 7 (332) Synthetic lethal (rvs161), synthetic
sick (rvs167)
GTS1 Glycine Threonine Serine repeat protein, transcription
activator activity
7 (160) Peptide scanning
RIM101 Regulator of IME2, transcriptional repressor involved in
the response to pH
7 (160) Peptide scanning
RVB2 RuVB-like, involved in transcription regulation 7 (123) Affinity purification
SAP30 SIT4 protein phosphatase-Associated Protein, subunit of
a histone deacetylase complex
1 (332), 7 (332) Synthetic sick
SDS3 Suppressor of Defective Silencing, involved in
transcriptional silencing and required for sporulation
1 (332), 7 (332) Synthetic lethal
SIN3 Switch INdependent, DNA binding subunit of
Sin3p-Rpd3p histone deacetylase complex
1 (332), 7 (332) Synthetic sick
SLN1 Synthetic Lethal of N-end rule, histidine kinase
osmosensor that regulates a MAP kinase cascade
7 (18) Two-hybrid
SLT2 Suppression at Low Temperature, serine/threonine MAP
kinase
1 (20, 332), 7 (20, 332) Synthetic lethal
SUM1 SUppresor of Mar1-1, nuclear protein involved in
silencing
1 (332), 7 (332) Synthetic sick
SWI4 SWItching deficient, involved in cell cycle-dependent
gene expression
1 (332), 7 (332) Synthetic lethal
TFC6 Transcription Factor C, subunit of RNA polymerase III
transcription initiation factor
7 (18) Two-hybrid
TY1B Transposon Ty1 protein B 7 (18) Two-hybrid
Cell cycle BBP1 Bfr1p Binding Protein, required for the spindle pole
body (SPB) duplication
7 (160) Peptide scanning
Continued on following page
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TABLE 1—Continued
Group Gene Encoded protein Type(s) of interaction(reference[s])b Experimental evidence
CYK3 CYtoKinesis, SH3 domain protein located in the mother-
bud neck, molecular function unknown
1 (332), 7 (332) Synthetic sick
ESP1 Extra Spindle Pole bodies, sister chromatid separase 7 (18) Two-hybrid
PCL2 PHO85 CycLin, forms a functional kinase complex with
Pho85p, activated by Swi5p
7 (163) Two-hybrid, direct binding, Co-IP
PCL9 PHO85 CycLin, forms a functional kinase complex with
Pho85p, activated by Swi5p
7 (163) Two-hybrid
RED1 REDuctional division, involved in chromosome
segregation during the first meiotic division
1 (114) Two-hybrid
Transport FEN1/ELO2,
ISUR5/VBM2
FENpropimorph resistance, fatty acid elongase, involved
in sphingolipid biosynthesis
1 (262) Genetic suppression
GRD19 Golgi Retention Deficient, sorting nexin required to
maintain late-Golgi-resident enzymes
7 (350) Two-hybrid
GUP1 Glycerol Uptake, plasma membrane protein with a
possible role in proton symport of glycerol
1 (332), 7 (332) Synthetic lethal
GYL1 GYp-Like, putative GTPase-activating protein, stimulates
Gyp5p GAP activity on Ypt1p
1 (18), 7 (18, 84, 317, 331) Two-hybrid, affinity purification
GYP5 GTpase-activating protein for Ypt Proteins, GAP for
yeast rab1
1 (18), 7 (18, 84, 160, 317) Two-hybrid, peptide scanning,
affinity purification
HSE1 Has Symptoms of class E mutants, subunit of the
endosomal Vps27p-Hse1p complex
7 (18) Two-hybrid
IVY1 Phospholipid-binding protein that Interacts with both
Ypt7p and Vps33p
7 (18) Two-hybrid
KAP122 KAryoPherin, responsible for import of the
Toa1p-Toa2p complex into the nucleus
7 (18) Two-hybrid
MGE1 Mitochondrial GrpE, involved in protein import into
mitochondria
1 (123) Affinity purification
MNN2 MaNNosyltransferase 1 (332), 7 (332) Synthetic sick
MNN9 MaNNosyltransferase 1 (332), 7 (332) Synthetic lethal
MNN10 MaNNosyltransferase 1 (332), 7 (332) Synthetic lethal
MRS3 Mitochondrial RNA Splicing, mitochondrial iron
transporter
7 (160) Peptide scanning
PEX14 PEroXisome related, peroxisomal membrane protein, a
central component of the peroxisomal protein import
machinery
7 (385) Peptide scanning
PHO84 PHOsphate metabolism, phosphate transporter and
low-affinity manganese transporter
7 (123) Affinity purification
POR1 PORin, mitochondrial porin (voltage-dependent anion
channel)
1 (123) Affinity purification
PSE1 Protein Secretion Enhancer, karyopherin/importin that
interacts with the nuclear pore complex
7 (18) Two-hybrid
RSP5 Reversal of Spt Phenotype 5, yeast NEDD4 ubiquitin
ligase
7 (123, 307) Two-hybrid, co-immunoprecipitation,
affinity purification, complex
isolation, and mass spectrometry
RUD3 Relieves Uso1-1 transport Defect, Golgi matrix protein
involved in the structural organization of the cis-Golgi
1 (332), 7 (332) Synthetic sick
SEC21 SECretory, COP1 complex component 7 (18) Two-hybrid
SEC22 SECretory, R-SNARE protein, cycles between ER and
Golgi
1 (332), 7 (332) Synthetic sick
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TABLE 1—Continued
Group Gene Encoded protein Type(s) of interaction(reference[s])b Experimental evidence
SEC27 SECretory, essential beta-coat protein of the COPI
coatomer
1 (123) Affinity purification
SRP54 Signal Recognition Particle subunit 7 (18) Two-hybrid
SPF1 Sensitivity to Pichia farinosa killer toxin, P-type ATPase,
ion transporter of the ER membrane involved in ER
function and Ca2 homeostasis
1 (332), 7 (332) Synthetic lethal
SUR4/ELO3,
/VBM1
SUppressor of rvs161 and rvs167 mutations, elongase III
synthesizes 20–26-carbon fatty acids from C18-CoA
primers
1 (53) Genetic suppression
SXM1 Suppressor of mRNA eXport Mutant, nuclear transport
factor (karyopherin)
1 (18) Two-hybrid
VPS21/YPT51 Vacuolar Protein Sorting, Rab5-like GTPase 1 (97, 332), 7 (97, 296, 332) Synthetic sick
Metabolism
and
biogenesis
ARG1 ARGinine requiring, acetylglutamate synthase 7 (123) Affinity purification
BNI4 Bud Neck Involved, required for localization of chitin
synthase III to the bud neck
1 (332), 7 (332) Synthetic sick (rvs161), synthetic
lethal (rvs167)
CCW12 Covalently linked Cell Wall protein, expression
down-regulated by alpha factor
1 (332), 7 (332) Synthetic lethal
CHS3 CHitin Synthase-related, chitin synthase III 1 (332), 7 (332) Synthetic sick
CHS5 CHitin Synthase-related, molecular function unknown 1 (332), 7 (332) Synthetic sick
CHS6 CHitin Synthase-related, molecular function unknown 1 (332), 7 (332) Synthetic sick
CHS7 CHitin Synthase-related, molecular function unknown 1 (332), 7 (332) Synthetic sick
COR1 CORe protein of QH2 cytochrome c reductase 7 (123) Affinity purification
CSF1 Cold Sensitive for Fermentation 1 (332), 7 (332) Synthetic lethal
DEP1 Disability in regulation of Expression of genes involved
in Phospholipid biosynthesis
1 (332), 7 (332) Synthetic sick
DOA1 Degradation Of Alpha2, regulatory component of the
proteasome pathway
1 (332), 7 (332) Synthetic sick
ECM29 ExtraCellular Mutant, major component of the
proteasome
7 (123) Affinity purification
FKS1 FK506 Sensitivity, catalytic subunit of 1,3--D-glucan
synthase
7 (332) Synthetic lethal
FUS2 cell FUSion, required for the alignment of parental
nuclei before nuclear fusion during mating
1 (18, 21, 97, 136, 221) Two-hybrid, Co-IP
GDH3 Glutamate DeHydrogenase 3 7 (97) Two-hybrid
HOC1 Homologous to OCh1, -1,6-mannosyltransferase
involved in cell wall mannan biosynthesis
1 (332), 7 (332) Synthetic sick (rvs161) synthetic
lethal (rvs167)
HOM6 HOMoserine requiring, homoserine dehydrogenase 7 (123) Affinity purification
HSP90 Heat Shock Protein, cytoplasmic chaperone 1 (389), 7 (332) Synthetic lethal
IDH1 Isocitrate DeHydrogenase 7 (123) Affinity purification
ILV5 IsoLeucine-plus-Valine requiring, acetohydroxy acid
reductoisomerase
7 (123) Affinity purification
IPT1 Inositol PhosphoTransferase 1 (10) Genetic suppression
LPD1 LiPoamide Dehydrogenase 7 (123) Affinity purification
KGD2 -KetoGlutarate Dehydrogenase 7 (123) Affinity purification
Continued on following page
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TABLE 1—Continued
Group Gene Encoded protein Type(s) of interaction(reference[s])b Experimental evidence
KRE1 Killer toxin REsistant, cell wall glycoprotein involved in
-glucan assembly
1 (332), 7 (332) Synthetic sick
KRE6 Killer toxin REsistant, cell wall glycoprotein involved in
-glucan assembly
7 (20) Synthetic sick
LYS12 LYSine requiring 7 (123) Affinity purification
MET18 METhionine requiring 7 (123) Affinity purification
MUS81 MMS and UV Sensitive, Helix-hairpin-helix protein 7 (18) Two-hybrid
PDI1 Protein Disulfide Isomerase 1 (114) Two-hybrid
PHO23 PHOsphate metabolism, component of the Rpd3 histone
deacetylase complex
1 (332), 7 (332) Synthetic sick
PMI40 PhosphoMannose Isomerase 7 (123) Affinity purification
PRE10 PRoteinase yscE, 20S proteasome -type subunit 7 (123) Affinity purification
PSK1 Pas domain-containing Serine/threonine protein Kinase 7 (160) Peptide scanning
SKT5 Activator of Chs3p (chitin synthase III) 1 (332), 7 (332) Synthetic sick (rvs161), synthetic
lethal (rvs167)
SMI1 Suppressor of MAR Inhibitor, involved in (1,3)--glucan
synthesis
7 (332) Synthetic sick
SML1 Suppressor of Mec Lethality, ribonucleotide reductase
inhibitor
7 (160) Peptide scanning
SRV2 Suppressor of RasVal19, adenylyl cyclase-associated
protein
7 (59, 176) Two-hybrid, synthetic sick
SUR1 SUppressor of rvs161 and rvs167 mutations, catalytic
subunit of a mannosylinositol phosphorylceramide
synthase
1 (53) Genetic suppression
SUR2 SUppressor of rvs161 and rvs167 mutations, sphingosine
hydroxylase
1 (53) Genetic suppression
TPS1 Trehalose-6-Phosphate Synthase, regulator of glucose
influx into the cell and into glycolytic pathway
1 (332), 7 (332) Synthetic sick
TRP5 TRyPtophan requiring 7 (123) Affinity purification
UBI4 UBIquitin 7 (123) Affinity purification
UBP7 UBIquitin-specific Protease 7 (123) Affinity purification
URA7 URAcil requiring 7 (18, 123) Affinity purification
RNA and
translational
regulation
CDC33 Cell Division Cycle, cytoplasmic mRNA cap binding
protein
7 (123) Affinity purification
DED1 DEaD-box protein, ATP-dependent DEAD (Asp-Glu-
Ala-Asp)-box RNA helicase
7 (123) Affinity purification
KRS1 Lysyl (K) tRNA Synthetase 7 (123) Affinity purification
LCP5 Lethal with Conditional Pap1, essential protein involved
in maturation of 18S rRNA
7 (18) Two-hybrid
MSU1 Degradosome associates with the ribosome and mediates
turnover of RNAs
7 (18, 331) Two-hybrid
PRP40 Pre-mRNA Processing, U1 snRNP protein involved in
splicing
7 (114) Two-hybrid
RPC40 RNA Polymerase C subunit 7 (123) Affinity purification
SES1 SEryl-tRNA Synthetase 7 (123) Affinity purification
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failed to block the formation of clathrin-coated vesicles and
had less impact on -factor endocytosis even than deletion of
clathrin heavy or light chain. Clathrin does not even appear to
associate with the AP-2 adaptor in yeast (130, 377).
Other adaptors are known to bind clathrin heavy chain and
to function in clathrin-mediated endocytosis in vertebrates.
Mammalian epsin (57, 58) and AP180 (2, 216) are both known
to bind clathrin heavy chain, promote assembly of clathrin
coats, and function in clathrin-dependent endocytosis. In yeast,
clathrin heavy chain does associate with the yeast epsins
(Ent1p and Ent2p) (362) and AP180 adaptors (Yap1801 and
Yap1802) (361). The Ent1p and Ent2p adaptors are required
for endocytosis in yeast (362), however, Yap1801 and Yap1802
are not required individually or collectively (361). Yap1801
and Yap1802 are also not required for clathrin coat assembly
or clathrin-coated vesicle formation in yeast (130).
For some time it was not clear whether clathrin-coated pits
exist on the yeast plasma membrane as they do in vertebrates.
TABLE 1—Continued
Group Gene Encoded protein Type(s) of interaction(reference[s])b Experimental evidence
SLF1 Associates with translating ribosomes 7 (18) Two-hybrid
SNP1 U1snRNP 70K protein homolog 7 (160) Peptide scanning
Others and
unknown
CUE5 Coupling of Ubiquitin conjugation to ER degradation 7 (160) Peptide scanning
DEM1 Differentially Expressed in Malignancies, molecular
function unknown
7 (160) Peptide scanning
ECM30 ExtraCellular Mutant, function unknown 7 (18) Two-hybrid
GFD2 Great for Full DEAD box protein activity, molecular
function unknown
7 (18) Two-hybrid
HUA1 Unknown function 7 (59, 136) Two-hybrid
HUA2 Unknown function 7 (59) Two-hybrid
RXT2 Molecular function unknown 1 (332), 7 (332) Synthetic sick
SDS23 Homolog of S. pombe SDS23, implicated in
APC/cyclosome regulation
1 (114) Two-hybrid
YBP2 Yap1 Bing Protein, protein with a role in resistance to
oxidative stress
7 (18, 136) Two-hybrid, affinity purification
YBR108W Hypothetical ORF 1 (339), 7 (59, 97, 136, 160) Two-hybrid, peptide scanning
YBR239C Hypothetical ORF 7 (160) Peptide scanning
YBR255W Hypothetical ORF 1 (332), 7(332) Synthetic sick
YDL156W Hypothetical ORF 7 (160) Two-hybrid, peptide scanning
YDR154C Hypothetical ORF 1 (136) Two-hybrid
YDR239C Hypothetical ORF 7 (160) Peptide scanning
YGL085W Hypothetical ORF 7 (160) Peptide scanning
YLR111W Hypothetical ORF 1 (332), 7 (332) Synthetic sick
YLR243W Hypothetical ORF 7 (123) Affinity purification
YNL086W Hypothetical ORF 7 (59) Two-hybrid
YNL152W Hypothetical ORF 7 (160) Peptide scanning
YPL009C Hypothetical ORF 7 (160) Peptide scanning
YPR091C Hypothetical ORF 7 (160) Peptide scanning
a This table contains a comprehensive listing of all reported genetic and physical interactions. Many interactions require further confirmation. Note that some
interactions of Rvs proteins are with proteins whose predominant subcellular localization seems incompatible with interaction (e.g., Pdi1p is a protein of the ER lumen).
The existence of additional (perhaps minor) cytoplasmic pools of these proteins cannot be formally excluded and so these putative interactions are included here.
Abbreviations: ELISA, enzyme-linked immunosorbent assay; Co-Ip, coimmunoprecipitation; MAP, mitogen-activated protein; SPB, spindle pole body; R-SNARE,
R-type soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor; CoA, coenzyme A; ORF, open reading frame; APC, anaphase promoting
complex; MMS, methyl methanesulfonate. This table does not include all of the synthetic lethal interactions recently reported in reference 84a.
b 1, interaction with Rvs161; 7, interaction with Rvs167.
c Information on gene/gene product nomenclature and function was obtained from the Saccharomyces Genome Database (R. Balakrishnan, K. R. Christie, M. C.
Costanzo, K. Dolinski, S. S. Dwight, S. R. Engel, D. G. Fisk, J. E. Hirschman, E. L. Hong, R. Nash, R. Oughtred, M. Skrzypek, C. L. Theesfeld, G. Binkley, C. Lane,
M. Schroeder, A. Sethuraman, S. Dong, S. Weng, S. Miyasato, R. Andrada, D. Botstein, and J. M. Cherry [http://www.yeastgenome.org/ {November 2005}]).
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Two very recent studies, discussed below, were the first to
demonstrate that a pool of clathrin exists on (or near) the
plasma membrane in yeast cells and colocalizes with cortical
actin patches (144, 223).
Is dynamin required for receptor endocytosis in yeast? Yeast
cells possess three dynamin-like proteins (Vps1p, Dnm1p, and
Mgm1p). Vps1p localizes to the Golgi apparatus and/or per-
oxisomes (124, 274). Deletion of the VPS1 gene that encodes
Vps1p (vps1) does not abolish endocytic internalization (226).
A recent study showed that deletion or mutation of Vps1p
perturbs actin patch polarization and abolishes endocytic in-
ternalization, but only at elevated temperature (383). Dnm1p
localizes to the surface of mitochondria (86, 166). Deletion of
the DNM1 gene that encodes Dnm1p did not affect the kinetics of
-factor internalization, although subsequent trafficking of -fac-
tor to the vacuole was delayed (92). Mgm1p localizes to the
intramembrane space of mitochondria and therefore a role in
endocytosis seems unlikely (although it has not been directly
tested) (373). Dnm1p and Mgm1p regulate mitochondrial mor-
phology (17, 86, 229, 289). Interestingly, none of the yeast dy-
namin-like proteins have been shown to interact physically with
clathrin, AP-2 adaptor, or either Rvs protein.
In yeast, internalization of receptors by endocytosis is de-
pendent on prior covalent attachment of the protein ubiquitin
to the receptor cytoplasmic tail (117). Ubiquitin is attached to
specific lysine residues in the receptor tail by the ubiquitin
protein ligase Rsp5p (63, 64). Ubiquitin-dependent endocyto-
sis requires the attachment of only a single ubiquitin molecule
(monoubiquitination) (327). This is in contrast to targeting of
cytoplasmic proteins for degradation by the 26S proteasome,
which requires attachment of chains containing multiple ubiq-
uitin molecules (polyubiquitination). The requirement for mono-
ubiquitination for receptor endocytosis can be bypassed by the
use of recombinant receptors in which the C terminus of the
receptor tail is fused to ubiquitin (327). Are rvs161 and rvs167
mutants defective in receptor-mediated endocytosis of -factor
because they cannot ubiquitinate the -factor receptor cyto-
plasmic tail? This has not yet been thoroughly investigated, but
a recent study indicated that the -factor receptor tail is still
ubiquitinated in rvs167 cells (307).
The polymerization of actin monomers into actin filaments
is a process that can produce mechanical force. It has been
proposed that the requirement for actin cytoskeletal proteins
for endocytic internalization in yeast may reflect a role for
actin polymerization in producing the force necessary to sever
endocytic pits and release endocytic vesicles (71, 213, 214).
Live cell imaging has been used to visualize endocytosis in
yeast and to look for colocalization of endocytosed plasma
membrane receptors with proteins important for actin poly-
merization during internalization (143). Transient colocaliza-
tion of endocytosed receptors with proteins implicated in de
novo actin filament assembly occurs at sites of endocytic inter-
nalization. Moreover, correlations have been observed be-
tween the movement of actin filament assembly proteins and
endocytic vesicles (132, 139, 143, 144, 223).
During endocytic internalization clathrin first assembles to
form a cortical patch. Clathrin is soon joined in the patch by
Las17p and a second Arp2/3p activator protein, Pan1p. Other
actin filament assembly proteins are then recruited, including
End3p, Sla1p, and Sla2p. These proteins assemble sequentially
to form cortical patches that are initially stationary and do not
yet contain F-actin. Next, Abp1p, the Arp2/3p complex itself,
and actin are recruited to the patch. The Arp2/3p complex is
responsible for de novo nucleation of actin filaments. Las17p,
Pan1p, and Abp1p are believed to promote actin filament
assembly by interacting with and stimulating the Arp2/3p com-
plex. Following recruitment of actin and the Arp2/3p complex
an actin cloud is formed via Arp2/3p-dependent de novo actin
filament assembly. Finally, type I myosins are transiently re-
cruited to the stationary patch. Type I myosins are a class of
actin-dependent motor that also have the potential to interact
with and activate the Arp2/3p complex and have been pro-
posed to function in endocytic vesicle fission. Las17p, Pan1p,
and type I myosins remain in a stationary patch on the mem-
brane, while the cortical patch initiates slow movement for a
distance of 200 nm perpendicular to the plane of the mem-
brane. At first End3p, Pan1p, Sla1p, and Sla2p move with the
actin patch but then they gradually dissociate. In contrast,
Abp1p, Arp2/3p, and actin move slowly into the cell with the
actin patch and remain associated as the actin patch undergoes
a subsequent fast long-range movement (132, 139, 143, 144).
Important questions remain concerning the role of Arp2/3p-
activating proteins such as Las17p, Pan1p, Abp1p, and type
I myosins in endocytosis. In vitro evidence has suggested that
the yeast Arp2/3p complex is inactive unless activated by
these proteins (372). This is consistent with the requirement
of WASp (mammalian ortholog of Las17p) for mammalian
Arp2/3 activity in actin filament nucleation. A recent study,
however, showed that the dependence of Arp2/3p activity on
activating proteins in vitro is affected by the source of actin.
The original assays that showed the Las17p dependence of
Arp2/3p activity used mammalian muscle actin. When yeast
actin was used instead there was strong Arp2/3p-dependent
actin polymerization even in the absence of Las17p (although
the addition of Las17p further enhanced Arp2/3p activity).
This study concluded that Arp2/3p-dependent polymerization
of yeast actin does not absolutely require an activating protein
(at least in vitro) (360). However, other studies found a strict
requirement for Arp2/3p-activating proteins for Arp2/3p-de-
pendent actin assembly even when the assay was performed
using only yeast actin (101). Whether activating proteins are
required for Arp2/3p activity in yeast is an important question.
If they are indeed dispensable for Arp2/3p activation in vitro
and this is also true in vivo, then the role of Arp2/3p complex
“activators” in actin-dependent movement and endocytosis
may need to be revisited.
Interestingly, two recent studies found that there is a cortical
pool of clathrin in yeast in the form of small motile patches
(144, 223). Inhibition of actin patch assembly by treatment of
wild-type cells with the actin polymerization inhibitor latrun-
culin A or in cells lacking the actin assembly protein Sla2p
(sla2) or End3p (end3) arrests cortical clathrin patch move-
ment, extends clathrin patch lifetime, and results in a dramatic
accumulation of clathrin at the cortex (144, 223). Interestingly,
in cells lacking Rvs161p or Rvs167p clathrin patch lifetime is
not extended and clathrin does not accumulate at the cortex.
Hence, not all mutations that block endocytic internalization
have this effect on clathrin. It is not yet clear why loss of Sla2p
or End3p has such different effects from loss of Rvs161p or
Rvs167p.
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Several lines of evidence suggest that cortical clathrin in
yeast, while not essential, is involved in endocytic internaliza-
tion. First, after treatment of cells with latrunculin A to induce
clathrin accumulation at the cortex, some cortical clathrin
patches colocalize with endocytic cargo (e.g., -factor recep-
tors). In untreated yeast cells some cortical clathrin patches
colocalize with Arp2/3p-activating proteins and are recruited
to patches at the cortex just prior to recruitment of Arp2/3p-
activating proteins to the patch. Moreover, accumulation of
clathrin at the cortex upon latrunculin A treatment requires
either the yeast AP180 adaptor Yap1801p or Yap1802p or a
different type of yeast clathrin adaptor related to vertebrate
epsin (Ent1p or Ent2p). Finally, loss of clathrin heavy chain or
clathrin light chain reduces the number and the lifetime of
cortical patches containing Las17p and Sla1p, although the
movement of the remaining Las17p and Sla1p patches and
disassembly of these proteins during movement appears unaf-
fected. This evidence directly implicates yeast clathrin in actin-
dependent receptor-mediated endocytosis (144, 223).
Although Rvs161p and Rvs167p have not been shown to
activate the Arp2/3p complex for actin filament assembly in
vitro, they do interact with several other proteins that are
known Arp2/3p activators (see below). This, together with
their ability to directly bind membranes (see below), makes the
Rvs proteins ideal candidates for linking actin filament assem-
bly to membrane dynamics during endocytic internalization. Is
actin patch movement off the plasma membrane or the cou-
pling of this actin patch movement to internalization of endo-
cytic cargo such as plasma membrane receptors dependent on
Rvs161p and/or Rvs167p? Rvs161p and Rvs167p have recently
been shown to assemble into cortical patches at sites of endo-
cytosis. Rvs161p and Rvs167p are recruited after Abp1p to
patches during the initial actin cloud formation but while
the patches are still stationary on the plasma membrane. When
the patches exhibit the initial slow movement over a distance
of 200 nm perpendicular to the plane of the membrane
Rvs161p and Rvs167p undergo a very rapid movement over a
distance of 100 nm and then immediately dissociate. While
treatment of cells with latrunculin A to disassemble all F-actin
does not prevent Rvs167p localization to cortical patches it
does block movement of Rvs167p patches off the membrane
(144).
The effect of rvs161 and rvs167 mutations on actin patch
dynamics during endocytosis has been examined recently and is
particularly interesting (144). In the absence of Rvs161p and
Rvs167p the actin patch (as defined by Sla1p) still assembles
on the plasma membrane. Upon recruitment of Abp1p the
patch undergoes the initial slow movement perpendicular to
the plane of the plasma membrane and Sla1p gradually disso-
ciates as in wild-type cells. However, in cells lacking Rvs161p
or Rvs167p these patches do not undergo the second phase of
rapid long-range movement. Instead, many of the actin patches
appear to stop and then exhibit an abberant retrograde move-
ment back to the plasma membrane. Interestingly, Abp1p,
which normally is retained on the patch during rapid long-
range movement in wild-type cells, dissociates prior to the
retrograde movement in rvs161 and rvs167 mutants. It has
been proposed that invagination proceeds in the absence of
Rvs161p and Rvs167p but membrane scission fails. As a con-
sequence the coat complex defined by Sla1p is then retracted
back to the plasma membrane driven by membrane tension.
The actin assembly complex defined by Abp1p that normally
drives the subsequent rapid long-range patch movement in
wild-type cells falls off the invaginated membrane as the invag-
ination retracts in rvs161 and rvs167 mutant cells (144).
Rvs161p and Rvs167p function in endocytosis as a het-
erodimer. The ability of Rvs protein overexpression to perturb
receptor-mediated endocytosis of -factor in wild-type cells
requires simultaneous overexpression of both proteins. The
level of overexpression achieved in these experiments (which
used elevated gene dosage rather than a strong promoter) did
not affect the growth of wild-type cells or exacerbate the
growth defect of rvs167 mutant cells, but overexpression of
Rvs167p in rvs161 cells caused mild inhibition of growth.
Rvs161p overexpression in rvs167 cells or, conversely, Rvs167p
overexpression in rvs161 cells enhances the defect in recep-
tor-mediated endocytosis of -factor. Interestingly, this exacer-
bation of the endocytic defect occurs without obvious exacerba-
tion of the actin patch polarization defect. Clearly, endocytosis is
very sensitive to the total amount and ratio of Rvs161p and
Rvs167p, but actin patch polarization and cell growth are less
sensitive (180).
Role for Rvs161p and Rvs167p in postinternalization traf-
ficking through endosomes? The strong defect in receptor
internalization in rvs161 and rvs167 mutants has made it diffi-
cult to test possible defects in postinternalization traffic to the
vacuole (213, 215). Defects in postinternalization traffic are
often (although not always) associated with defects in biosyn-
thetic traffic through endosomes to the vacuole. This is because
the endocytic pathway and the vacuole biosynthetic pathway
meet in the prevacuolar compartment, which is a type of en-
dosome (214). Vacuole biogenesis appears normal in rvs161
and rvs167 mutant cells. Neither end6-1 (Rvs161p-R59K mu-
tation) nor rvs167 affects the appearance of the vacuole. Traf-
fic of newly synthesized soluble vacuolar proteins from the late
Golgi apparatus via endosomes to the vacuole can be moni-
tored based on the kinetics of endoplasmic reticulum (ER)-
dependent and Golgi apparatus-dependent glycosylation and
the proteolytic processing event that occurs upon arrival in the
vacuole. These events appear normal in rvs161 and rvs167
mutant cells even at elevated temperature (37°C). Neither
rvs161 nor rvs167 cells are defective in vacuolar protein sorting
because they do not missort soluble vacuolar proteins into the
extracellular medium (215).
It is possible that Rvs161p and Rvs167p function in the late
endocytic pathway but redundantly with other proteins. In sup-
port of this possibility, combining mutations in rvs167 with
mutations in two genes encoding proteins known to function in
the late endocytic pathway, YPT51 (296) and VPS20 (97), re-
sults in double mutant cells that either have severely reduced
viability compared to either single mutant or are totally invia-
ble, respectively (Table 1). YPT51 (also known as VPS21) en-
codes Ypt51p, which is one of three yeast orthologs of human
early endosomal Rab5 and is important for vacuolar protein
sorting and traffic of internalized -factor from early endo-
somes to late endosomes. The interaction with Ypt51p is spe-
cific because Rvs167p does not genetically interact with Ypt7p,
the ortholog of human late endosomal Rab7, which functions
in trafficking of internalized -factor from late endosomes to
the vacuole (297). VPS20 encodes a small coiled-coil protein
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(Vps20p) also required for postinternalization endocytic traf-
ficking and vacuolar protein sorting (376). Interestingly, vps20
mutants exhibit severely reduced viability upon entry into sta-
tionary phase (i.e., nutrient starvation) (7). This further sup-
ports a functional link between Vps20p and the Rvs161p and
Rvs167p proteins.
Roles of Rvs161p and Rvs167p in the Secretory Pathway
Rvs161p and Rvs167p are not essential for all secretory
membrane traffic. A functional secretory pathway is essential for
viability of all cells, including budding yeast. In the absence of a
functional secretory pathway cells are unable to deliver newly
synthesized plasma membrane components to the cell surface and
the cell can neither grow in size nor divide. The viability of both
rvs161 and rvs167 single mutants and the rvs161 rvs167 double
mutant shows that the secretory pathway is not blocked (at least
under normal growth conditions) in the absence of Rvs proteins
(12, 42, 53). Trafficking of newly synthesized soluble vacuolar
proteins from the ER to the Golgi apparatus was also unaffected
in rvs161 or rvs167 mutants even at elevated temperature (37°C)
(215). Transport of the soluble secreted enzyme invertase from
the ER via the Golgi apparatus to the cell surface was not affected
in either rvs161 or rvs167 mutant cells (298). Hence, Rvs proteins
are not strictly essential for a functional secretory pathway.
Rvs proteins may be required for polarized secretion during
cell division. Several lines of evidence suggest the rvs mutants
have a secretory pathway that is not fully functional. rvs167 mu-
tant cells exhibit delocalization of cell wall chitin (12). This sug-
gests a defect in polarized secretion of chitin synthases to the bud
site. Defects in cell wall biogenesis are further supported by an
electron microscopy study of cell wall (septum) deposition at the
neck of dividing rvs161 and rvs167 mutant cells (20). Wild-type
yeast cells deposit septum at the bud neck and then cleave the
septum and divide so rapidly that electron micrographs reveal few
cells in the process of forming a septum. In contrast, a much
greater proportion of rvs161 and rvs167 mutant cells are seen in
electron micrographs in the process of depositing septa, strongly,
suggesting that deposition of septum is considerably slowed (20).
Defects in cell wall deposition may arise because of inefficient
delivery of cell wall biosynthetic enzymes to the division site.
Rvs proteins and post-Golgi apparatus traffic. Further evi-
dence for a role of Rvs161p and Rvs167p in the secretory pathway
comes from genetic studies. rvs161 and rvs167 mutations exhibit
negative genetic interactions with mutations affecting the uncon-
ventional type V myosin Myo2p (myo2). rvs161 myo2 and rvs167
myo2 double mutants exhibit a lethal phenotype (19). Myo2p
plays a role in motor-driven polarized transport of Golgi appara-
tus-derived vesicles along actin cables to the bud (104, 138, 150,
253, 273, 286). myo2 mutations are also lethal in combination with
a subset of secretion (sec) mutations that affect delivery of Golgi
apparatus-derived transport vesicles to the plasma membrane
(104). This suggests rvs161 and rvs167 may also have defects in
this late step of the secretory pathway. Moreover, as discussed
further below, mutations in two genes, SUR4 and SUR5/FEN1,
that suppress the defects of rvs161 and rvs167 mutants also sup-
press the defects in snc1 snc2 double mutants, which are known to
be defective in post-Golgi apparatus traffic (48).
Further hints for a role in vesicle traffic for Rvs161p and
Rvs167p comes from large-scale two-hybrid screens that iden-
tified interactions between Rvs167p and components of the
exocyst complex, notably Sec8p and Exo70p (Table 1) (18).
The exocyst complex is required for fusion of Golgi apparatus-
derived transport vesicles with the plasma membrane. More-
over, a recent genome-wide genetic interaction study of
Rvs161p and Rvs167p revealed that loss of either protein is
lethal in pairwise combination with deletions affecting the
same set of (nonessential) secretory proteins. This indepen-
dent evidence is consistent with the results of the earlier two-
hybrid study and further supports the view that the Rvs pro-
teins function in secretion (84a).
Rvs161p and Rvs167p also interact with two proteins that
regulate Rab GTPases: Gyp5p (GYP5/YPL249c gene product)
and Gyl1p (GYL1/YMR192w gene product) (Table 1). The SH3
domain of Rvs167p binds Gyp5p, whereas full-length Rvs161p
appears to be required for its interaction with Gyp5p. The
SH3 domain of Rvs167p binds Gyl1p and phosphorylation of
Rvs167p inhibits this interaction (18, 84, 85, 123, 317, 331).
Rab GTPases cycle between an active GTP-bound form and an
inactive GDP-bound form. Rab GTPase-activating proteins
(Rab-GAPs) stimulate GTP hydrolysis and promote inactiva-
tion, while Rab GDP/GTP exchange proteins (Rab-GEFs)
stimulate GDP/GTP exchange and promote activation (287,
309). Gyp5p has strong Rab-GAP activity in vitro and is most
active on the Rab GTPase Ypt1p, which functions in ER-to-
Golgi apparatus traffic (see below), although it also has signif-
icant activity on the Rab GTPase Sec4p, which functions in
post-Golgi apparatus traffic (49). During subcellular fraction-
ation Gyp5p and Gyl1p copurified with post-Golgi apparatus
vesicles and plasma membrane. Gyp5p was shown to physi-
cally interact with Sec4p. gyp5 interacts genetically with
sec2 mutations affecting the Sec4p GEF. At low tempera-
ture, gyp5 gyl1 double mutant cells exhibit a slight defect
in growth and polarized secretion and accumulate secretory
vesicles at sites of polarized growth (33).
In wild-type cells, transport vesicles bud from donor com-
partments and efficiently dock and fuse with acceptor compart-
ments. Hence, transport vesicles are transient and rarely visible
in electron micrographs. In contrast, both rvs161 and rvs167
mutant cells accumulate vesicles at sites of polarized growth.
rvs161 mutants accumulate vesicles mainly at the bud neck
during cell division, however, some vesicle accumulation at the
nascent bud site and in the small growing buds is also observed.
In contrast, rvs167 mutants accumulate vesicles mainly at the
nascent bud site and in small buds, however, some vesicle
accumulation at the bud neck during cell division is also ap-
parent. The vesicle accumulation in both rvs mutants is appar-
ent even under optimal growth conditions, but becomes dra-
matic under conditions of stress, e.g., in the presence of sublethal
levels of Na. In both mutants, exposure to Na initially re-
sults in vesicle accumulate at sites of growth, but later vesicles
distribute throughout the mother cell and bud (20). myo2 mu-
tants (see above) accumulate what appear to be similar vesicles
(104, 138).
If Rvs proteins transport vesicles to the plasma membrane,
what cargo is transported in these vesicles? The content of the
vesicles that accumulate in rvs mutants has not been examined.
Several other actin cytoskeletal mutations also cause accumu-
lation of vesicles and in some cases the contents have been
analyzed. For example, the vesicles that accumulate in act1 and
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sla2 mutant cells contain Ypt1p. Ypt1p is a Rab family GTPase
equivalent to mammalian Rab1 that localizes to the Golgi
apparatus and functions in ER-Golgi apparatus traffic in yeast
(206). It has been proposed that the Ypt1p vesicles are not
transport vesicles but rather Golgi apparatus fragments.
Interestingly, there are emerging links between Rvs167p and
regulators of Ypt1p GTPase activity (see below) and it is possible
that altered activity of Ypt1p may lead either to accumulation of
transport vesicles or perhaps to organelle fragmentation. Insight
into the nature of the cargo transported in the vesicles that accu-
mulate in rvs mutant cells came from a recent genomewide mu-
tant screen (250). RVS161 was one of 137 genes (including sterol
and sphingolipid biosynthesis genes) that, when deleted, resulted
in reduced cell surface delivery and intracellular accumulation of
a lipid raft-associated integral membrane protein marker but are
not required for secretion of the soluble protein invertase into the
extracellular medium.
Rvs proteins and ER-to-Golgi apparatus traffic. Recent ev-
idence suggests that the Rvs proteins may also function earlier
in the secretory pathway. Rvs167p exhibits two-hybrid interac-
tion with the COP-I component Sec21p (	-COP) (18). COP-I
is a coat complex that functions early in the secretory pathway
and mediates the budding of transport vesicles that shuttle
cargo between the ER and Golgi apparatus. A genomewide
mass spectrometry analysis of yeast protein complexes identi-
fied Sec27p in a complex with Rvs161p and Rvs167p (123).
Sec27p is the -COP subunit of the COP-I coat complex.
These interactions are thought-provoking but await more de-
tailed analysis.
Negative genetic interactions have been observed with two
mutations that affect ER-to-Golgi apparatus membrane traffic,
sec22 and rud3 (84). Sec22p is a vesicle-associated soluble
N-ethylmaleimide-sensitive fusion protein attachment protein
receptor that functions specifically in ER-to-Golgi apparatus
transport. Rud3p (also known as Grp1p) is a matrix protein of
the early Golgi apparatus. Genetic interactions suggest that
Sec22p, present on ER-derived transport vesicles, and Rud3p,
present on an early Golgi apparatus compartment, function in
concert to promote fusion of ER-derived transport vesicles
with the early Golgi apparatus. sec22 and rud3 exhibit negative
genetic interactions and overexpression of Rud3p rescues the
phenotype of some sec22 mutations (153).
Further evidence for a role of Rvs proteins in ER-to-Golgi
apparatus traffic came from the discovery that both Rvs161p
and Rvs167p interact with regulators of the ER-to-Golgi ap-
paratus Rab GTPase Ypt1p. Ypt1p, like other Rab GTPases,
cycles between an active GTP-bound form and an inactive
GDP-bound form. Rvs161p and Rvs167p both directly bind
Gyp5p (which as mentioned above has strong Rab-GAP activ-
ity in vitro on Ypt1p) and Gyl1p (Table 1) (18, 84, 85, 123, 317,
331). Consistent with Gyp5p’s being a Ypt1p Rab-GAP, ge-
netic interaction data are consistent with an in vivo role for
Gyp5p in negatively regulating Ypt1p (49). Gyl1p shares ex-
tensive amino acid sequence homology with Gyp5p and was
initially proposed to also be a Rab-GAP for Ypt1p (317). Unex-
pectedly, Gyl1p lacks detectable Rab-GAP activity on Ypt1p in
vitro. However, Gyl1p binds to Gyp5p, possibly via coiled-coil
interactions, and stimulates its GAP activity on Ypt1p (84).
There is some evidence that Gyp5p and Gyl1p function in
ER-to-Golgi apparatus traffic with Rvs167p, despite the lack of
strong mutant phenotypes. Gyl1p overexpression is slightly in-
hibitory for growth of wild-type cells. Interestingly, simul-
taneous overexpression of both Gyl1p and Gyp5p is lethal
specifically in sec22 and rud3 cells, which are partially com-
promised in ER-to-Golgi apparatus transport (although the
effect of overexpression of Gyl1p and Gyp5p on ER-to-Golgi
apparatus transport has not yet been directly tested). In this
way, overexpression of Gyp5p and Gyl1p mimics loss of
Rvs167p (84). Another study, however, found that Gyp5p and
Gyl1p function in post-Golgi apparatus traffic (see above) (33).
Perhaps Gyp5p and Gyl1p function in early steps of the secre-
tory pathway with Ypt1p and in late steps of the secretory
pathway with Sec4p.
Neither Gyp5p nor Gyl1p localizes to cortical actin patches;
instead they exhibit diffuse cytoplasmic staining (49). Some
reports also find cortical staining at nascent bud sites, the
tips of small growing buds, and the bud neck during cytoki-
nesis. These are also areas where Rvs167p patches localize,
but the distributions only partially overlap. Interestingly,
Gyp5p-GFP localization to the bud tip and bud neck is lost in
both rvs161/rvs161 and rvs167/rvs167 homozygous dip-
loid cells, suggesting both Rvs proteins may be important for
Gyp5p localization to these sites. Loss of Gyp1p and Gyl1p,
either singly or in combination, did not result in Rvs pheno-
types with the possible exception of bipolar bud site selec-
tion. Furthermore, overexpression of Gyp5p and Gyl1p did
not perturb actin patch polarization or endocytosis, so the
inhibitory effect seems to be restricted to ER-to-Golgi ap-
paratus transport (33, 84, 317).
A model has been proposed in which Gyp5p, Gyl1p, and
Rvs167p function together in a complex whose role in ER-to-
Golgi apparatus transport overlaps that of Sec22p and Rud3p.
In this model Gyp5p and Gyl1p negatively regulate Rvs167p
function (84). Another possibility to consider is that Rvs167p
negatively regulates Gyp5p and Gyl1p. Loss of Rvs167p would
lead to increased Gyp5p Rab-GAP activity and a reduction in
the pool of active GTP-bound Ypt1p. As GTP-bound Ypt1p is
required for vesicle fusion, it may be interesting to test if the
vesicles that accumulate in rvs161 and rvs167 mutants bear
Ypt1p and furthermore if hyperactivation of Gyp5p Rab-GAP
activity in rvs161 and rvs167 mutant cells plays an important
role in the observed vesicle accumulation.
Rvs proteins and mating. Unlike animal cells, yeast cells are
surrounded by a thick polysaccharide cell wall. When the tips
of each mating projection come into contact the two mating
cells are still separated by intervening cell wall material. Ex-
amination of wild-type cells in the process of mating reveals
that after mating projections come into contact a seal is made
at the outer perimeter of the initial contact zone. This outer
perimeter seal remains intact, but intervening cell wall material
within the initial zone of contact is rapidly removed. This
process of cell wall removal continues until the plasma mem-
brane of each mating cell is exposed. The two plasma mem-
branes then undergo a fusion event and cytoplasmic continuity
is established. The nucleus of each mating cell migrates to the
site of cell-cell fusion, and these haploid nuclei then also fuse,
resulting in one diploid nucleus.
An inability to mate can result from defective cell cycle
arrest, mating projection formation, cell fusion, or nuclear
fusion. As mentioned above, rvs161 (fus7) was identified as a
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bilateral cell fusion mutation. In matings between rvs161 mu-
tants (rvs161 
 rvs161) mating projections are formed and
cell-cell contact is established, but cell-cell fusion is compro-
mised (Fig. 4) (20, 21, 91, 158).
Consistent with a novel function in mating cells, an Rvs161p-
GFP fusion was observed to redistribute to the tip of the
mating projection upon treatment of haploid cells with -fac-
tor mating pheromone. Interestingly, Rvs167p-GFP has also
been reported to redistribute to the tip of the mating projec-
tion upon pheromone treatment. Upon contact between the
tips of the two mating projections, Rvs161p-GFP remains con-
centrated at the site of cell contact throughout the processes of
cell wall removal and plasma membrane fusion. Electron mi-
croscopy showed that rvs161 mutant cells form cell-cell con-
tacts that are abnormally large (Fig. 5). In mating wild-type
cells, the intervening cell wall at sites of contact appears to be
rapidly removed. Electron micrographs that show wild-type
cells in the process of removing the intervening cell wall are
less common. In contrast, rvs161 mutant cells are often seen
with wide contacts and at intermediate stages of cell wall re-
moval (11, 20, 21, 91).
Although the frequency of successful matings of rvs161 cells
with wild-type cells is normal, electron micrographs reveal
apparent delays and abnormalities even in these matings (21).
Matings of rvs167 cells (rvs167 
 rvs167) also show apparent
delays in cell wall removal at contact sites similar to that of
rvs161 
 rvs161 matings despite the fact that the frequency of
successful rvs167 
 rvs167 matings is similar to that of matings
between wild-type cells (Fig. 6) (20). Evidence of a role for
both Rvs161p and Rvs167p in mating was also found in a
recent genome-wide genetic interaction study (84a). The ap-
parent delay in localized removal of cell wall at sites of cell-cell
contact in rvs161 and rvs167 cells may be due to the larger area
of wall that has to be removed. Alternatively, polarized deliv-
ery of transport vesicles carrying cell wall-degrading enzymes
to the site of contact may be affected.
Electron micrographs show that in wild-type cells vesicles
appear at sites where mating projections achieve cell-cell con-
tact. These vesicles do not spread out evenly across the entire
area of the contact, but instead form a tight cluster with a
diameter of 0.6 m, which is considerably less than the diam-
eter of the zone of cell-cell contact (1 m in wild-type and 2 to
3 m in rvs161 cells). Cell wall is degraded not throughout the
region of cell-cell contact, but rather at a small zone within this
region known as the fusion pore. Plasma membrane contact
and fusion likely occur at the fusion pore. Intriguingly, the site
where vesicles cluster is precisely the site of the fusion pore.
The diameter of the fusion pore is 0.5 m, which is similar
to the diameter of the vesicle cluster. The vesicles that cluster
at the fusion pore may carry enzymes that degrade cell wall
carbohydrates. Interestingly, some cell fusion mutants do not
accumulate any vesicles at the site of cell contact (e.g., fus1
cells). Other cell fusion mutants accumulate vesicles but they
do not form tight clusters at the fusion pore (e.g., spa2 mu-
tants). In contrast, both vesicle accumulation and clustering at
the fusion pore appear normal in rvs161 mutants (91).
Electron micrographs reveal that mating rvs161 cells exhibit
an electron-dense plaque at the site of cell-cell contact (Fig. 5).
This plaque may represent a fusion intermediate comprising
newly deposited membrane material. This plaque is not ob-
served in cell fusion mutants that do not accumulate or cluster
vesicles, suggesting that this plaque material is transported by
the vesicles observed in clusters at the fusion pore. Interest-
ingly, the electron-dense plaques observed in rvs161 cells are
major sites of plasma membrane invagination (Fig. 5) (91).
Perhaps rvs161 cells have defects in fission of the necks of these
plasma membrane invaginations resulting in accumulation of
plaque material at the fusion pore.
In crosses to wild-type cells, why do rvs161 cells exhibit a defect
in default mating but not in mating in response to a pheromone
gradient? Comparison of several mutants defective in default
mating revealed a close correlation between defects in cell fusion
and defects in default mating (56). It was proposed that default
mating requires a much higher level of cell fusion activity than
mating in response to pheromone gradients. Hence, cell fusion
FIG. 4. Rvs161p functions in cell-cell fusion during mating. Shown are
matings between two wild-type haploids (panels A and B) or between two
rvs161 mutant haploids (panels C to F) visualized by fluorescence/dif-
ferential interference contrast optics. Cell nuclei are stained with the
fluorescent dye 4,6-diamidino-2-phenylindole. Cell-cell fusion allows cy-
toplasmic mixing and the nuclei of each mating partner meet at the site of
cell fusion to fuse and create a single diploid nucleus. In the case of
rvs161 
 rvs161 matings, delays in cell-cell fusion (apparent by differ-
ential interference contrast) result in delays in nuclear fusion. This leads
to the persistence of two nuclei. In panels C and D nuclear fusion is taking
place despite incomplete removal of the intervening cell wall (partial Fus
phenotype) and in panels E and F nuclear fusion has been completely
blocked by the inability to remove intervening cell wall (full Fus pheno-
type). (Reproduced from reference 21 by copyright permission of the
Rockefeller University Press.)
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defects so mild that they barely affect mating using pheromone
gradients still cause strong defects in default mating. When mat-
ing in response to a pheromone gradient, yeast cells may use the
gradient to more accurately localize the cell fusion machinery at
the projection tip. Yeast cells mating in response to a pheromone
gradient are also more persistent in their attempts to mate. Either
of these factors may compensate for a lowered cell fusion activity
during normal pheromone gradient mating but not during default
mating.
Could the cell fusion defect in rvs161 cells be attributable to the
defect in actin patch polarization or endocytosis? To address this
question a collection of rvs161 mutant alleles was generated.
rvs161 mutations confer defects in growth on media containing 1
M Na or nonfermentable carbon sources such as glycerol (12,
42). Mutations in RVS161 that specifically affect sensitivity to Na
and utilization of glycerol (these mutations affect actin cytoskel-
etal organization and endocytosis [ACE]) or that specifically
affect cell-cell fusion during mating (CF) were isolated.
FIG. 5. Ultrastructure of wild-type, fus2, rvs161, and rvs161 fus2 cells during cell-cell fusion. Shown are electron micrographs of wild-type (WT),
fus2, rvs161, and rvs161 fus2 cells undergoing cell-cell fusion during mating. Note that wild-type cells exhibit restricted zones of cell-cell
contact during fusion while fus2, rvs161, and rvs161 fus2 mutants exhibit very wide zones of cell-cell contact during fusion. Wild-type and
mutant cells all exhibit numerous vesicles that cluster at the zone of cell-cell fusion. Note that plasma membrane invaginations/tubules accumulate
at the zone of fusion in the mutant cells, but are less common in wild-type cells. Labels indicate plasma membrane invaginations (black arrows),
vesicle clusters (black arrowheads), electron-dense plaques (white arrows), and nonremoved cell wall remnants (asterisks). Bars  1 m. (These
previously unpublished images are shown here with the kind permission of Alison Gammie.)
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FIG. 6. Ultrastructure of wild-type, rvs161, and rvs167 cells during cell-cell fusion. Shown are electron micrographs of wild-type, rvs161, and
rvs167 cells undergoing cell-cell fusion during mating. Panels a to c, matings between two wild-type cells; panels d to f, matings between two
rvs161 cells; panels g and h, matings between two rvs167 cells. Bar, 1 m. Labeled organelles: n, nucleus; v, vacuole; vs, vesicles; g, Golgi
apparatus. (Reproduced from reference 20 with permission of the publisher. Copyright John Wiley and Sons Ltd.)
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Intriguingly, rvs161 CF mutations do not affect actin cytoskel-
etal organization or endocytosis. Conversely, rvs161 ACE mu-
tations do not affect cell-cell fusion during mating. For exam-
ple, the rvs161 mutant originally identified in the screen for
endocytosis mutants (end6) (Rvs161p-R59K) is not defective
in cell-cell fusion during mating. Hence, Rvs161p has at least
two independent cellular roles, endocytosis/actin cytoskeleton
(ACE) and cell-cell fusion during mating (CF) (21).
Rvs161p consists only of a BAR domain, and hence both
ACE and CF functions lie within this domain (Fig. 1). Strik-
ingly, all ACE mutations map to the N-terminal 65% of
Rvs161p, while all CF mutations map to the C-terminal 35% of
Rvs161p. Thus, the Rvs161p BAR domain can be subdivided
into an N-terminal ACE domain regulating actin cytoskeleton
and endocytosis and a C-terminal CF domain regulating cell
fusion. Rvs161p transcript levels increase fourfold and the
level of Rvs161p protein also increases following exposure of
haploid cells to mating pheromone. This strongly supports the
view that Rvs161p provides some function specific for CF de-
spite the fact that Rvs161p clearly has functions other than CF
and is still expressed in both haploid cells not treated with
mating pheromone and in diploid cells which cannot mate (21).
Vesicles and plasma membrane invaginations accumulate at
the site of cell-cell fusion in cells lacking Rvs161p (rvs161). Are
these defects linked to the CF defect or the ACE defect? The
rvs161 CF mutants were used to address this important question.
Interestingly, rvs161CF mutants still accumulate both vesicles and
plasma membrane invaginations at the site of cell-cell fusion,
although the total number of vesicles and invaginations per cell
was somewhat lower than in cells lacking Rvs161p. Therefore,
while some of the vesicles and plasma membrane invaginations
are probably attributable to the ACE defect, a subset certainly
appear to be specific for the CF defect.
Electron micrographs reveal that rvs161 cells accumulate two
types of vesicle. One type of vesicle has a diameter of 86  5 nm
and is found in vegetative cells predominantly at sites of polarized
growth (Fig. 7). These are presumably the vesicles that accumu-
late when the ACE function is perturbed. A second type of vesicle
with a diameter of 54 nm was observed in mating cells at the tip
of the mating projection and at the site of cell-cell fusion (Fig. 7).
These vesicles may be a novel type of secretory vesicle that de-
livers cell wall-degrading enzymes to the tips of mating projection
and that accumulates when the CF function of Rvs161p is per-
turbed. The diameters of the vesicles that accumulate and form
clusters at sites of cell-cell contact in the rvs161 CF mutant fus7
are also small (50 nm) (Fig. 5) (20, 21, 91).
What is the role of Rvs161p in cell-cell fusion during mating?
Two genetically defined pathways important for fusion during
mating have been identified. One pathway is dependent on the
Fus1p protein and the other on the Fus2p protein. Both Fus1p
and Fus2p are important for cell-cell fusion during both default
mating and mating in response to pheromone gradients, and the
expression of both proteins is induced by treatment with mating
pheromone. Fus1p is an O-glycosylated integral plasma mem-
brane protein, while Fus2p is a cytoplasmic coiled-coil protein
that localizes to patches at the cortex of the mating projection.
The functions of Fus1p and Fus2p are partially redundant, since
loss of both proteins has more severe effects on cell-cell fusion
than loss of each individual protein (56, 67, 335, 336).
Analysis of fus1 rvs161 and fus2 rvs161 double mutants
places Rvs161p in the Fus2p pathway of cell-cell fusion. Indeed,
Rvs161p and Fus2p coimmunoprecipitate from yeast extracts.
Moreover, CF mutations in Rvs161p abolish interaction with
Fus2p. The Rvs161p BAR domain and Fus2p are both predicted
to form coiled-coil structures so it is likely that Fus2p interacts via
coiled-coil interactions with Rvs161p. Why is Rvs161p-Fus2p in-
teraction important for mating? Further work revealed that when
Fus2p is bound to Rvs161p it is stable, but when Rvs161p-Fus2p
interaction is abrogated by CF mutations Fus2p becomes unstable
and is degraded. Overexpression of Fus2p compensates for an
inability of a CF mutant form of Rvs161p to bind Fus2p and
restores efficient mating. However, the converse is not true, i.e.,
overexpression of Rvs161p cannot compensate for loss of Fus2p.
Hence, a major role of Rvs161p is to stabilize Fus2p (21).
An understanding of Fus2p function in cell-cell fusion is
starting to emerge. A key finding was that mating yeast cells
exhibit a transient flux of Ca2 ions across the plasma mem-
brane immediately prior to cell-cell fusion. This results in a
transient increase in the level of free intracellular Ca2 and
activation of various downstream signaling proteins. There are
two Ca2 influx systems, one of high affinity and one of low
affinity. The latter has been named the low-affinity Ca2 influx
system. Induction of the low-affinity Ca2 influx system (but
not of the high-affinity system) is dependent on an integral
plasma membrane protein known as Fig1p and on several
known cell-cell fusion proteins, including Rvs161p, Fus1p, and
Fus2p. Loss of Fig1p (fig1) results in a mating defect that can
be rescued by elevated Ca2 in the growth medium. Rvs161p
and Fus2p may be essential for the low-affinity Ca2 influx
system because they play an important role in delivery of Fig1p
to the plasma membrane or in the activation of Fig1p Ca2
channel activity at the plasma membrane (210).
Rvs161p and Fus2p have at least one additional role in
mating. Unlike Fig1p (or the low-affinity Ca2 influx syste),
Rvs161p and Fus2p are required for mating pheromone-in-
duced activation of the cell wall integrity Mpk1p/Slt2p mito-
gen-activated protein kinase cascade important for remodeling
of the cell wall during mating (210). In fus2 cells, cell wall
material, in particular (1,3)-glucan, is improperly deposited
at the tip of the mating projection, where removal of cell wall
is required for cell-cell fusion. The mating defects caused by
rvs161 or fus2 are partially suppressed by overexpression of
the protein Lrg1p, which is a Rho-GAP specific for Rho1p.
Rho1p in turn is an activator of the cell wall biosynthetic
enzyme (1,3)-glucan synthase (52). Loss of Lrg1p (lrg1)
appears to increase the activity of (1,3)-glucan synthase and
enhance cell wall deposition. This in turn inhibits cell-cell fu-
sion. Lrg1p localizes in wild-type cells to the tip of the mating
projection, where it may act to locally inhibit Rho1p and
(1,3)-glucan synthase to restrict cell wall deposition. Over-
expression of Lrg1p in fus2 mutants reduces the improper
(1,3)-glucan deposition at the tip of the mating projection
and corrects the mating defect (76).
rvs Mutations Interact with Actin and Myosin Mutations
Rvs phenotypes are associated with mutations affecting
other actin cytoskeleton proteins. In the original screens for rvs
mutants, only a very few of the many mutations screened af-
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FIG. 7. Defects in vesicle fusion in rvs161 mutant cells result in vesicle accumulation. Shown are electron micrographs of wild-type (A), rvs161
(B), and rvs167 (C) yeast cells. The panels on the left depict cells grown under standard conditions,while those on the right depict cells grown
in medium containing sublethal levels (3.4%, wt/vol) of Na. Bar, 1 m. Labeled organelles: n, nucleus; v, vacuole; vs, vesicles; g, Golgi apparatus
apparatus; ps, primary septum; s, septum. The arrow indicates cell wall abnormalities. (Reproduced from reference 20 with permission of the
publisher. Copyright John Wiley and Sons Ltd.)
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FIG. 7—Continued.
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fected survival upon starvation without also having nonspecific
effects on cell viability and thereby satisfied the criteria for a
true Rvs phenotype (42). However, subsequent screens for
mutations that affect arrest in G0 when cells are starved of
nutrients identified not only the Rvs proteins, but also other
actin cytoskeletal and endocytosis proteins. Moreover, proteins
such as Whi2p that were originally thought to be specific reg-
ulators of the cell cycle in response to nutrients are now known
to also be required for actin patch polarization and endocyto-
sis. Hence, cell cycle arrest in response to starvation and long-
FIG. 7—Continued.
66 REN ET AL. MICROBIOL. MOL. BIOL. REV.
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
m
br.asm
.org/
D
ow
nloaded from
 
term viability upon starvation appear to require not only pro-
teins such as Whi2p, Rvs161p, and Rvs167p, but a functional
actin cytoskeleton and/or endosomal system in general (24).
Essentially all the phenotypes associated with loss of
Rvs161p or Rvs167p are also phenotypes associated with mu-
tations in actin (10, 15, 19, 206, 215, 363). Among the collection
of act1 charged-to-alanine mutant alleles described above
(363), there is a strong correlation between act1 alleles that
affect growth in the presence of Na and those that affect
utilization of nonfermentable carbon sources. Interestingly, a
number of act1 alleles confer reduced viability upon starvation.
These alleles tend to be those that also affect growth in the
presence of Na (19). These phenotypic similarities between
mutations affecting actin, Rvs161p, and Rvs167p suggest a
close connection between Rvs161p and Rvs167p function and
actin cytoskeleton function.
Genetic interactions between Rvs proteins and actin. Fur-
ther support for a functional connection between the Rvs pro-
teins and the actin cytoskeleton comes from genetic interaction
data. The first genetic interaction was discovered by chance.
Both the act1-1 mutation affecting actin and the end6 (later
renamed rvs161-E6) R59K substitution in Rvs161p are reces-
sive (i.e., act1-1/ACT1 and rvs161-E6/RVS161 heterozygous
diploids are without obvious phenotype). Remarkably, how-
ever, a diploid doubly heterozygous for act1-1 and rvs161-E6
(act1-1/ACT1 rvs161-E6/RVS161) displays the mutant pheno-
type (i.e., is unable to grow at elevated temperature). This type
of genetic interaction is known as nonallelic noncomplemen-
tation because rvs161-E6 and act1-1 affect different genes (i.e.,
are nonallelic), but nevertheless do not exhibit genetic comple-
mentation. This genetic interaction is specific for the rvs161-E6
allele, because rvs161 and act1-1 fully complement, as one
would expect. Furthermore, rvs167 and act1-1 also fully com-
plement (215). A subsequent study showed rvs161-E6 exhibits
nonallelic noncomplementation with act1-1 for several other
phenotypes, including bipolar bud site selection, growth in the
presence of Na, and utilization of nonfermentable carbon
sources (19).
What does nonallelic noncomplementation tell us about
Rvs161p and actin? There are two ways in which nonallelic
noncomplementation can arise. One is based on gene dosage.
A doubly heterozygous diploid will have only half the normal
level of each protein and this may be insufficient. This does not
account for the case of rvs161-E6 and act1-1 because nonallelic
noncomplementation was not observed with rvs161 and
act1-1 even though this diploid would have only half the nor-
mal level of each protein. The other way in which nonallelic
noncomplementation can arise is by the formation of a toxic
complex between the two mutant proteins. This better ac-
counts for the nonallelic noncomplementation of rvs161-E6
and act1-1 because it explains why rvs161, which does not
encode a protein, would not show the same genetic interaction.
Nonallelic noncomplementation suggests the mutant form of
Rvs161p (Rvs161p-R59K) binds the mutant form of actin in
vivo and this complex has deleterious effects.
A more extensive study of genetic interactions between actin
and Rvs161p and Rvs167p was subsequently reported. Actin
and Rvs161p or actin and Rvs167p mutations were combined
in haploid cells and the double mutants created were examined
for combinations that resulted in more severe defects than
found in the original single mutants. A striking result was that
genetic interaction is allele specific. Some actin mutations (e.g.,
act1-1) in combination with either rvs161 or rvs167 re-
sulted in lethality. In contrast, other actin mutations (e.g.,
act1-4) in combination with rvs161 or rvs167 yielded dou-
ble mutants that were no more defective than the single
mutants. The act1 alleles that are lethal in combination with
rvs mutations may affect the interaction of actin with a
protein that is functionally redundant with Rvs proteins in
some essential cellular process (19).
The three-dimensional structure of rabbit muscle actin has
been determined and the very high amino acid sequence ho-
mology of rabbit muscle actin to yeast actin has led to a plau-
sible predicted structure for yeast actin. The residues altered in
each act1 mutant have been mapped onto the predicted yeast
actin structure (125, 363). Several mutations that are lethal
when combined with rvs167 map to a patch on the surface of
the actin molecule where myosins are known to bind. Although
only a few act1 mutations were tested for lethality with
rvs161, those that exhibit lethality also map to the same patch
on the surface of actin (19).
Genetic interactions between Rvs proteins and yeast myo-
sins. The yeast genome encodes five MYOsin genes (MYO1 to
MYO5). Myosins all contain a globular domain known as the
S1 fragment or head domain. This domain has ATPase activity
and binds actin. The energy of ATP hydrolysis is coupled to
association and dissociation of the myosin head domain with
actin filaments and directed movement of the myosin along
actin filaments. Myosins in muscle have long coiled-coil tail
domains that associate in a tail-to-tail orientation to form
dimers known as thick filaments. The myosin thick filaments
interdigitate actin thin filaments, and hydrolysis of ATP by
myosin is coupled to sliding of the myosin thick filaments over
the actin thin filaments during muscle fiber contraction.
Not all myosins have coiled-coil tail domains, nor do all
myosins form dimers. The myosins that do have coiled-coil tail
domains and form dimers are known as type II myosins or
conventional myosins because they resemble muscle myosin.
Other myosins may have short tail domains that bind cargo,
organelles, vesicles, mRNA, etc., that is then transported along
actin filaments by the activity of the ATPase head domain (70,
71, 95, 213, 214, 252, 358).
Genetic interactions between each yeast myosin and
Rvs161p and Rvs167p have been examined. The strongest ge-
netic interaction resulted when loss of the only type II conven-
tional myosin in yeast, Myo1p (myo1), was combined with
rvs161 or rvs167; these double mutants were inviable (19).
Myo1p is the myosin that forms the actomyosin contractile ring
during cytokinesis (16, 178, 354). Hence, this genetic interac-
tion suggests a role for Rvs161p and Rvs167p in cytokinesis.
Neither rvs161 nor rvs167 mutants have been tested for defects
in cytokinesis, however, loss of the Rvs167p-associated pro-
teins Las17p and Vrp1p causes defects in cytokinesis. In the
case of Vrp1p the cytokinesis and actin patch polarization
defects are genetically separable and probably represent
distinct activities (173, 218, 260, 328). Loss of the Rvs161p
ortholog in the fission yeast Schizosaccharomyces pombe
(Hob3) affects cytokinesis (276). Like rvs161 and rvs167,
both las17 and vrp1 mutations are lethal in combination
with myo1 (275). A tight block in cytokinesis may explain
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why some rvs161 and rvs167 mutant cells continue to display
buds with nuclei even under conditions of nutrient starva-
tion (12, 42).
The myo2-66 mutation is not lethal in combination with
rvs161 or rvs167, but the double mutants grow much more
poorly than either single mutant (19). MYO2 encodes Myo2p,
which is a type V unconventional myosin and the only essential
myosin in yeast. Myo2p localizes to zones of polarized growth
where actin patches are also found, but does not strictly colo-
calize with actin patches. A conditional allele, myo2-66, causes
temperature-sensitive defects in polarized secretion to the bud
and accumulation of what appear to be secretory vesicles,
similar to rvs161 and rvs167 mutants. Moreover, myo2-66 is
lethal in combination with mutations that affect fusion of Golgi
apparatus-derived secretory vesicles with the plasma mem-
brane (104, 138). Myo2p has been proposed to move secretory
vesicles along actin cables to sites of surface growth, where
they dock and fuse with the plasma membrane (273). The
negative genetic interaction between myo2-66 suggests a role
for Rvs161p and Rvs167p in polarized secretion.
No genetic interactions between Rvs161p or Rvs167p and
the other yeast myosins, Myo4p (type V myosin), Myo3p (type
I myosin), or Myo5p (type I myosin), were observed (19).
Myo3p and Myo5p colocalize with Rvs167p in actin patches
and have redundant functions in actin patch polarization and
endocytosis (5, 96, 102). The type I myosins interact via an SH3
domain with Vrp1p and Las17p and via a C-terminal acidic tail
with the Arp2/3p complex and play a role in de novo actin
filament assembly (72, 161). Given the redundancy of Myo3p
and Myo5p, it would be interesting to know the phenotype of
myo3 myo5 rvs161 and myo3 myo5 rvs167 triple
mutants.
Actin mutations that map to the surface patch and affect
binding of myosin head domains may genetically interact with
rvs mutations because the myosin(s) whose binding is affected
has redundant function with the Rvs proteins (19). If this
explanation is correct, the myosins whose binding is affected
may be Myo1p and Myo2p. The Rvs proteins may help to
stabilize actin-myosin interactions and become essential when
actin-myosin interaction is affected by mutation of either pro-
tein. Alternatively, the Rvs proteins may act downstream to
tether actin filaments to sites of vesicle fusion or play a role in
vesicle fusion itself.
Rvs Proteins and Membranes
Association of cortical actin cytoskeleton with membranes.
The ability of yeast Rvs proteins to associate with lipid mem-
branes has been examined only recently. The diffuse cytoplas-
mic distribution initially reported for Rvs161p did not suggest
an association with membranes (21). In the case of Rvs167p,
which localizes to cortical actin patches, a membrane associa-
tion seemed easier to envisage (11). Cortical actin patches have
been visualized by electron microscopy and at least some actin
patches are found at sites where the plasma membrane forms
“finger-like” invaginations. The invaginations exhibit immuno-
reactivity for Abp1p and actin. Antibodies against actin deco-
rate transverse striations along the invagination that were pro-
posed to be actin filaments. While some actin patches were
observed in contact with the plasma membrane invaginations,
other actin patches did not appear to be in contact with the
plasma membrane. This may be due to an ability of actin
patches to reversibly associate and dissociate from plasma
membranes. Alternatively, due to technical limitations, elec-
tron microscopy may not reveal all the plasma membrane con-
tacts.
Fractionation of Rvs proteins with membranes. Subcellular
fractionation approaches initially revealed that the majority of
Rvs167p and a significant fraction of Rvs161p are in tight
association with membranes in vivo (10, 98). Recently, purified
Rvs161p and Rvs167p were shown to directly bind liposomes in
vitro (84a).
Rvs proteins and lipid rafts. Membranes both in mammalian
cells and in yeast have been shown to consist of a number of
distinct “microdomains” characterized by distinct protein and
lipid compositions. The best characterized of these microdomains
are lipid rafts. Lipid rafts are formed by the lateral association of
sphingolipids and sterols (cholesterol in mammalian cells and
ergosterol in yeast) and have the biochemical property that,
when maintained on ice, they resist solubilization by nonionic
detergents such as Triton X-100. This property has led to lipid
rafts’ being also referred to as detergent-resistant membranes
or detergent-insoluble glycosphingolipid-enriched membranes
(22, 113, 159, 233). In wild-type cells, both Rvs167p and
Rvs161p are associated with detergent-insoluble membranes.
In mutant cells deficient in sphingolipid biosynthesis Rvs161p
becomes detergent soluble, suggesting the Rvs proteins may
partition into glycosphingolipid-enriched lipid raft micro-
domains (10, 97). Further evidence that Rvs proteins are as-
sociated with glycosphingolipid-enriched lipid raft membranes
in vivo has come from genetic approaches. A key discovery was
that mutations that affect glycosphingolipid biosynthesis sup-
press the full range of rvs phenotypes (10, 53, 97, 300, 381) (see
below).
In yeast, the glycosylphosphatidylinositol (GPI)-anchored
protein Gas1p and the integral plasma membrane H-ATPase
Pma1p are markers of lipid rafts (9). Lipid rafts form in the ER
(9). Export of lipid raft proteins such as GPI-anchored proteins
from the ER has requirements distinct from those for nonraft
proteins, in particular a requirement for continuing glyco-
sphingolipid biosynthesis (127, 311).
A distinct class of transport vesicle that is lipid raft enriched
mediates the transport of lipid rafts from the ER. The forma-
tion of this type of transport vesicle has been reconstituted in
vitro and requires the Rab GTPase Ypt1p. In reactions defi-
cient in Ypt1p lipid rafts are still exported from the ER but
instead of being transported in lipid raft-enriched vesicles they
are transported by default in vesicles containing nonraft pro-
teins (202). Mutations that affect sphingolipid biosynthesis per-
turb delivery of Pma1p to the cell surface (9). This suggests
that sorting of Pma1p to the cell surface involves partitioning
into lipid rafts. Interestingly, mutations affecting the actin
patch protein Sla2p reduce Pma1p levels at the plasma mem-
brane, suggesting that sorting of lipid raft proteins to the cell
surface requires a functional actin cytoskeleton (217).
One of the important functions of lipid rafts is in providing
a platform for integration of signal transduction pathways. One
of the best examples is the activation of the mitogen-activated
protein kinase Raf by the small GTPase H-Ras, which only
occurs when H-Ras partitions into lipid raft microdomains (27,
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249). In yeast there exist five integral plasma membrane pro-
teins, Wsc1p to Wsc4p and Mid2p, that act as sensors of dif-
ferent stress conditions (152, 179, 241, 346). Wsc1p is the
sensor responsible for signaling actin patch depolarization in
response to elevated temperature or exposure to Na (10, 52).
Wsc1p localizes in part to lipid rafts (179). Protein kinase C
(PKC) and mitogen-activated protein kinases regulate polar-
ization and depolarization of actin patches upon exposure of
cells to stress and downstream of Wsc1p. Exposure of wild-type
yeast cells to high temperature or to high Na induces depo-
larization of actin patches over a period of about 30 min. In the
continual presence of the stress, cells gradually adapt, and after
90 min the actin patches have returned to a fully polarized
distribution (35).
Protein kinase C (Pkc1p) is implicated both in depolariza-
tion of actin patches and in actin patch repolarization. In
contrast, the PKC1-dependent mitogen-activated protein ki-
nase Slt2p/Mpk1p is not implicated in depolarization of actin
patches in response to heat stress, but is specifically required
for adaptation to heat stress and subsequent actin patch repo-
larization. The PKC effectors that mediate actin patch depo-
larization are yet to be identified (52). Loss of PKC results in
loss of cell wall integrity and cell lysis during bud growth. In
comparison, loss of the downstream mitogen-activated protein
kinase Slt2p has less severe phenotypes and these mutants are
viable but exhibit depolarized actin patches, mild cell wall
defects, and temperature sensitivity as do cells deficient in
Rvs161p or Rvs167p. Intriguingly, rvs mutations exhibit strong
genetic interactions with slt2 mutations: while both rvs and slt2
single mutants are viable, an rvs slt2 double mutation is lethal
(10). The terminal phenotype of rvs slt2 mutants is reminiscent
of that of pkc1 mutants (arrested cells exhibit cell lysis during
bud growth).
Are rvs mutants defective in actin patch repolarization? In-
deed, loss of either Rvs protein does not affect stress-induced
actin patch depolarization, but blocks repolarization. Depolar-
ization of actin patches is a physiological response to stress.
Actin patch depolarization observed in untreated rvs mutant
cells may be due to stresses encountered normally during
growth to which wild-type cells but not rvs mutant cells adapt
easily. Restoration of actin patch polarity may require repair of
cell wall damage induced by elevated temperature or Na.
Slt2p and Rvs proteins may function in distinct pathways down-
stream of PKC that are important for repair of cell wall dam-
age and actin patch repolarization. Slt2p may be required for
induction of cell wall repair enzymes via phosphorylation of
specific transcription factors. Rvs proteins may be required for
polarized delivery of newly synthesized cell wall repair en-
zymes to the cell surface. Consistent with this, mutation of the
cell wall repair enzyme -glucan synthase (kre6) causes only
mild growth defects, but kre6 rvs167 double mutants are barely
viable (10). Mapping of in vivo phosphorylation sites in
Rvs167p has not revealed phosphorylation of any site that
matches the PKC consensus, and it is not yet clear if Rvs167p
is a PKC substrate.
Suppression of Rvs phenotypes by mutations affecting gly-
cosphingolipid biosynthesis. Loss of Rvs161p or Rvs167p re-
sults in diverse phenotypes. Several studies have sought to
determine if all these phenotypes result from one basic under-
lying deficiency. In one study, extragenic suppressor mutations
that rescue the various rvs defects were isolated and charac-
terized. The rationale behind this approach is that by charac-
terizing the mutations that rescue the rvs mutant defects we
may gain insight into what caused those rvs defects. Extragenic
mutations were isolated that suppress rvs161 (sur). Four sep-
arate screens were performed to isolate sur mutations that
restore different rvs phenotypes, i.e., viability upon glucose
starvation, utilization of nonfermentable carbon sources (glyc-
erol/ethanol), growth in the presence of 3-AT, and growth in
the presence of Na. Since the starting strain had a deletion of
the RVS161 gene, all suppressor mutations isolated affect other
genes (i.e., they are extragenic) (53).
Of 100 extragenic suppressor mutations isolated, some
suppressed only the specific Rvs phenotype they were se-
lected on (e.g., restored growth in the presence of Na, but not
survival upon glucose starvation). Ten suppressor mutations,
however, that suppressed all Rvs phenotypes were recovered.
These sur mutations suppressed the phenotypes not only of
rvs161 but also rvs167 and rvs161 rvs167 double mutants. All sur
mutations were recessive and genetic complementation analy-
sis showed they affect four separate genes called SUR1 to SUR4
(53). Interestingly, sur1-4 mutations suppress vesicle accumu-
lation in rvs161 and rvs167 mutant cells (20). sur4 (vbm1) and
fen1/sur5 (vbm2) were also isolated in an independent study as
mutations that suppress the growth and vesicle accumulation
defects of snc1 snc2 double mutants (48). Snc1p and Snc2p are
vesicle-associated soluble N-ethylmaleimide-sensitive fusion
protein attachment protein receptors that localize to post-
Golgi apparatus secretory vesicles and mediate docking and
fusion of these vesicles with the plasma membrane (251).
Snc1p interacts genetically with both Ras GTPases and Srv2p,
suggesting a role in response to nutrient availability (98).
The sur single mutants do not exhibit reduced viability upon
starvation and they grow well on nonfermentable carbon
sources. sur1-3 mutants sporulate well and exhibit a bipolar
budding pattern in diploids, but sur4 mutants have severe de-
fects in sporulation and bipolar bud site selection, like rvs
mutants. The sporulation defect exhibited by sur4 arises in
spite of the ability of sur4 mutants to utilize nonfermentable
carbon sources and survive nitrogen starvation. Moreover, sur4
rvs161 and sur4 rvs167 double mutant diploids are able to
sporulate efficiently even though each single mutant diploid is
not. These data suggest Rvs and Sur4p proteins have specific
roles in sporulation. Where tested, deletion of each SUR gene
suppresses rvs161 and rvs167 mutant phenotypes, similar to the
original sur mutation. This suggests the sur mutations isolated
in the mutant screen are loss-of-function mutations (53).
The genes affected by the sur1, sur2, and sur4 mutations have
been identified (the gene affected by the sur3 mutation is still
unknown). SUR1, SUR2, and SUR4 encode ER-localized inte-
gral membrane proteins that function in biosynthesis of glyco-
sphingolipids (Fig. 8). Unlike glycerol-based phospholipids
that comprise a glycerol base to which one phosphate and two
long-chain fatty acids (C16 to C18) are esterified, glycosphin-
golipids contain a phytosphingosine base with one very long
chain fatty acid (C26) attached via an amide linkage (54). The
phytosphingosine base is synthesized by the transfer of serine
to palmitic acid (as palmitoyl-coenzyme A) to form 3-keto-
dihydrosphingosine followed by two reduction steps, first yield-
ing dihydrosphingosine and then phytosphingosine (Fig. 8).
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The C26 fatty acid is then attached to phytosphingosine to yield
ceramide. Ceramide is converted into glycosphingolipids, which
in yeast are inositolphosphoceramide, mannosylinositolphospho-
ceramide, and mannosyldiinositylphosphoceramide (54).
The product of the SUR2 gene (Sur2p) is the reductase that
converts dihydrosphingosine to phytosphingosine during syn-
thesis of the ceramide base. The product of SUR4 (Sur4p) is
required for elongation of fatty acid chains by fatty acid syn-
thase, e.g., conversion of palmitate (C16) to very long chain
fatty acids (C26). As very long chain fatty acids are incorpo-
rated into sphingolipids, sur4 mutants are also defective in
sphingolipid biosynthesis. SUR4 is also known as ELOngation
3 (ELO3). The SUR1 gene product (Sur1p) acts downstream of
SUR2 and SUR4 and is required for conversion of ceramide to
glycosphingolipids. The mannosylation of inositolphosphocer-
amide to yield mannosylinositolphosphoceramide is dependent
on Sur1p (54). IPT1 is the gene required for conversion of
mannosylinositolphosphoceramide to mannosyldiinositylphos-
phoceramide (the step after the Sur1p step). Deletion of IPT1
(ipt1) suppresses the phenotypes of rvs161mutants (rvs167
was not tested), and hence IPT1 is also a SUR gene (10).
When the amino acid sequence of SUR4/ELO3 was de-
termined it was noticed that two other yeast genes encode
homologous proteins. One, FEN1, was originally identified
as the gene affected in a mutant resistant to the toxic sterol
biosynthesis inhibitor fenpropimorph. Indeed, mutation of
SUR4/ELO3 also results in resistance to fenpropimorph.
The mechanism by which these mutations confer resistance to
fenpropimorph has not been elucidated, however, this result does
suggest that Sur4p has a function closely related to that of
Fen1p. Further characterization of Fen1p revealed that it, like
Sur4p, is involved in the elongation of fatty acids to give the
C26 fatty acid utilized in sphingolipid biosynthesis and FEN1 is
also known as ELO2. fen1 mutations, like sur4 mutations, affect
bipolar budding in homozygous diploids. Also like sur4 muta-
tions, fen1 mutations suppress the phenotypes of rvs161 and
rvs167, and FEN1/ELO2 is also known as SUR5. sur4 fen1
double mutants are inviable. This shows Sur4p and Fen1p have
redundant functions in an essential process, presumably syn-
thesis of very long chain fatty acids (262, 300).
The other gene that encodes a protein homologous to Sur4p
is also required for fatty acid elongation and has been named
ELO1. Unlike FEN1/ELO2 and SUR4/ELO3, which are re-
quired for fatty acid elongation to yield very long chain fatty
acids with a chain length of C26, ELO1 is involved in elongation
of medium-chain C12 to C16 fatty acids to long-chain C16 to C18
fatty acids. Deletion of ELO1 does not affect doubling time or
bipolar bud site selection. Moreover, elo1 mutations do not
suppress the phenotypes of rvs mutants (so ELO1 is not a SUR
gene). This finding shows that suppression of rvs is specific to
mutations that affect glycosphingolipid synthesis, which re-
FIG. 8. Sphingolipid biosynthesis in yeast. The yeast sphingolipid biosynthetic pathway indicating the steps blocked by sur1, sur2, sur4, fen1/sur5,
and ipt1 mutations that suppress the phenotypes of rvs161 and rvs167 mutants. CoA, coenzyme A; LCB, long-chain base; PI, phosphatidylinositol;
Inos-P, inositol-1-P; Cer, ceramide; IPC, inositolphosphorylceramide; MIPC, mannosyl-inositolphoshorylceramide; M(IP)2C, mannosyl-diinosi-
tolphoshorylceramide; Man-P-Inos, mannose(-1,2)inositol-1-P. (Reprinted from reference 54 with permission from Elsevier.)
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quires C26 but not C16-18 fatty acids (262, 285).
The phospholipid composition of rvs and sur single and
double mutants has been compared. The total amount of phos-
pholipid in rvs161 was similar to that of the wild type, but the
phospholipid content was reduced twofold in sur1, rvs161
sur1, sur4, and rvs161 sur4 mutant cells. The rvs161 mutant
does not have an altered phospholipid composition. In all sur1
and sur4 mutants the percentage of phosphatidylcholine and
phosphatidylethanolamine increased, while the percentage of
phosphatidylglycerol plus cardiolipin and phosphatidylinositol
decreased. The decrease in phosphatidylinositol was slight in
sur1 mutants but dramatic in sur4 mutants (approximately 70%
reduction). The abundance of phosphatidylserine was relatively
normal in all mutants (53). It is more likely the suppression of rvs
phenotypes is associated with the altered glycosphingolipid com-
position rather than the altered phospholipid composition.
SUppressor of Rvs167 7 (SUR7) was identified in a screen to
identify wild-type genes that, when overexpressed, suppress the
Rvs phenotype of rvs167-1. Overexpression of SUR7 partially
rescued all the defects of rvs167 as well as rvs161 and rvs161
rvs167 double mutants. Deletion of SUR7 (sur7) did not con-
fer any of the phenotypes of rvs mutants except for a somewhat
reduced efficiency of sporulation. sur7 did not suppress any
phenotypes when combined with the rvs161 or rvs167 mutation.
The mechanism of SUR7 suppression therefore appears to
differ from that of sur1-5. SUR7 encodes an integral membrane
protein (Sur7p) with three or four predicted transmembrane
domains whose expression is regulated and peaks in late G2-M
of the cell cycle. Sur7p localizes to numerous small cortical
patches, which are distinct from actin patches (300, 381).
Sur7p is implicated in glycosphingolipid biosynthesis, but at
a different step than Sur1-5p. The phytosphingosine base of
sphingolipids can be either C18 or C20 in length and is also
variably hydroxylated. Glycosphingolipids are classified as class
A, B, C, or D based on whether the phytosphingosine base has
1, 2, 3, or 4 hydroxyl groups, respectively. The plasma mem-
branes of sur7 cells contain the normal ratio of sphingolipids
with C18 and C20 phytosphingosine bases, but they exhibit a
reduced amount of the more heavily hydroxylated class C and
D glycosphingolipids and a corresponding accumulation of
class B glycosphingolipids with only two hydroxyl groups. The
phospholipid composition was unaffected in plasma membranes
from sur7 cells (381). Given that SUR7 overexpression, but not
deletion of SUR7, suppresses rvs161 and rvs167 mutant pheno-
types, it will be interesting to see the effect of SUR7 overexpres-
sion on glycosphingolipid and phospholipid composition.
How do sur mutations suppress Rvs phenotypes? Does
altered glycosphingolipid composition in sur mutant cells affect
lipid raft-based signaling pathways that control depolarization
and/or repolarization of actin patches? In support of this idea,
sur4 and fen1 cells depolarize their actin patches somewhat
faster than wild-type cells upon exposure to Na. In contrast,
sur1, sur2, and ipt1 cells are not able to fully depolarize their
actin patches upon exposure to Na. Adaptation to the Na
stress and repolarization of actin patches were normal in sur4,
fen1, sur1, and sur2 cells, but slower in ipt1 cells. Importantly,
each rvs161 sur double mutant cell was able to adapt to stress
and repolarize actin patches after Na-induced depolarization,
whereas rvs161 single mutant cells were not. The suppressing
effect of sur mutations on Rvs phenotypes is not restricted to
rvs mutants: sur1, sur2, sur4, fen1, and ipt1 also restore growth
of act1 mutant cells in the presence of Na although effects on
actin patches in act1 mutant cells were not investigated (10).
How do sphingolipids influence actin patch depolarization
and repolarization? In mammalian cells, sphingolipids such as
ceramide act as important second messengers in a wide variety
of signaling pathways that regulate differentiation, prolifera-
tion, apoptosis, and malignancy (111, 112, 156, 228). Sphingoid
bases (e.g., phytosphingosine) are important second messen-
gers in yeast and exogenous phytosphingosine is sufficient to
restore endocytosis in yeast mutants unable to synthesize en-
dogenous sphingolipids. Restoration of endocytosis in sphin-
golipid-deficient mutants by exogenous phytosphingosine does
not require incorporation into ceramide or glycosphingolipids,
so the phytosphingosine does not have to be incorporated into
lipid raft components. Instead, restoration of endocytosis by
exogenous phytosphingosine depends on its ability as a second
messenger to activate protein kinases Pkh1p/Pkh2p, which in
turn activate PKC, which results in activation of the down-
stream mitogen-activated protein kinase Mpk1p/Slt2p. These
signaling pathways regulate many cellular responses, including
actin patch repolarization (82, 83, 156, 384).
There are two views about the importance of actin patch
repolarization for suppression. According to one view, actin
patch repolarization is critical and suppression of Rvs phe-
notypes is interpreted according to the effects of both phyto-
sphingosine base and lipid raft-dependent Wsc1p on actin
patch distribution. The levels of endogenous phytosphingosine
and lipid rafts in sur mutants are proposed to influence the
phenotype of rvs mutants. According to the second view, sup-
pression still may involve phytosphingosine but can occur with-
out actin patch repolarization.
Balguerie et al. reported data in support of the first view.
fen1 mutants, which repolarize more rapidly than the wild type,
are blocked at an early step of glycosphingolipid synthesis and
accumulate phytosphingosine. Excess endogenous phytosphin-
gosine in fen1 mutants (and possibly also sur4 mutants, which
are also blocked at an early step) is proposed to induce repo-
larization of actin patches to such an extent that Rvs161p is no
longer necessary. sur1, sur2, and ipt1 mutant cells are blocked
later in the glycosphingolipid biosynthetic pathway and do not
accumulate phytosphingosine but may also have reduced levels
of lipid rafts due to lowered glycosphingolipid levels. When
exposed to Na these mutants are not able to fully depolarize
their actin patches, so repolarization may not require Rvs161p.
As mentioned above, one pool of Wsc1p localizes to lipid
rafts (179). If lipid rafts are important for signaling actin
patch depolarization, this may explain why mutants such as
sur1, sur2, and ipt1 mutants cannot fully depolarize their
actin patches (10).
Germann et al. reported data in support of the second view.
This study confirmed that sur4 suppresses the Na sensitivity
of rvs161 and rvs167 mutants. It did so, however, without sig-
nificantly restoring actin patch polarization. Furthermore, in
sur4 cells Rvs167p does not localize to actin patches but
redistributes to the cytoplasm, where it is proteolytically de-
graded. This reinforces the view that, despite improved growth,
the actin patch defect is not rescued by sur4. This study
identified several novel Rvs167p-interacting proteins and
showed that some do not localize to actin patches. Intriguingly,
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the most critical Rvs167p-interacting proteins for sur4-medi-
ated suppression were two proteins, Acf2p and Gdh3p (Table
1), that do not localize to actin patches. In contrast, the
Rvs167p-interacting proteins Abp1p and Sla1p, which do lo-
calize to actin patches, were not required for sur4-dependent
suppression of rvs161 and Abp1p was not required for sur4-
dependent suppression of rvs167 (note that Sla1p could not
be tested because sla1 rvs167 is lethal [176]). Interestingly,
Acf2p and Gdh3p fractionate with Rvs167p in detergent-insol-
uble membranes, suggesting all three proteins localize to lipid
rafts such as Rvs161p (10, 97).
These findings are in agreement with recent evidence from
several other studies that found actin patch polarization is not
strictly required for growth even at elevated temperatures. The
idea that actin patch polarization may be important for growth
came from two observations: no viable mutant that lacks actin
patches has yet been reported (hence the existence of actin
patches appears to be essential) (149), and many mutants that
exhibit depolarized actin patches also exhibit slow growth at
normal temperature and are unable to grow at elevated tem-
perature. Examples include loss of Rvs167p, Rvs161p, Sla1p,
Sla2p/End4p, Sac6p, Srv2p, Vrp1p, Las17p, and point muta-
tions in actin, Pan1p, and Arp2/3p complex subunits (15, 60,
126, 173, 176, 181, 197, 215, 219, 321, 340, 363, 364). There are,
however, strains in which actin patch polarization is lost with-
out abolishing growth at elevated temperature, for example, in
the wild type or in vrp1 mutants overexpressing Las17p (219),
vrp1 mutants expressing a fragment of Vrp1p (328), or mu-
tants deficient in capping protein Cap2p (cap2) (3) or the
actin-regulatory kinase Prk1p (prk1) (387). Some mutations
in Ysl2p (ysl2-1) (296) and in actin (act1) (15) also severely
perturb actin patch polarization without resulting in tempera-
ture-sensitive growth.
It is possible that alterations in cellular lipid composition
induce growth defects in rvs mutants and suppression of growth
defects in sur mutants via mechanisms unrelated to their effects
on actin patch distribution. It is interesting that the sphingoid
base component of sphingolipids can cause cell damage and
induce apoptosis in mammalian cells (111, 112, 228). In S. cere-
visiae the sphingoid base phytosphingosine regulates growth
via ceramide-activated protein phosphatase (CAPP) (75, 224).
Lipids other than sphingolipids can also affect growth and
viability. A recent study found that endogenous free fatty acids
and diacylglycerol induce apoptosis upon entry into stationary
phase in S. pombe. This apoptosis pathway is caspase indepen-
dent, i.e., independent of the yeast caspase-like protease (388).
Finally, protein N-myristoylation is known to be essential for
survival under starvation conditions in S. cerevisiae and re-
quires the medium-chain fatty acid myristate (7). Perhaps lev-
els of myristate vary depending on the level of very long chain
fatty acids. The contribution of lipid-mediated signaling to the
various defects in rvs mutant cells is an area that has not yet
been fully explored.
Regulation of Rvs167p by Phosphorylation
Insight into how Rvs proteins function to link nutrient avail-
ability to G1-S cell cycle progression came from the discovery
that Rvs167p is regulated by the kinase Pho85p (163). Pho85p
is a yeast cyclin-dependent kinase (Cdk) like the major cell
cycle-regulatory Cdk known as Cdc28p in budding yeast (Cdc2/
Cdk2 in fission yeast and mammalian cells) (200). The mam-
malian ortholog of budding yeast Pho85p is Cdk5, and its
activity is critical for neuronal function (303). Mammalian
Cdk5 has been shown to functionally substitute for Pho85p
when expressed in budding yeast, so Cdk5 and Pho85p are
functional orthologs (129, 225).
As for all Cdks, the protein kinase activity of both Cdc28p
and Pho85p is dependent on their association with regulatory
subunits known as cyclins whose expression level often varies
through the cell cycle. Cdc28p is activated by one set of cyclins
known as G1 cyclins (Cln1p to Cln3p) in late G1 for entry into
the cell cycle and by two other sets of cyclins known as S-phase
and mitotic cyclins (Clb1p to Clb6p) at subsequent stages of
the cell cycle. Pho85p has 10 known cyclins known as Pho85
cyclins (Pcls). The Pcls have been classified into two subfamilies
based on homology, the Pcl1p/2p subfamily (comprising Pcl1p,
Pcl2p, Clg1p, Pcl5p, and Pcl9p) and the Pho80p subfamily (com-
prising Pho80p, Pcl6p-Pcl8p, and Pcl10p) (6, 170, 190).
In conjunction with different Pcls, Pho85p plays a role in
phosphate and glycogen metabolism as well as a role in G1-S
cell cycle progression. Pcl1p and Pcl2p in association with
Pho85p are functionally redundant with Cdc28p and the G1
cyclins Cln1p and Cln2p in G1-S cell cycle progression. This
late G1 role is specific to Pcl1p and Pcl2p, as other Pcls are not
able to perform this function (in the case of the highly Pcl2p-
homologous Pcl9p, this may simply be due to insufficient ex-
pression in late G1). Two-hybrid screens identified Rvs167p as
a Pcl2p- and Pcl9p-associated protein and the interaction was
confirmed by coimmunoprecipitation of Rvs167p with Pcl2p
from lysates and binding of recombinant Pcl2p and Rvs167p in
vitro. All Pcl1p/2p subfamily Pcls bind strongly to Rvs167p, but
Pho80p subfamily Pcls bind Rvs167p only weakly (163).
Do pho85, pcl2, or pcl9 mutants exhibit Rvs phenotypes?
As the Pcl1p/2p subfamily Pcls exhibit functional redundancy,
a strain with deletions of all five genes encoding Pcl1p/2p
subfamily Pcls (referred to in reference 163 as quint) was
constructed. Both quint and loss of Pho85p (pho85) resulted
in essentially the full range of Rvs phenotypes. Consistent
with a role for Pho85p/Pcl2p in regulation of Rvs167p, Pho85p/
Pcl2p phosphorylates Rvs167p in vitro and phosphorylation of
Rvs167p in vivo is partially dependent on Pcl1p/Pcl2p subfam-
ily Pcls. Rvs167p is phosphorylated only in G1 phase, consistent
with in vivo phosphorylation by Pho85p in association with
Pcl1p and Pcl2p (which are expressed specifically in G1). There
are three major phosphorylation sites in vivo and all are lo-
cated in the GPA-rich domain, S299, S379, and S321. When
S321 is mutated T323 is phosphorylated instead, so T323 is a
potential phosphorylation site but is not normally phosphory-
lated. Phosphorylation of S299 and S379 in vivo is partially
dependent on Pcl1p/Pcl2p, but phosphorylation of S321 is not
(85, 163).
Rvs167p is hyperphosphorylated upon exposure of cells to
mating pheromone, suggesting a role for Rvs167p phosphory-
lation also in the mating response. Hyperphosphorylation re-
quires Pho85p and specifically Pcl2p (whose expression is in-
duced by mating pheromone). Hyperphosphorylation also
requires the mitogen-activated protein kinase Fus3p, which is
induced by mating pheromone and functions in the mating
pheromone response pathway. In vitro, Fus3p phosphorylates
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the same sites in the Rvs167p GPA-rich domain as Pho85p/
Pcl2p (i.e., S299, S321, S370, and, when S321 is missing, T323)
(85). Hyperphosphorylation of Rvs167p by Fus3p supports a
role for Rvs167p in mating, as proposed previously (11, 20).
Is phosphorylation of Rvs167p important for its function?
An Rvs167p mutant protein in which S299, S321, T323, and
S379 were all replaced with alanine (Rvs167-4A) did not result
in Rvs phenotypes. This was perhaps not unexpected since
these phosphorylation sites all lie within the GPA-rich domain,
which has been shown previously to be nonessential for known
Rvs167p functions (38, 299). Under normal conditions,
rvs167-4A was also not lethal in combination with any muta-
tions that are known to be lethal in combination with rvs167
(176). However, under conditions of high temperature and in
the presence of Na rvs167-4A was lethal in combination with
sla1. Moreover, testing of the set of systematic deletions
covering each nonessential S. cerevisiae open reading frame
revealed that a mutant carrying the novel combination end3
rvs167 is inviable. Furthermore, end3 is also lethal in com-
bination with rvs167-4A. Rvs167p phosphorylation may there-
fore be important in the absence of Sla1p and essential in the
absence of End3p (85).
End3p and Sla1p form a complex with the Arp2/3p complex-
activating protein Pan1p (62, 322). Activation of the Arp2/3p
complex by Pan1p may be essential in the absence of Las17p,
as loss of both Pan1p and Las17p results in lethality (62).
Given the deleterious interactions between rvs167-4A and mu-
tations affecting the Sla1p-End3p-Pan1p complex, loss of phos-
phorylation of Rvs167p may perturb Las17p function. This
would result in dependency on the Sla1p-End3p-Pan1p com-
plex for Arp2/3p activation. Indeed, the Rvs167p SH3 domain
binds Las17p in vitro (38, 181). Binding of GPA-SH3 to Las17p
(and also Ymr192p/Gyl1p) in vitro is considerably reduced by
phosphorylation of the GPA-rich domain by Pho85p/Pcl2p.
Introduction of a charge via phosphorylation into the un-
charged GPA-rich domain may induce major conformational
changes in the GPA-rich domain that affect the neighboring
SH3 domain and its ability to bind Las17p and other proteins.
In this case Rvs167-4A (which cannot be phosphorylated) may
bind Las17p too strongly and perhaps inhibit Las17p-depen-
dent Arp2/3p activation, causing dependency on Sla1p-End3p-
Pan1p (85).
Regulation of Rvs167p by Ubiquitination
The role of ubiquitination in endocytosis extends beyond
ubiquitination of the receptor tail by the ubiquitin protein
ligase Rsp5p. Ubiquitination of the endocytic machinery may
also be essential for endocytosis (64). Genetic interactions
between Rsp5p and a number of actin patch proteins required
for endocytosis support an additional role for Rsp5p in regu-
lation of actin patches and the endocytic machinery (146).
Substrates ubiquitinated by Rsp5p often associate with Rsp5p
and can be identified by protein interaction screens.
In a high-throughput mass spectrometry analysis of the
yeast proteome, a protein complex containing Rsp5p and
Rvs167p was identified (123). Rvs167p also associates with
Sla1p (59, 123) and both Rvs167p and Sla1p immunopre-
cipitate with Rsp5p from yeast lysate, showing Rvs167p,
Sla1p, and Rsp5p form a complex in vivo (307). Consistent
with the possibility that Rvs167p is ubiquitinated by Rsp5p,
mass spectrometry analysis of the yeast proteome detected
ubiquitin attached to K481 in the Rvs167p SH3 domain
(122, 236).
The Rvs167p-Rsp5p association is direct and mediated by
the Rsp5p WW domains and the Rvs167p GPA-rich domain.
WW domains bind motifs of the consensus PPXY and the
Rvs167p GPA-rich domain includes one motif (PPAY) that
matches exactly and two motifs (PSY and PQY) that match
less closely. All three motifs contribute to the interaction with
Rsp5p. The Sla1p-Rsp5p association is also direct and medi-
ated by residues 420 to 720 of Sla1p, which contains Sla1p
Homology Domain 1 (SHD1) and a coiled-coil domain. It has
been proposed that the Sla1p-Rvs167p complex may be the
yeast equivalent of the vertebrate CIN8-endophilin complex.
While Rvs167p is often compared to vertebrate amphiphysin, it
is also related to vertebrate endophilin, which has a domain
structure similar to that of amphiphysin but was discovered
more recently (Fig. 1). Sla1p exhibits sequence homology to
CIN8 and the two proteins have a similar domain structure.
Moreover, like the yeast Sla1p-Rvs167p complex, the verte-
brate CIN8-endophilin complex interacts with the ubiquitin
ligase Rsp5p (known as Nedd4 in vertebrates) and functions in
endocytosis (240, 305, 307, 313).
The ubiquitin ligase Rsp5p is responsible for Rvs167p mo-
noubiquitination, since an rsp5 mutation results in loss of the
modified form of Rvs167p. Moreover, Rsp5p binding to
Rvs167p is also important for monoubiquitination, since com-
bined mutation of the PPXY, PSY, and PQY motifs in the
Rvs167p GPA-rich domain or combined mutation of the three
Rsp5p WW domains not only reduce Rvs167p-Rsp5p associa-
tion but also reduce the level of monoubiquitinated Rvs167p in
vivo. Interestingly, although the GPA-rich domain mediates
binding of Rvs167p to Rsp5p, it is not the site at which ubiq-
uitin is attached (indeed, the GPA-rich domain contains no
lysine residues and hence cannot be ubiquitinated). K481 in
the SH3 domain is the only site ubiquitinated in Rvs167p.
Hence, binding of Rsp5p to the Rvs167p GPA-rich domain
induces monoubiquitination of K481 in the Rvs167p SH3 do-
main (307).
Is monoubiquitination of Rvs167p important for in vivo
function? As discussed above, neither the GPA-rich nor SH3
domain is required for any of the known biological roles of
Rvs167p (38). Consistent with this, mutated forms of Rvs167p
lacking PPXY and PXY motifs in the GPA-rich domain, with
a K481R substitution in the SH3 domain (to prevent ubiquitin
attachment), or lacking the SH3 domain entirely were fully func-
tional for receptor-mediated endocytosis (307). An Rvs167p
mutant construct lacking the SH3 domain was previously found
to be only partially functional for growth in the presence of
Na, possibly due to lowered expression (38, 299). Similarly,
the mutant Rvs167p construct with a K481R substitution in the
SH3 domain was also only partially functional for growth in the
presence of Na. However, this requirement is for K481 only,
not ubiquitination of K481. An Rvs167p mutant construct lack-
ing a PPXY motif does not bind Rsp5p and is not ubiquitinated
on K481, but nevertheless is fully functional for growth in the
presence of Na. Hence, K481, but not ubiquitination of K481, is
important for some functions of Rvs167p (307).
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Genomic and Proteomic Approaches and the Diverse
Network of Rvs Interactions
Large-scale two-hybrid screens for Rvs161p- and Rvs167p-
interacting proteins. The first large-scale screen to identify all
Rvs161p- and Rvs167p-interacting proteins was reported by
Bon et al. Full-length RVS161 and RVS167 genes in both cen-
tromeric (low copy) and multicopy plasmids were used as bait.
Each prey sequence isolated by either Rvs161p or Rvs167p was
then tested against the other bait. Finally, selected preys were
tested against each individual domain of both proteins. Nu-
merous potential interacting proteins were identified (Table
1). Interestingly, five preys interacted with Rvs161p and
Rvs167p, specifically Las17p, Rvs167p itself, App1p, Gyp5p,
and Gyl1p (18).
Subsequently, more global analyses of protein-protein inter-
actions among all proteins encoded by the S. cerevisiae genome
were performed by Uetz et al. and by Ito et al. Uetz et al. used
a genomewide set (6,000) of full-length genes as baits and
identified two interactors for Rvs161p and 10 for Rvs167p. Ito
et al. also used a genomewide set of 6,000 full-length genes as
baits and preys and tested each combination systematically.
The interacting proteins identified in this screen overlapped
only slightly with those obtained by Uetz et al., however, only
three interactions for Rvs161p and five for Rvs167p were iden-
tified in this screen (Table 1) (136, 339).
A third study by Drees et al. aimed to produce a protein
interaction map for proteins implicated in cell polarity devel-
opment; 68 selected baits relevant to cell polarity were chosen
and used to screen an array of preys representing about 90% of
the S. cerevisiae genome. A network of interactions was re-
vealed that links signaling proteins, the actin cytoskeleton, and
organelles to polarity cues. This network included Rvs161p and
Rvs167p homo- and heterointeractions as well as Rvs167p
interactions with 14 other proteins (59) (Table 1).
Identification of Rvs167p SH3 domain-interacting proteins
by phage display. Phage display is a technique in which librar-
ies of ligand peptides are displayed on the surface of bacterio-
phages and screened for the ability to interact with an immo-
bilized receptor the bait). In phage display, sequencing the
bacteriophage DNA is used to identify those proteins that
confer interaction with the bait. This technique has the draw-
back of low accuracy (false-positives). One study combined
computational prediction of interactions using phage display
ligand consensus sequences with large-scale two-hybrid inter-
action analysis to identify interactions involving yeast SH3 do-
mains, including the Rvs167p SH3 domain. Phage display was
used to define the binding consensus motifs of each SH3 do-
main (which were analyzed computationally by a position-spe-
cific scoring matrix) to identify potential binding partners for
each SH3 domain. Then the SH3 domain baits were screened
against yeast two-hybrid libraries and an ordered array of in-
teracting open reading frames was established. A phage display
network containing 394 interactions among 206 proteins and a
two-hybrid network containing 233 interactions among 145 pro-
teins were established. Graph theoretical analysis identified 59
highly likely interactions common to both networks. This revealed
nine potential partners for the Rvs167p SH3 domain (331).
Another study combined phage display and synthesis of pep-
tides on cellulose membranes to search for all the peptides in
the yeast proteome with the potential to bind to certain SH3
domains, including the Rvs167p SH3 domain. Peptides that
matched a relaxed consensus as deduced by phage display
experiments were identified. Then all these peptides were syn-
thesized at high density on a cellulose membrane and probed
with the SH3 domains. The SH3 domains were grouped by this
approach into five classes with partially overlapping specificity.
This approach, named the whole interactome scanning exper-
iment, permits identification of the partners of any peptide
recognition module by peptide scanning of a proteome. The
whole interactome scanning experiment found 24 potential
partners for the Rvs167p SH3 domain (160) (Table 1).
Identification of Rvs161p- and Rvs167p-interacting proteins
by high-throughput proteomics. In the quest for comprehen-
sive analysis of protein-protein interactions, high-throughput
mass spectrometric analyses leading to protein complex iden-
tification have been developed as a powerful proteomic ap-
proach. Selected yeast proteins were chosen as baits, epitope
tagged, transiently overexpressed, and used for immunopre-
cipitation of protein complexes from cell extracts. Proteins in
each purified complex were resolved by polyacrylamide gel
electrophoresis, stained, excised from gels, and trypsin di-
gested before mass spectrometric analysis. With 725 bait pro-
teins, 3,617 associated proteins covering 25% of the yeast pro-
teome were detected, including four Rvs161p and 27 Rvs167p
interactors (Table 1) (123).
Mapping the genetic interactions of Rvs161p and Rvs167p
by synthetic genetic array. To identify functional relationships
between genes, a method for systematic construction of double
mutants, termed synthetic genetic array analysis, was devel-
oped for S. cerevisiae. A haploid carrying a query mutation
(conditional or deletion) linked to a dominant selectable
marker and expressed from a mating type-specific promoter is
crossed to an array of approximately 4,700 haploid open read-
ing frame deletion mutants (nonessential genes) of the oppo-
site mating type, where each open reading frame deletion is
marked with a drug resistance gene. The diploid progeny are
then sporulated to yield recombinant meiotic haploid progeny
and those recombinant progeny expressing both deletion
markers (double mutants) are selected. The inviability or sick-
ness of these meiotic double mutant progeny represents neg-
ative genetic interactions that may suggest the affected genes
are functionally related. Synthetic genetic array analysis of 132
queries allowed the construction of a network of approximately
1,000 genes and 4,000 functional interactions. Of these, 47
involved Rvs161p and 51 involved Rvs167p (Table 1) (332). A
more recent SGA analysis focusing specifically on Rvs161p and
Rvs167p found 49 lethal combinations for each gene. Strik-
ingly, the genetic interactors identified for each Rvs protein
were identical (84a).
Rvs161p and Rvs167p physical and genetic interactions sug-
gest multiple functions in vivo. Interactions found by high-
throughput approaches should be regarded as putative until
further characterized, however, these studies have provided
the first global view of the cellular processes in which Rvs161p
and Rvs167p are (or may be) implicated. What is interesting
is that the Rvs161p and Rvs167p interactors represent a
diversity of both organelles and structures as well as cellular
processes (Fig. 9). Some Rvs161p and Rvs167p physical
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interactors are cytoplasmic, while others are nuclear. Some
interactors are components of cortical actin patches, while
others are not.
One interesting finding from the large-scale two-hybrid and
peptide-scanning screens was the potential interaction of
Rvs167p with Bsp1p (59, 160, 331). Bsp1p is a protein that
interacts with two of the three yeast orthologs of vertebrate
synaptojanin (Inp52p/Sjl2p and Inp53p/Sjl3p). As will be dis-
cussed further below, in vertebrates the function of BAR do-
main proteins is closely linked to the function of synaptojanin.
In yeast, Bsp1p has been implicated in the recruitment of
Inp52p/Sjl2p and Inp53p/Sjl3p to cortical actin patches (366).
The diversity of potential Rvs161p and Rvs167p interactors
is striking. Even among those interactors known to function in
membrane traffic, some function in endocytosis and others in
exocytosis. Many Rvs161p- and Rvs167p-interacting proteins
function in nucleocytoplasmic transport, some in translocation
of secreted proteins into the ER, and others in mitochondrial
import. Some interactors are involved in transcription, others
in translation, and still others in degradation of proteins and
mRNAs. Several are cell cycle regulators. Many are compo-
nents of the cytoskeleton. However, the largest number of
Rvs161p and Rvs167p interactors are metabolic enzymes.
Hence, Rvs161p and Rvs167p should not be thought of as strictly
endocytic proteins or as strictly actin patch components. They
perhaps should be thought of as proteins that perform a basic
molecular function that is so important and fundamental that it
has been utilized again and again by multiple cellular structures
for the provision of multiple cellular functions.
FISSION YEAST BAR DOMAIN PROTEINS
Hob1p AND Hob3p
Hob3p, Fission Yeast Ortholog of Rvs161p
Hob3p has a domain structure similar to that of Rvs161p. A
fission yeast (Schizosaccharomyces pombe) gene encoding a
protein that comprises a BAR domain only and is homologous
to S. cerevisiae Rvs161p was identified by homology search with
the Rvs161p sequence and named homologue of bin3 (hob3).
Hob3p exhibits 56 and 29% sequence identity to S. cerevisiae
Rvs161p and human Bin3 (see below), respectively. Hob3p is
not essential, but Hob3p-deficient cells (hob3) are more elon-
gated than wild-type cells and tend to form clumps, suggesting
a defect in cytokinesis or cell separation. Wild-type fission
yeast cells, unlike budding yeast cells, are cylindrical. A small
percentage of hob3 cells are spherical rather than cylindrical,
indicating that in some Hob3p-deficient cells there is a loss of
cell polarity. These morphological defects do not worsen upon
a shift in temperature, osmotic strength, or nutrient availabil-
ity, and loss of Hob3p does not affect the rate of cell prolifer-
ation at high (37°C) or low (21°C) temperature or upon nitro-
gen starvation. Furthermore, overexpression of Hob3p does
not inhibit the growth of wild-type S. pombe cells (276).
Hob3p functions in polarization of the cortical actin cy-
toskeleton but not endocytosis. Loss of Hob3p perturbs the
actin cytoskeleton. Actin patches are not polarized to the grow-
ing cell tips in interphase hob3 cells as is the case in wild-type
cells but are often randomly distributed along the length of the
cell. During cytokinesis, actin patches are not efficiently polar-
ized to the medial site of division in hob3. Actin patches are
often distributed randomly in the daughter cell, mother cell, or
both. Loss of actin cytoskeleton polarization often causes de-
fects in cytokinesis and accumulation of multinucleate cells.
Indeed, hob3 cells tend to become multinucleate, consistent
with an impairment of cytokinesis. Unlike S. cerevisiae rvs161
mutants, S. pombe hob3 cells endocytose the membrane-sol-
uble fluorescent dye FM4-64 with the same kinetics as wild-
type cells, and the appearance of the endocytic compartments
is normal. Moreover, hob3 mutants mate with the same effi-
ciency as wild-type cells and thus lack the cell-cell fusion defect
of S. cerevisiae rvs161 mutants (276).
Functional conservation between Hob3p, Rvs161p, and human
Bin3. Hob3p function is fully conserved in Bin3 (see below), but
only partially conserved in Rvs161p. The cell morphology and
actin patch polarization defects of hob3 mutants are fully res-
cued by ectopic expression of the human Bin3 protein. In con-
trast, ectopic expression of S. cerevisiae Rvs161p restored normal
cell morphology to hob3 mutants but only partially restored the
actin cytoskeleton. Rvs161p restored F-actin localization to the
cell middle during cell division, but there was no significant im-
provement in actin patch polarization to cell tips in interphase
cells. In contrast, expression of S. cerevisiae Rvs167p did not
rescue any of the defects observed in hob3 mutants. Interest-
ingly, ectopic expression of Hob3p in S. cerevisiae rvs161 mu-
tants rescued growth in the presence of Na, but ectopic expres-
sion of human Bin3 (or Bin1) in rvs161 cells did not (276). This
shows that Rvs161p function is still conserved in Hob3p, but that
human Bin3 has diverged during evolution.
Hob1p, Fission Yeast Ortholog of Rvs167p
Hob1p has a domain structure similar to that of Rvs167p.
An S. pombe gene encoding a protein with homology to S.
cerevisiae Rvs167p and mammalian Bin1 was identified by
homology search. This gene was named homolog of Bin1
(hob1). Hob1p has a domain structure similar to Rvs167p
with an N-terminal BAR domain, a central domain, and a
C-terminal SH3 domain. The BAR domain of Hob1p exhibits
51% homology to the BAR domain of Rvs167p and only 27 to
28% homology to the BAR domains of mammalian amphiphy-
sin 1 and Bin1 (277).
Hob1p is not required for polarization of the cortical actin
FIG. 9. Functional classification of Rvs161p and Rvs167p-interact-
ing proteins. Pie chart depicting the proportions of the total set of
known Rvs161p- and Rvs167p-interacting proteins (including both
physical and genetic) which belong to each functional category.
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cytoskeleton or endocytosis. Hob1p is not an essential protein
and Hob1p-deficient cells (hob1) exhibit relatively normal
morphology, but are slightly more elongated than wild-type S.
pombe cells. Hob1p-deficient cells exhibit no defect in cell
proliferation or in mating and retain a fully polarized actin
cytoskeleton. Endocytosis of the membrane-soluble fluores-
cent dye FM4-64 is also unaffected by loss of Hob1p (or even
by loss of both Hob1p and Hob3p). Hob1p-deficient cells also
remain fully viable upon nitrogen starvation, at a range of
temperatures, and in the presence of 250 mM Na. The ex-
pression of S. pombe Hob1p in S. cerevisiae rvs167 cells did
not restore growth on medium containing Na. This sug-
gests that Hob1p function has diverged from that of
Rvs167p during evolution. Overexpression of Hob1p weakly
inhibits growth but does not affect cell morphology. In con-
trast, overexpression of the Hob1p BAR domain alone does
not inhibit growth, while overexpression of the central and
SH3 domains is inhibitory for growth only when combined
with exposure to high Na (131, 277).
Hob1p interacts with actin assembly proteins and protein
kinases that regulate cell polarity. Hob1p localizes to cortical
actin patches whose distribution is polarized to sites of surface
growth at cell tips (equivalent to buds in budding yeast) and
the medial region in cells undergoing division (equivalent to
the bud neck in budding yeast). This localization is similar to
that of Rvs167p in budding yeast. Unlike Rvs167p, however,
localization of Hob1p to patches is abolished by disassembly of
F-actin by treatment with the actin polymerization inhibitor
latrunculin A (131).
Hob1p interacts with proteins important for actin filament
assembly, such as the fission yeast ortholog of budding yeast
Las17p, Wsp1p. Interaction requires the Hob1p SH3 domain,
as in the case of Rvs167p-Las17p interaction in budding yeast,
but differs in that it also requires the BAR domain. Wsp1p is
essential for Hob1p localization to cortical patches since
Hob1p adopts a diffuse cytoplasmic distribution when Wsp1p
expression is repressed. Overexpression of Hob1p causes
Wsp1p to redistribute from patches to the cytoplasm, and this
effect requires the Hob1p SH3 domain that interacts with
Wsp1p. Overexpression of Hob1p also reduces the ability of
cell extracts to support Wsp1p-dependent actin filament as-
sembly in vitro, suggesting that Hob1p may inhibit Wsp1p.
Repression or complete loss of Wsp1p alone has mild effects
on cell polarity and growth, but repression of Wsp1p expres-
sion in hob1 mutants severely inhibits growth and induces
aberrant round-cell morphology. Overexpression of Wsp1p
also inhibits growth and causes cells to become somewhat
roundish, and these defects are corrected by additional over-
expression of Hob1p. Hence, Hob1p and Wsp1p appear to
have multiple functions in growth and polarity, and some of
these are probably synergistic, while others are antagonistic
(131).
Hob1p also interacts with the protein kinase Nak1p. Nak1p
plays an essential role in polarized growth in fission yeast and
is a member of the germinal center kinase-like kinases that
form a subgroup of the p21-activated kinase family of kinases
that have a conserved role in cell polarity. The Hob1p BAR
domain mediates interaction of Hob1p with Nak1p. Repres-
sion of Nak1p expression causes S. pombe cells to become
round. Loss of Nak1p does not affect Hob1p localization to
patches, but causes depolarization of Hob1p patches. Repres-
sion of Nak1p expression has mild effects on growth in the
presence of Na, but combination with loss of Hob1p causes
severe growth sensitivity to Na, suggesting that Nak1p and
Hob1p have some redundant functions. Consistent with this,
overexpression of Hob1p or of the Hob1p BAR domain alone
partially restores growth and normal elongated cell morphol-
ogy to cells in which Nak1p expression is repressed. In contrast,
overexpression of the Hob1p central and SH3 domains did not
restore normal cell morphology to Nak1p-deficient cells, in-
deed, it induced even more severe growth defects, perhaps by
interfering with endogenous Hob1p function (131).
These results strongly implicate Hob1p in organization of
the actin cytoskeleton, in growth under stress conditions, and
in cell polarity. It seems that the lack of effect of hob1 on cell
polarity, growth in the presence of Na, or actin cytoskeleton
organization is due to functional redundancy with both Wsp1p
and Nak1p. Hence, Hob1p plays a role in cell polarity, actin
cytoskeleton organization, and growth under stress conditions
much like Rvs167p in budding yeast, but its role is more re-
dundant with Wsp1p/Las17p family proteins in fission yeast
than in budding yeast, and this obscures the hob1 phenotypes
in fission yeast.
Hob1p functions in regulating cell cycle progression in re-
sponse to nutrient availability. hob1 cells have a defect in cell
cycle progression under nitrogen-limiting conditions. Unlike S.
cerevisiae cells, which spend most of their cell cycle in G1 phase
prior to DNA replication, S. pombe cells spend most of their
cell cycle in G2 phase after DNA replication. Hence, S. pombe
cells normally exhibit a 2C DNA content. Upon nitrogen star-
vation, however, S. pombe cells continue to divide and at each
division exhibit a smaller cell size than during the previous
division. Eventually, the starved cells reach a minimum size at
which they are unable to satisfy the cell size requirement to
enter the next S phase. The starved cells therefore accumulate
in G1 with a 1C DNA content and eventually enter G0. In
contrast to wild-type cells, hob1 cells starved of nitrogen
maintain a 2C DNA content. The hob1 cells do arrest and
presumably enter G0, but do so directly from G2. Despite their
2C DNA content, hob1 cells remain viable even after pro-
longed periods of nitrogen starvation (277).
Functional Conservation of Hob1p and Bin1
and Divergence of Rvs167p
Ectopic expression in hob1 cells of the ubiquitous human
Bin1 isoform that lacks exon 10, Bin1101213 (SH3p9),
but not human amphiphysin 1 or Bin2, restored the ability to
arrest in G1 and enter G0 with a 1C DNA content upon nitro-
gen starvation. This suggests that Hob1p function is most con-
served with human Bin1101213/SH3p9. Ectopic expres-
sion of human Bin1101213/SH3p9 in rvs167 S. cerevisiae
cells did not rescue growth in the presence of Na, again
suggesting that Rvs167p function has diverged from that of
Bin1101213/SH3p9 and Hob1p. Intriguingly, overexpres-
sion of hob3 in hob1 cells efficiently rescued the cell cycle
arrest defect. Hence, it has been proposed that Hob3p func-
tions in the same signaling pathway as Hob1p, but downstream
of Hob1p (277).
Hob1p functions in regulation of cell cycle progression in
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response to DNA damage. Loss of Hob1p also causes hyper-
sensitivity to both chemical (phleomycin)- and UV-induced
DNA damage, but not to inhibitors of DNA replication (e.g.,
hydroxyurea). hob1 cells arrest cell cycle progression nor-
mally in response to DNA damage (so the checkpoint is still
functional), but presumably the ability of the mutant cells to
repair the DNA damage and then reenter the cell cycle is
impaired. Combination of hob1 with rad3 and chk1 mu-
tations, which are also hypersensitive to DNA damage, re-
vealed that hob1 rad3 double mutants are considerably
more sensitive to phleomycin than either single mutant, i.e.,
Hob1p and Rad3p genetically interact. In contrast, hob1
chk1 double mutants are only as sensitive to phleomycin as
the more sensitive single mutant (hob1). It has been proposed
that Rad3p and Hob1p act in distinct pathways that each con-
tribute to repair of DNA damage (277).
Hob1p functions in a cell stress signal transduction path-
way upstream of Hob3p. Unexpectedly, the lethality caused by
DNA damage in hob1 cells is dependent on hob3. hob1
hob3 double mutants, unlike hob1 single mutants, are not
hypersensitive to DNA damage. The mechanisms involved are
still unclear, but the data seem consistent with a function for
Hob3p in cell cycle arrest downstream of Hob1p. Interestingly,
the steady-state levels of both Hob1p and Hob3p increase
dramatically upon exposure of cells to DNA damage. The level
of Hob1p increases within 15 min of phleomycin treatment,
while the increase in Hob3p levels is slightly delayed and be-
comes apparent only after 30 min and the levels of both pro-
teins remain elevated for at least 24 h. The increase in Hob3p
protein levels is absolutely dependent on Hob1p, as it is absent
in hob1 cells (277). Whether Rvs161p and Rvs167p levels
increase upon exposure of S. cerevisiae cells to DNA damage
and if loss of Rvs proteins causes sensitivity to DNA damage
has not been examined.
VERTEBRATE BAR DOMAIN PROTEIN AMPHIPHYSIN 1
Endocytic Recycling of Synaptic Vesicles
Nerve terminals are known to be sites highly active in en-
docytosis. When synaptic vesicles fuse with the plasma mem-
brane (plasmalemma) and release their cargo of neurotrans-
mitters into the presynaptic cleft, synaptic vesicle membrane
material is rapidly recovered back into the cell via endocytosis.
These empty synaptic vesicles are then used for storage of
newly synthesized neurotransmitters. Endocytosis of the syn-
aptic vesicle membrane occurs at clathrin-coated pits. Clathrin
assembles to form a coat on the cytoplasmic face of the plasma
membrane at subdomains where endocytosis occurs and this
assembly is driven by the plasma membrane-clathrin assembly
complex AP-2. Clathrin assembly promotes curvature of the
plasma membrane, leading to the formation of an invagination
known as a clathrin-coated pit. Progressive invagination results
in the formation of a deeply invaginated clathrin-coated pit
connected to the plasma membrane by a narrow neck of mem-
brane (120, 121, 155, 283, 290, 293, 295, 315, 368).
Role of dynamin 1 in synaptic vesicle recycling. The GTPase
dynamin 1 is required for the scission of the neck of deeply
invaginated clathrin-coated pits to release free clathrin-coated
vesicles into the cytoplasm. Dominant negative mutant forms
of dynamin 1 block receptor-mediated endocytosis of trans-
ferrin and epidermal growth factor, but do not affect fluid-
phase endocytosis (45, 116, 121, 344). Upon a shift to the
restrictive temperature, Drosophila melanogaster cells carrying
a temperature-sensitive mutation of dynamin (shibire) become
paralyzed due to failure of nerve transmission. Examination of
neurons from shibire mutant flies reveals the accumulation of
deeply invaginated pits at the synaptic plasmalemma that ap-
pear to be arrested prior to fission (155, 184). In vitro treat-
ment of permeabilized nerve terminals (synaptosomes) with
nonhydrolyzable GTP analogs to inhibit dynamin 1 results
in accumulation of deeply invaginated clathrin-coated pits
blocked prior to fission. Moreover, electron-dense rings that
contain dynamin 1 are visible at the necks of these deeply
invaginated pits (121, 315).
Discovery of Amphiphysin 1 in Chicken Brain
The function of amphiphysin 1 in the brain has been the
topic of an earlier review (368).
Chicken amphiphysin 1 has a domain structure similar to
that of budding yeast Rvs167p. Amphiphysin 1 was originally
identified by expression cloning in a large-scale immunoscreen
for novel proteins of the chicken synaptic plasma membrane.
Amphiphysin 1 is a hydrophilic protein with the only hydro-
phobic segment at residues 478 to 499. Chicken amphiphysin 1
has a predicted size of 75 kDa, but its electrophoretic mobility
suggests a protein of 115 kDa (175). Aberrant gel mobility is
not specific to chicken amphiphysin and has been reported
also for rat, mouse, and human amphiphysin 1 (47, 50),
Bin11013 (278), and Bin16a1213 (amphiphysin 2)
(23, 168, 256, 367) (Fig. 1).
The N terminus of amphiphysin 1 features a short amphi-
pathic -helix. This is followed by the BAR domain, which, as
in the case of Rvs161p and Rvs167p, is also predicted to have
a strongly -helical secondary structure and has a high density
of charged residues (Fig. 1) (47, 175, 220). The BAR domain is
followed by a highly basic region with a high content of glycine,
proline, alanine, serine, and threonine residues, similar to the
Rvs167p GPA-rich region (Fig. 1). This region of amphiphysin
1 is predicted to adopt extensive -turn secondary structure.
The C-terminal half of amphiphysin 1 is highly acidic and
terminates, as in the case of Rvs167p, with a single SH3 do-
main (Fig. 1) (12, 175).
Chicken amphiphysin 1 is expressed in neurons. A single
major chicken amphiphysin 1 transcript was shown to be most
abundant in chicken brain (both forebrain and cerebellum)
and also present in the adrenal gland. Initial studies reported
an absence of amphiphysin 1 transcripts in other tissues of
chicken, including skeletal muscle, lung, testis, liver, spleen,
pancreas, and heart. Amphiphysin 1 protein is highly expressed
in the chicken central nervous system, including forebrain,
cerebellum, hippocampus, olfactory bulb, and spinal cord. A
cross-reacting protein in the rat is expressed in the brain and
adrenal gland but also present in the anterior and posterior
pituitary (175). A subsequent study showed a rat protein rec-
ognized by antiserum to human amphiphysin 1 is also ex-
pressed in the testis (256). In the chicken forebrain, amphiphy-
sin 1 is present throughout the cortex and is highly enriched at
punctate structures that represent presynaptic terminals. Elec-
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tron microscopy reveals that amphiphysin 1 immunoreactivity is
concentrated around clusters of synaptic vesicles in the presynap-
tic cytoplasm, but is absent from postsynaptic neurons (175).
Minor pool of chicken amphiphysin 1 is tightly associated
with synaptic vesicles. During subcellular fractionation a small
pool of amphiphysin 1 is present in purified chicken synaptic
vesicles, but it is also present in purified chicken synaptosomal
plasma membrane. The rat brain contains an antigen that
cross-reacts with both chicken and human amphiphysin 1 an-
tisera (see below). In subcellular fractionation of the rat brain,
amphiphysin 1 distributes partly in the soluble fraction and
partly in the sedimentable fraction. Highly purified synaptic
vesicles from rat and chicken also contain amphiphysin 1, but
it is only a minor component. The cross-reacting rat protein
copurifies with rat synaptophysin-positive synaptic vesicles and,
although peripheral, behaves almost like an integral mem-
brane component. As for the integral membrane protein syn-
aptophysin, neither physiological salt (0.15 M KCl), high salt (1
M KCl), nor pH 3 buffer was able to efficiently strip the rat
amphiphysin 1-cross-reacting protein from the synaptic vesi-
cles, however, both proteins were solubilized from synaptic
vesicles by detergent (50, 80, 175, 256).
Because only a small pool of the rat amphiphysin 1-cross-
reacting protein is associated with synaptic vesicles and there is
a large cytoplasmic pool, it is not enriched in synaptic vesicles
during purification. Fractionation of crude rat synaptosome
lysates reveals that approximately 75% of the amphiphysin
1-cross-reacting protein in the initial lysate remains in a high
speed (260,000 
 g) supernatant, while only 25% pellets with
membranes. When rat synaptosomal membranes are subjected
to Triton X-114 extraction to separate hydrophilic peripheral
membrane proteins (recovered in the aqueous phase) from
hydrophobic integral membrane proteins (recovered in the
detergent phase) the rat amphiphysin 1-cross-reacting protein
is present exclusively in the aqueous phase. There is no appar-
ent difference in electrophoretic migration of the membrane-
associated or soluble form of the rat amphiphysin 1-cross-
reacting protein, and the biochemical feature that distinguishes
these two forms is unknown. The name amphiphysin was cho-
sen to reflect the existence of both soluble and membrane-
associated pools of this protein (175).
Discovery of Human Amphiphysin 1
Human amphiphysin 1 is the autoantigen in stiff-man syn-
drome with breast cancer. Subsequently, human amphiphysin
1 was discovered as the 128-kDa autoantigen in breast cancer
patients with the rare neurological condition stiff-man syn-
drome (SMS). SMS is characterized by severe muscle rigidity
throughout the body and intermittent spasms and is caused by
an autoimmune response against antigens in the central ner-
vous system. How breast cancer leads to an autoimmune re-
sponse against amphiphysin 1 is not clear, but it has been
proposed that elevated expression of amphiphysin 1 or a re-
lated protein in breast tumors may trigger an autoimmune
reaction against amphiphysin 1.
Cloning of the human amphiphysin 1 gene based on homol-
ogy to chicken amphiphysin 1 revealed that human amphiphy-
sin 1 has a predicted size of 76 kDa, which is smaller than the
apparent size of 128 kDa based on gel electrophoresis. Aber-
rant electrophoretic behavior was also observed for chicken
amphiphysin 1. Human amphiphysin 1 has the same domain
structure as chicken amphiphysin 1, with an N-terminal BAR
domain, a central alanine- and glutamate-rich domain contain-
ing a proline-rich motif and hydrophobic region, and a C-
terminal SH3 domain (Fig. 1). The autoimmune sera from
SMS patients were predominantly directed against the am-
phiphysin 1 SH3 domain (47, 50). Amphiphysin 1 does have
some tissue-specific splice variants, e.g., amphiphysin Ir, which
is retina specific (128), but few compared to Bin1 (Table 2)
(see below).
Human amphiphysin 1 has a domain structure similar to
that of yeast Rvs167p. Human amphiphysin 1 displays strong
sequence similarity to Rvs161p and Rvs167p within the N-
terminal amphipathic -helix and BAR domain (domain A in
reference 47) (Fig. 1). Within this region, a stretch of 209
residues in amphiphysin 1 shares 42% amino acid sequence
similarity and 25% identity with the corresponding 208 resi-
dues in yeast Rvs161p and 39% similarity and 22% identity
with the corresponding 223 residues in yeast Rvs167p. Am-
phiphysin 1 also shares homology with Rvs167p within the
C-terminal SH3 domain (domain D in reference 47). Although
the central insert domain of amphiphysin 1 (domains B and C
in reference 47) is not as conserved in Rvs167p, the Rvs167p
GPA-rich region and amphiphysin 1 central insert domain
both feature proline-rich motifs and a single hydrophobic
stretch (12, 47, 298). The latter are also conserved in chicken
amphiphysin 1 (175).
Mammalian amphiphysin 1 is highly expressed in the brain
but is also expressed in other tissues. Like chicken and rat
amphiphysin 1, human amphiphysin 1 is highly expressed in
the brain, where it localizes to punctate presynaptic termini
(46, 175, 256). Human amphiphysin 1 and dynamin 1 colocalize
extensively in the brain to presynaptic termini and both also
exhibit a diffuse cytoplasmic localization (46). Although highly
expressed in the brain, amphiphysin 1 transcripts and antigen
are also expressed in certain other tissues (e.g., testis, ovary,
pituitary, pancreas, and adrenal gland) (50, 80, 256, 367). Am-
phiphysin 1 has also been reported to be overexpressed in
some breast tumors and breast cancer cell lines (77).
Amphiphysin 1 interacts with the endocytic proteins dy-
namin 1 and synaptojanin 1. Consistent with the possibility
that amphiphysin 1 functions with dynamin 1 in brain, gel
overlay experiments using recombinant fragments of am-
phiphysin 1 as probes revealed interaction between an SH3
domain-containing fragment of amphiphysin 1 and a brain
protein with a size (100 kDa) characteristic of dynamin 1.
Affinity purification approaches using the amphiphysin 1 SH3
domain as affinity ligand confirmed that dynamin 1 is a major
amphiphysin 1 SH3 binding protein in the brain. Dynamin 1
and amphiphysin 1 also coimmunoprecipitate from brain ex-
tracts, suggesting they form complex in vivo (46). Binding of a
recombinant glutathione S-transferase (GST) fusion protein
containing only the human amphiphysin 1 SH3 domain to
endogenous dynamin 1 in rat brain extracts has also been
demonstrated (256).
Dynamin 1 is not the only major binding partner for the
amphiphysin 1 SH3 domain in the brain. A major 145-kDa
protein was also affinity purified from brain extracts using the
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TABLE 2. Nomenclature of various BAR domain proteins and their splice variantsa
Type Nameb (reference) Other name(s) Exon(s) missing Remarks
Different amphiphysin 1
isoforms
Amphiphysin 1 (or I)
isoform 1 (47)
Longer amphiphysin isoform expressed in
brain.
Amphiphysin 1 (or I)
isoform 2 (77)
Shorter amphiphysin isoform expressed in
brain. Also detected in breast carcinoma.
Amphiphysin 1 (or I)
(326)
Retina-specific amphiphysin isoform,
contains two novel insertions.
Different
BIN1/amphiphysin 2/
amphiphyin II/Amph2/
BRAMP2/SH3p9/ALP1/
amphiphysin IIm
isoforms
BIN1-iso1 (245)1 Amphiphysin IIa (255); S11/R3-a;
BRAMP2 (168)
10 Expressed in brain and concentrated in
nerve terminals. Localizes to the
cytoplasm.
BIN1-iso2 (245)1 Amphiphysin IId (255); S11/R3-b 10; 12a Expressed in brain. Localizes to the
cytoplasm and nucleus.
BIN1-iso3 (245)1 Amphiphysin IIc1 (255) 10; 12 (a, b, c) Expressed in brain. Localizes to the
cytoplasm and nucleus.
BIN1-iso4 (245)2 6a; 12 (b, c, d) Expressed in brain and possibly in muscle.
Localizes to the cytoplasm and nucleus.
BIN1-iso5 (245)3 Amphiphysin IIb (255) 6a; 10; 12 (b, c) Expressed in brain. Localizes to the
cytoplasm and nucleus.
BIN1-iso6 (245)3 AP II2 (338) 6a; 10; 12 (b, c, d) Expressed in brain. Localizes to the
cytoplasm and nucleus. Aberrantly
expressed in melanoma (93).
BIN1-iso7 (245)3 Amphiphysin IIc2 (255) 6a; 10; 12 (a, b, c) Expressed in brain. Localizes to the
cytoplasm and nucleus.
BIN1-iso8 (245)2 Amph 2-7 (369) 6a; 12 (a, b, c, d) Expressed in muscle and localizes to the
nucleus.
BIN1-iso9 (245)4 BIN1-10 (356); SH3P9 (306);
AP II3 (338)
6a; 10; 12 (a, b, c, d) Ubiquitously expressed.
BIN1-iso10 (245)5 BIN1-10-13 (356); ALP1 (141);
amphiphysin IIm (100);
Amph 2-6 (369)
6a; 10; 12 (a, b, c, d); 13 Ubiquitously expressed, the only Amph
II/Bin1 isoform in macrophages.
BIN1-iso11 Amph 2-1 (369) 10; 13 Expressed in brain.
BIN1-iso12 Amph 2-2 (369) 10; 12d; 13 Expressed in brain.
BIN1-iso13 Amph 2-3 (369) 10; 12 (a, b, c, d); 13; 14;
15; 16
Expressed in brain, lacks SH3 domain.
BIN1-iso14 Amph 2-4 (369) 6a; 10; 11; 12 (a, b, c, d);
13; 14; 15; 16
Expressed in brain, lacks SH3 domain.
BIN1-iso15 Amph 2-5 (369) 10; 12 (a, b, c, d); 13 Expressed in brain.
Endophilin family proteins Endophilin A1 (134) Endophilin 1 (323); SH3P4 (323);
SH3GL2 (99); EEN-B1 (304)
Expressed mainly in brain.
Endophilin A2 (134) Endophilin 2 (323); SH3P8 (323);
SH3GL1 (99); EEN (304)
Ubiquitously transcribed (270), but only
translated in brain and testis (269).
Endophilin A3 (134) Endophilin 3 (323); SH3P13 (323);
SH3GL3 (99);
EEN-B2 (304)
Expressed mainly in brain and testis.
Endophilin B1 (134) SH3GLB1 (244); Bif-1 (43) Expressed mainly in heart, placenta, and
skeletal muscle, cytoplasmic protein.
Endophilin B2 (134) SH3GLB2 (244) Expressed mainly in heart, placenta, and
skeletal muscle, cytoplasmic protein.
a This table adopts the Bin1 exon nomenclature proposed by Wechsler-Reya et al. (356); however, one additional missing exon located between exons 6 and 7 is
referred to here as exon 6a. In the recently introduced systematic nomenclature, exon 6a is renamed exon 7 and the following exons have been assigned new numbers
(n  1) with respect to the exon numbers referred to here and in the previous literature reports. The new systematic Bin1 splice isoform nomenclature and some of
the exon information shown in this table was obtained from the National Center for Biotechnology Information and the U.S. National Library of Medicine, Bethesda,
Md., via the following internet URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dbgene&cmdRetrieve&doptfull_report&list_uids274.
b Superscript numbers are as follows: 1, Bin16a1213 in the text; 2, Bin11013 in the text; 3, Bin16a1213 in the text; 4, Bin1101213 in the text; 5,
Bin1101213 in the text. Note: Bin11213 in the text refers collectively to Bin16a1213 and Bin16a1213; Bin112 in the text refers collectively to
Bin16a1213, Bin16a1213, Bin16a1213, and Bin16a1213; Bin110 in the text refers collectively to Bin11013 and Bin11013.
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amphiphysin 1 SH3 domain (46). This protein was subse-
quently identified as a polyphosphoinositide 5-phosphatase
and named synaptojanin 1. Amphiphysin 1 and synaptojanin 1
extensively colocalize in brain sections to presynaptic termi-
nals. Like dynamin 1, synaptojanin 1 is implicated in synaptic
vesicle endocytosis via its regulation of phosphoinositide levels
(188). Synaptojanin 1 also is a major binding partner of the
SH3 domain of another BAR domain protein, endophilin A1
(also called SH3p4 and SH3GL2) (51, 192) (see below).
Intriguingly, the amphiphysin 1 SH3 domain is also able to
mediate an intramolecular interaction. This is predicted to
involve the SH3 domain binding to highly conserved proline-
rich sequences located within the central insert domain. In-
tramolecular interactions of the amphiphysin 1 SH3 domain
may be in competition with intermolecular interactions and
regulate amphiphysin 1 SH3 domain interactions with other
proteins such as dynamin 1 and synaptojanin 1 (74). The three-
dimensional structure of the amphiphysin 1 SH3 domain has
not yet been solved, but is predicted to be similar to that of the
Bin1 SH3 domain. The Bin1 SH3 domain also interacts with
dynamin 1 and synaptojanin 1 (see below) and its three-dimen-
sional structure has been solved (232).
The amphiphysin 1 SH3 domain interacts with a single PSR-
PNR motif (residues 833 to 838) in the C-terminal proline-rich
domain (PRD) of dynamin 1. Deletion of this motif or R835D/
R838D/P836A substitutions within this motif abolish associa-
tion of a recombinant dynamin 1 PRD fragment with both
endogenous amphiphysin 1 in brain extracts and purified re-
combinant amphiphysin 1 in overlay blots. The amphiphysin 1
SH3 domain is critical for interaction with dynamin 1. The
double amino acid substitution G684R/P687L within the target
binding cleft of the amphiphysin 1 SH3 domain abolishes in-
teraction with both dynamin 1 and synaptojanin 1. The disso-
ciation constant for amphiphysin 1 SH3 domain interaction
with the dynamin 1 PRD is approximately 190 nM, which is
relatively high affinity for an interaction mediated by an SH3
domain. A similar motif, PXRPXR in the C-terminal PRD of
synaptojanin 1, may mediate interaction of synaptojanin 1 with
the amphiphysin 1 SH3 domain (46, 105, 302).
Amphiphysin 1 Interacts with Clathrin
and the AP-2 Adaptor
Other domains of amphiphysin 1 also interact with proteins
implicated in synaptic vesicle endocytosis. The c (and to a
lesser extent a) subunit of the plasma membrane clathrin
assembly complex AP-2 has been shown to associate with am-
phiphysin 1 (46, 352). Moreover, c adaptin and amphiphysin
1 colocalize in the brain. However, although the a and c
subunits of AP-2 bind SH3 domains of other proteins (e.g., the
SH2-SH3 adaptor protein Grb2) neither protein binds the
amphiphysin 1 SH3 domain. The interaction of amphiphysin 1
with a and c is mediated by non-SH3 domains of amphiphy-
sin 1 (see below) (46). Interestingly, amphiphysin 1 (and Bin1,
see below) also binds clathrin heavy chain. This interaction is
also mediated by sequences in amphiphysin 1 that are distinct
from the SH3 domain (see below) (187, 301, 302).
Regulation of Amphiphysin 1 Interactions
by Phosphorylation
Amphiphysin 1, like dynamin 1 and synaptojanin 1, is con-
stitutively phosphorylated in resting neurons, but is rapidly
dephosphorylated upon nerve terminal depolarization and syn-
aptic vesicle exocytosis. Stimulated dephosphorylation affects
only certain residues in amphiphysin 1, because some basal
phosphorylation remains even after nerve depolarization.
Stimulated dephosphorylation is not dependent on exocytosis
of synaptic vesicles because it is not affected by prior treatment
of neurons with tetanus toxin to block synaptic vesicle exocy-
tosis. Dephosphorylation is, however, dependent on extracel-
lular Ca2. This suggests transmembrane Ca2 ion flux may be
required (13, 189, 193, 222, 271, 302).
Stimulated dephosphorylation of amphiphysin 1 in nerve
terminals is also blocked by inhibitors of Ca2/calmodulin-
dependent protein phosphatase 2B (calcineurin) (e.g., FK506
and cyclosporine A), but not by inhibitors of protein phospha-
tase 1 or 2A (e.g., okadeic acid). This suggests a role for
calcineurin in stimulated dephosphorylation of amphiphysin 1.
Moreover, purified recombinant calcineurin (rendered consti-
tutively active by mutation) dephosphorylates amphiphysin 1
directly in vitro. Amphiphysin 1 can be induced to undergo
multiple rounds of phosphorylation and dephosphorylation in
synaptosomes in response to a series of induced nerve depolar-
izations separated by rest periods to restore polarization. This
suggests that cycles of constitutive phosphorylation and stimu-
lated dephosphorylation are physiologically important for am-
phiphysin 1 function in synaptic vesicle recycling in vivo (13).
Subcellular fractionation shows that while the sedimentable
membrane-bound pool of amphiphysin 1 contains equal amounts
of the fully phosphorylated and partially dephosphorylated forms,
the cytoplasmic pool is predominantly dephosphorylated. Inter-
estingly, this does not reflect the localization of the kinase that
phosphorylates amphiphysin 1. Addition of ATP and incubation
at 37°C resulted in phosphorylation of amphiphysin 1 present
in the cytosolic fraction but not amphiphysin 1 present in the
membrane fraction. Interestingly, nonhydrolyzable GTP analogs
strongly stimulate amphiphysin 1 phosphorylation in the presence
of brain cytosol in vitro. Hence, amphiphysin 1 may be phosphory-
lated by a kinase whose activity is regulated by a GTP-binding
protein (13).
Amphiphysin 1 Subcellular Localization
in Presynaptic Terminals
Amphiphysin 1 localizes to endocytic intermediates. There
is a large cytoplasmic pool of amphiphysin 1 in rat brain (13,
50, 80, 175, 256). Permeabilization of rat brain synaptosomes
followed by treatment with a nonhydrolyzable GTP analog is
known to induce the formation of deeply invaginated clathrin-
coated pits. Immunoelectron microscopy on synaptosomes
treated in this way shows that amphiphysin 1 localizes to the
accumulated clathrin-coated buds and also partially colocalizes
with dynamin 1 at the necks of deeply invaginated clathrin-
coated pits. Amphiphysin 1 also localized to the less abundant
clathrin-coated pits observed in untreated synaptosomes,
showing that localization of amphiphysin 1 to endocytic inter-
mediates is physiologically relevant and not simply an artifact
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induced by nonhydrolyzable GTP analogs. Amphiphysin 1 is
not present on all clathrin-coated pits and dynamin 1-coated
tubules, however, and its distribution on those clathrin-coated
pits where it is found is irregular and patchy. This suggests that,
unlike clathrin or AP-2, amphiphysin 1 is not a major coat
component (13).
Amphiphysin 1 also localizes to the actin-rich cytomatrix.
Amphiphysin 1 is also found in the actin-rich cortical cytoma-
trix, which is distinct from endocytic intermediates but sur-
rounds clusters of synaptic vesicles (13). This localization sug-
gests amphiphysin 1 may have a role in the cortical actin
cytoskeleton, perhaps analogous to the role of Rvs167p in
cortical actin patches in yeast (11). It is interesting that in
Drosophila melanogaster, amphiphysin is expressed in a range
of polarized cells (including epithelial cells), where it localizes
to the actin-rich apical plasma membrane domain (386). This
suggests a conserved role for amphiphysin family proteins in
organization of the cortical actin cytoskeleton.
Amphiphysin 1 functions in polarized growth. The strongest
evidence that amphiphysin 1 plays a role in organization of the
cortical actin cytoskeleton and cell polarity comes from a study
looking at neurite outgrowth in cultured hippocampal neurons.
Hippocampal neurons plated at low cell density in culture form
axonal and dendritic processes that exhibit dramatic polarized
growth. As the cells approach confluence the axonal processes
eventually contact other cell bodies and form synapses in vitro.
When hippocampal neurons are initially plated, the amphiphy-
sin 1 expression level is detectable but low, however, a dra-
matic increase in amphiphysin 1 expression accompanies neu-
rite outgrowth and synapse formation. Moreover, amphiphysin
1 and dynamin 1 become highly concentrated at the tips of
actively growing axons and dendrites and at high magnification
can be seen to localize to numerous patches containing F-actin
distributed throughout the cortex of the growth cone. As
growth cones come into contact with other neurons in culture
and mature into synapses, amphiphysin 1 and dynamin 1 con-
centrate at the synaptic termini, analogous to amphiphysin 1
and dynamin 1 localization in mature brain (212).
Neurons derived from temperature-sensitive Drosophila dy-
namin mutants (shibire mutants) and cultured in vitro fail to
form neurites upon a shift to the restrictive temperature (184).
Also, down-regulation of dynamin 1 in cultured hippocampal
neurons prevents neurite outgrowth and causes growth cone
collapse (333). Does amphiphysin 1 also play a role in neurite
outgrowth and synaptogenesis? Consistent with a role for am-
phiphysin 1 in neurite outgrowth, down-regulation of am-
phiphysin 1 expression using antisense oligonucleotides leads
to a severe block in neurite outgrowth such that many cells fail
to form neurites and the cells that do form neurites exhibit only
a few short neurites. Hence, loss of amphiphysin 1 causes
collapse of growth cones on both dendrites and axons. Inter-
estingly, this effect is reversible, as removal of the antisense
oligonucleotides leads to reestablishment of growth cones and
recommencement of neurite outgrowth (212).
The defect in neurite outgrowth caused by amphiphysin 1
down-regulation is not due to effects on endocytosis, because
the level of down-regulation achieved was insufficient to block
receptor-mediated endocytosis. The cortical actin cytoskeleton
is grossly perturbed by amphiphysin 1 down-regulation, how-
ever, with loss of F-actin polarization to growing neurite tips.
In contrast, there is no apparent effect of this treatment on the
microtubule cytoskeleton. It has been proposed that disorga-
nization of the actin cytoskeleton may be responsible for the
block in neurite outgrowth (212). This loss of cell polarity in
neurons is perhaps analogous to what is seen in yeast cells
lacking Rvs161p or Rvs167p (12, 215, 298). No interaction of
amphiphysin 1 with G-actin or F-actin has been observed,
however, despite their colocalization in patches. In contrast,
yeast Rvs167p not only colocalizes with actin in patches, but
also interacts genetically and in two-hybrid screens with actin
(4, 11, 180, 212, 215).
Amphiphysin 1 Functions in Endocytosis
Amphiphysin 1 interaction with dynamin 1 is essential for
endocytosis in neurons. The essential role of Rvs proteins in
endocytosis in yeast together with the observed interactions of
amphiphysin 1 with dynamin 1, clathrin, and AP-2 in neurons
suggested a possible role for amphiphysin 1 in synaptic vesicle
endocytosis. The first evidence for a role of amphiphysin 1 in
endocytosis came from experiments in which a recombinant
fusion protein containing the amphiphysin 1 SH3 domain was
microinjected into the giant reticulospinal synapse of the lam-
prey eel. Injection of the SH3 domain had no effect on the
number of synaptic vesicles or plasmalemmal clathrin-coated
pits in resting neurons. However, electrical excitation of the
injected neurons to induce synaptic vesicle exocytosis resulted
in persistent depletion of synaptic vesicle numbers and the
dramatic accumulation of deeply invaginated clathrin-coated
pits at the plasmalemma (Fig. 10). Injection of a synthetic
peptide corresponding to the motif in the dynamin 1 PRD that
binds the amphiphysin 1 SH3 domain had similar effects, while
a mutant amphiphysin 1 SH3 domain unable to bind dynamin
1 and an unrelated SH3 domain were without effect (293). The
results obtained from such domain microinjection experiments
should be taken as suggestive of a cellular role rather than
proof, however, as the injected domain can have off-target
effects, especially at these concentrations.
Amphiphysin 1 does not seem to play an essential role in
exocytosis in neurons. Injection of the amphiphysin 1 SH3
domain did not affect synaptic vesicle exocytosis and release of
neurotransmitters at low levels of nerve terminal stimulation.
However, at higher levels of stimulation, where the ability to
rapidly recycle synaptic membranes becomes more important,
neurotransmitter release was affected (293). These data are
consistent with the view that the amphiphysin 1 SH3 domain-
mediated interaction with a proline-rich motif in dynamin 1 is
essential for endocytosis but not for exocytosis of synaptic
vesicles. This is consistent with the finding that Rvs161p and
Rvs167p are not essential for exocytosis in yeast but loss of
these proteins does nevertheless perturb exocytosis, leading to
vesicle accumulation (20, 298).
As dynamin 1 performs the scission event at the necks of
invaginated clathrin-coated pits, it is possible that amphiphysin
1-dynamin 1 interaction is important for dynamin 1 recruit-
ment to the necks of clathrin-coated pits. Consistent with this,
the necks of the deeply invaginated clathrin-coated pits that
accumulate in neurons injected with the amphiphysin 1 SH3
domain appear to lack the electron-dense rings characteristic
of dynamin 1 (121, 293). What was not clear was if this role of
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FIG. 10. Amphiphysin 1 SH3 domain interactions are required for fission of endocytic vesicles. Lamprey giant reticulospinal synapses were
injected with a fusion protein comprising glutathione S-transferase and the human amphiphysin 1 SH3 domain (GST-amphSH3) and effects on
synaptic vesicle recycling from the plasmalemma (plasma membrane) to regenerate the cytoplasmic vesicle pool were examined. Panel A, electron
micrograph of a synapse in an axon injected with GST-amphSH3 and then maintained in low Ca2 (0.1 mM Ca2, 4 mM Mg2), without
stimulation. Panel B, electron micrograph of a synapse in an axon injected with GST-amphSH3 and then electrically stimulated at 0.2 Hz for 30
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amphiphysin 1 in recruitment of dynamin 1 is specific to neu-
rons. A potential SH3 domain binding motif in the dynamin 1
PRD was shown to be essential for localization to clathrin-
coated pits when dynamin 1 was expressed ectopically in
COS-7 cells. However, this motif is distinct from the PSRPNR
motif that has been shown to interact specifically with the
amphiphysin 1 SH3 domain and likely mediates interaction
with another SH3 domain protein (292).
Amphiphysin interaction with dynamin is also essential for
endocytosis in nonneuronal cells. Amphiphysin 1 may have a
more general function in recruiting dynamin family GTPases
to clathrin-coated pits during endocytosis in nonneuronal
cells. In support of this is the known role of Rvs proteins in
endocytosis in yeast. Further support came from the finding
that a 125-kDa isoform of amphiphysin is also expressed at
lower but still significant levels in nonneuronal cells, includ-
ing muscle, testis, lung, and fibroblast. Moreover, the am-
phiphysin 1 SH3 domain interacts with a nonneuronal iso-
form of dynamin expressed endogenously in the fibroblast
cell line COS-7 (369).
To investigate whether amphiphysin 1 functions in endocy-
tosis in nonneuronal cells, the amphiphysin 1 SH3 domain was
transiently expressed in COS-7 cells and the effect on receptor-
mediated endocytosis was examined. Expression of the am-
phiphysin 1 SH3 domain abrogated endocytic uptake of both
transferrin and epidermal growth factor in COS-7 fibroblasts,
but had no effect on fluid-phase uptake of fluorescein isothio-
cyanate-labeled dextran. Overexpression of other SH3 do-
mains that bind to dynamin, but via motifs distinct from the
amphiphysin 1 SH3, did not inhibit transferrin endocytosis.
The effect of the amphiphysin 1 SH3 domain on endocytosis is
due to perturbation of dynamin, since transient overexpression
of dynamin neutralized the effect of the amphiphysin 1 SH3
domain and restored endocytosis (369). Similarly, microinjec-
tion of the amphiphysin 1 SH3 domain into cultured 3T3-L1
adipocytes inhibited receptor-mediated endocytosis of trans-
ferrin and caused accumulation of the Glut4 glucose trans-
porter at the plasma membrane (349). These results are sug-
gestive of a role for amphiphysin 1 in endocytosis, but the
overexpressed amphiphysin 1 SH3 domain may engage in off-
target interactions leading to nonspecific effects.
As discussed above, there appears to be a role for am-
phiphyin 1 in regulation of the cortical actin cytoskeleton dur-
ing polarized growth. Intriguing, links between dynamin and
the actin cytoskeleton are also emerging. Dynamin 2 in non-
neuronal cells modulates the activation of the Arp2/3 actin
filament nucleation complex and thereby de novo actin fila-
ment assembly at the cortex (151, 157, 280, 281). Mechanical
force generated by de novo actin filament assembly may be
important for dynamin-mediated scission of the neck of clath-
rin-coated vesicles during endocytosis as well as in cortical
actin cytoskeletal dynamics during polarized growth.
Amphiphysin 1 interacts with clathrin and AP-2.Amphiphysin
1 also interacts with other components of clathrin coats. Am-
phiphysin 1 binds directly to clathrin heavy chain (187). Fur-
thermore, amphiphysin 1 binds the -adaptin subunit of the
AP-2 adaptor in vitro (352). Subsequently, it was found that
the appendage domain of -adaptin binds a non-SH3 domain
of amphiphysin 1 (46). Binding of a recombinant central insert
domain of human amphiphysin 1 to endogenous clathrin heavy
chain and -adaptin (a and c) in rat brain extract was sub-
sequently confirmed (256).
Does amphiphysin 1 act as an adaptor to link dynamin to
clathrin-coated pit components such as clathrin heavy chain
and AP-2? Although an early report suggested that dynamin 1
binds directly to the ear domain of -adaptin (352), subsequent
studies found that the direct dynamin 1–-adaptin interaction
is very weak. When amphiphysin 1 and dynamin 1 are both
overexpressed in COS-7 cells -adaptin forms complexes con-
taining both proteins but the -adaptin appendage domain
binds poorly to dynamin 1 compared to amphiphysin 1. The
ability of amphiphysin 1 to form heterotrimeric complexes with
-adaptin and dynamin 1 is consistent with the possibility that
amphiphysin 1 associates with clathrin-coated pits via interac-
tion with -adaptin and then recruits dynamin 1 to these pits
via its SH3 domain, a process that is likely to be perturbed by
overexpression of the isolated amphiphysin 1 SH3 domain. The
effects of amphiphysin 1 SH3 domain overexpression on dy-
namin subcellular localization were not investigated directly,
however, subcellular fractionation revealed that dynamin lev-
els in the membrane fraction are reduced by overexpression of
the amphiphysin 1 SH3 domain (367, 369).
The clathrin heavy chain and -adaptin binding sites on
amphiphysin 1 have been defined. Residues 262 to 405 of
human amphiphysin 1 mediate binding of both clathrin
heavy chain and -adaptin. The sites that interact with clath-
rin heavy chain and -adaptin are distinct, but adjacent.
Minimal -adaptin binding requires residues 322 to 340,
however, residues 340 to 363 are required for full-strength
interaction. The latter overlap with the clathrin heavy-chain
binding site and contain a DPF motif found in multiple
copies in other -adaptin binding proteins. Mutation of
residues 323 to 326 (FFED) abolishes -adaptin binding
without affecting clathrin heavy-chain binding. Binding to
clathrin heavy chain is conferred by residues 347 to 386 (256,
301, 302). The three-dimensional structure of the -adaptin
appendage domain has been determined and a model has
been proposed to account for its remarkable ability to me-
diate binding not only to amphiphysin 1 but also to several
other proteins in clathrin coats via a single interaction in-
terface (231, 334).
Mutational analysis identified two motifs that are important
for binding to clathrin heavy chain, LLDLD and WDLW.
LLDLD fits the consensus for clathrin heavy chain binding,
min in high Ca2 (2.6 mM Ca2 and 1.8 mM Mg2) to induce exocytosis of synaptic vesicles. Panel C, electron micrograph of a synapse in an axon
treated as in panel B showing the accumulation of invaginated endocytic pits at the plasmalemma. Panel D, electron micrograph of a synapse in
an axon injected with GST-amphSH3 and then electrically stimulated at 5 Hz for 30 min in high Ca2 (2.6 mM Ca2 and 1.8 mM Mg2) to induce
exocytosis of synaptic vesicles. Bars, 0.2 m. The bar in panel A applies to panels A to C. (Reprinted from reference 293 with permission of the
publisher. Copyright 1997 American Association for the Advancement of Science.)
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L(L/I)(D/E/N)(L/F)(D/E), proposed based on analysis of
clathrin binding sites in other clathrin coat components such as
the -adaptin subunit of AP-2 and AP-180. The affinity of the
recombinant clathrin-binding domain of amphiphysin 1 for
native clathrin triskelia was estimated at 1 nM (255). Mutation
of either LLDLD or WDLW motifs in amphiphysin 1 weakens
clathrin heavy-chain binding and the double mutation abol-
ishes clathrin heavy-chain binding, but has no effect on -adap-
tin binding. Combination of the mutations in -adaptin and
clathrin heavy-chain binding sites, as expected, abolish am-
phiphysin 1 interaction with both -adaptin and clathrin heavy
chain.
Amphiphysin 1 binds an N-terminal fragment of clathrin
heavy chain (residues 1 to 579 in rat clathrin heavy chain) in
vitro and this fragment contains the -propeller “foot” or “ter-
minal” domain of clathrin heavy chain. The foot domain is also
the site in clathrin heavy chain that binds a range of other
clathrin-associated proteins, including the -adaptin subunit of
AP-2, the adaptor AP-180, epsin, and -arrestin. These pro-
teins all have motifs similar to the LLDLD and WDLW motifs
in amphiphysin 1 that mediate interaction with the foot do-
main of clathrin heavy chain. In vitro, amphiphysin 1 competes
with AP-2 and AP-180 for binding to clathrin heavy chain,
suggesting all three proteins recognize the same site within the
foot domain of clathrin heavy chain. As AP-2 plays a key role
in clathrin assembly into plasma membrane clathrin-coated
pits, competition with AP-2 for binding clathrin heavy chain
may explain the loss of clathrin from plasma membrane-coated
pits observed upon overexpression of clathrin-binding frag-
ments of amphiphysin 1 (57, 58, 187, 194, 255, 256, 301).
Appendage domain of -adaptin mediates interaction with
amphiphysin 1. Amphiphysin 1 is required for efficient associ-
ation of dynamin 1 in brain lysates with -adaptin appendage
domain or clathrin heavy chain in vitro. Similarly, the addition
of recombinant amphiphysin 1 to extracts increases the asso-
ciation of both clathrin heavy chain and AP-2 with the dynamin
1 PRD in vitro. Hence, amphiphysin 1 can bind clathrin heavy
chain, AP-2, and dynamin 1 simultaneously and thus has the
potential to recruit dynamin 1 to plasma membrane clathrin-
coated pits (46, 231, 256, 301, 302, 334, 352).
Amphiphysin 1 interaction with clathrin and AP-2 is essen-
tial for endocytosis. Transient overexpression of amphiphysin
1 fragments that contain both the clathrin heavy chain- and
AP-2-binding domains in CHO cells potently blocks receptor-
mediated endocytosis of transferrin. Expression of these am-
phiphysin 1 fragments causes loss of clathrin heavy chain
from plasma membrane-coated pits and results in a diffuse
cytoplasmic clathrin heavy-chain distribution. It also causes
relocalization of AP-2 adaptors from clathrin-coated pits into
larger plasma membrane-associated aggregates. Transient over-
expression in CHO cells of a mutated amphiphysin 1 fragment
specifically unable to bind AP-2 has similar effects on clathrin
heavy chain and AP-2 subcellular distribution and also blocks
transferrin endocytosis. In contrast, overexpression of a mu-
tated amphiphysin 1 fragment specifically unable to bind clath-
rin heavy chain does not cause redistribution of clathrin heavy
chain but still induces aggregation of AP-2 adaptors and blocks
receptor-mediated endocytosis of transferrin. Hence, interac-
tion of amphiphysin 1 with both clathrin heavy chain and AP-2
may be important for clathrin-dependent endocytosis (301,
302). Again, however, these results from overexpression exper-
iments should be interpreted with caution due to the possibility
of off-target interactions and nonspecific effects.
Amphiphysin 1 interacts with endophilin A1/SH3p4/SH3GL2.
As well as clathrin heavy chain and AP-2, the amphiphysin 1
central insert domain also binds the other synapse-enriched
BAR domain protein endophilin A1 (also called SH3p4 and
SH3GL2) (Fig. 1). Recombinant endophilin A1 binds endog-
enous amphiphysin 1 in rat brain extracts via its SH3 domain
(the BAR domain does not interact). The recombinant central
insert domain of amphiphysin 1 binds endogenous endophilin
A1 in brain extracts and recombinant endophilin A1. These
results show that the endophilin A1-amphiphysin 1 interaction
is direct and mediated by the endophilin A1 SH3 domain and
the amphiphysin 1 central insert domain. A similar interaction
has been reported between endophilin A1 and a neuronal
splice variant of Bin1 (Bin16a1213) (see below). The
central insert domains of both amphiphysin 1 and Bin1
6a1213 include a proline-rich SH3 domain binding consen-
sus motif that may mediate the interaction (193, 255).
Amphiphysin 1 forms homodimers. The recombinant am-
phiphysin 1 BAR domain associates in overlay assays with
full-length endogenous amphiphysin 1 in brain extract, suggest-
ing that amphiphysin 1 forms homodimers (302). Amphiphysin
1 also forms heterodimers with Bin16a1213 in the brain
(see below).
Regulation of amphiphysin 1 complex formation by phos-
phorylation and dephosphorylation. Interestingly, amphiphy-
sin 1, dynamin 1, and synaptojanin 1 are phosphorylated in
resting synapses but are rapidly dephosphorylated upon syn-
apse stimulation and exocytosis of synaptic vesicle neurotrans-
mitters (they are referred to collectively as dephosphins) (13,
78, 193, 271, 272, 302, 330). Are associations of amphiphysin 1
with clathrin heavy chain, AP-2, dynamin 1, and synaptojanin 1
regulated during the cycle of synaptic vesicle exocytosis and
endocytosis at nerve terminals? Dynamin 1, synaptojanin 1,
clathrin heavy chain, and AP-2 coimmunoprecipitate with am-
phiphysin 1 from brain extracts. However, when brain extract is
preincubated with ATP and protein phosphatase inhibitors to
induce phosphorylation, amphiphysin 1, dynamin 1, and syn-
aptojanin 1 undergo a shift to slower electrophoretic mobilities
consistent with phosphorylation. Under these conditions dy-
namin 1, synaptojanin 1, clathrin heavy chain, and AP-2 no
longer coimmunoprecipitate with amphiphysin 1. The presence
of a protein kinase inhibitor (K252a) prevents both mobility
shift and loss of coimmunoprecipitation with amphiphysin 1,
consistent with regulation by phosphorylation (302).
Is phosphorylation of amphiphysin 1 or its binding partners
responsible for loss of complex formation? To address this,
studies were performed in which brain extracts were preincu-
bated with ATP and protein phosphatase inhibitors to induce
phosphorylation and then tested for binding to recombinant
amphiphysin 1 SH3 domain. This treatment reduced binding of
both dynamin 1 and synaptojanin 1 to the amphiphysin 1 SH3
domain in vitro. This shows that it is phosphorylation of dy-
namin 1 and synaptojanin 1 (not amphiphysin 1) that regulates
these protein interactions. In contrast, this treatment had little
effect on the binding of clathrin heavy chain or AP-2 to a
recombinant fragment of amphiphysin 1 comprising the clath-
rin heavy chain and AP-2 binding domains in vitro. This sug-
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gests that phosphorylation of clathrin heavy chain and AP-2
may not regulate association with amphiphysin 1. However, the
treatment did reduce amphiphysin 1 binding to a recombinant
fragment comprising the appendage domain of -adaptin and
the unphosphorylated form of amphiphysin 1 bound more ef-
ficiently than the phosphorylated form (302). Hence, phosphor-
ylation of amphiphysin 1 regulates association with -adaptin.
Protein phosphatase 2B/calcineurin is responsible for de-
phosphorylation of amphiphysin 1, dynamin 1, and synapto-
janin 1 upon nerve stimulation. The protein phosphatase re-
sponsible for stimulation-dependent dephosphorylation of
amphiphysin 1, dynamin 1, and synaptojanin 1 in synapses is
the Ca2-dependent protein phosphatase calcineurin (13, 189,
271, 302, 367). The addition of phosphatase inhibitors is nec-
essary to observe a shift in electrophoretic mobility of dynamin
1 and synaptojanin 1 upon treatment of brain extract with
ATP. The specific calcineurin inhibitor cyclosporine A alone is
sufficient to observe this shift in electrophoretic mobility upon
ATP treatment. However, addition of okadaic acid and vana-
date as well as cyclosporine A increases the shift in electro-
phoretic mobility compared to cyclosporine A alone. Protein
phosphatases other than calcineurin are therefore also likely to
play a role in dephosphorylation of endocytic proteins in syn-
apses (302).
Proline-rich central insert domain of amphiphysin 1 is
phosphorylated by Cdk5/p35 in vivo. Protein kinase C and
cyclin-dependent kinase 5 (Cdk5) have both been reported to
mediate constitutive phosphorylation of dynamin 1 and synap-
tojanin 1 in resting synapses (40, 165, 271, 319, 330). Different
results have been obtained with respect to phosphorylation of
amphiphysin 1 by PKC. One study found that, unlike dynamin
1 and synaptojanin 1, an inhibitor of PKC (Ro 31-8220) did not
block amphiphysin 1 rephosphorylation after stimulation-in-
duced dephosphorylation in brain synaptosomes (40). A sub-
sequent study found that Ro 31-8220 does block phosphoryla-
tion of amphiphysin 1 in brain synaptosomes and that activators
of PKC such as phorbol 12-myristate 13-acetate (PMA) stimulate
phosphorylation of amphiphysin 1 (367). However, PMA non-
specifically activates many kinases. Hence, despite evidence
for PKC phosphorylation of amphiphysin 1 in vitro, there is
no consensus on whether PKC phosphorylates amphiphysin
1 in vivo.
More recently, attention has focused on the potential role of
Cdk5 in regulation of amphiphysin 1. Amphiphysin 1 binds the
Cdk5 cyclin p35 in vitro and a recombinant fragment compris-
ing residues 1 to 306 of amphiphysin 1 is sufficient. This shows
that binding is mediated by either the N-terminal BAR domain
or the central proline-rich insert domain, but not by the C-
terminal SH3 domain. This may also be analogous to the situa-
tion in yeast, where the central GPA-rich domain of Rvs167p
mediates Pcl2p binding (163). The amphiphysin 1-p35 interaction
is likely to occur in vivo, as p35 coimmunoprecipitates with am-
phiphysin 1 (but not Cdk5) from rat brain extract (78).
Interestingly, p35 and the related Cdk5 cyclin p39 are ex-
pressed only in neurons and developing muscle cells (171, 242,
320, 337). Immunostaining of rat cortical neurons in culture
shows that amphiphysin 1 and p35 colocalize in growth cones.
Consistent with a role for Cdk5 and p35 in regulation of am-
phiphysin 1 in vivo, both Cdk5 and p35 have been implicated in
neurite outgrowth, synapse formation, and neuronal migration
such as amphiphysin 1. Amphiphysin 1 can be phosphorylated
by immunoprecipitates of the Cdk5/p35 complex from rat brain
or by recombinant Cdk5/p35 in vitro. Amphiphysin 1 Cdk5/p35
in vitro phosphorylation sites have been mapped to S261, S272,
S276, S285, and T310 (78, 272, 330). These Cdk5/p35 phos-
phorylation sites are all within the central proline-rich domain
of amphiphysin 1.
Two approaches have been used to determine whether
Cdk5/p35 phosphorylates amphiphysin 1 in vivo. One study
compared the phosphorylation status of amphiphysin 1 in rest-
ing synaptosomes from wild-type and p35-deficient mice with
and without treatment with the calcineurin inhibitor FK506. In
this study FK506 induced a very slight decrease in electro-
phoretic mobility, corresponding to phosphorylation in wild-
type mouse synaptosomes. This slight mobility shift was not
induced by FK506 in p35-deficient mice synaptosomes (330).
This suggests that Cdk5/p35 contributes to amphiphysin 1
phosphorylation in presynaptic terminals, although other ki-
nases may be required for full phosphorylation.
The second study examined rephosphorylation of amphiphy-
sin 1 following dephosphorylation induced by nerve terminal
stimulation. Purified synaptosomes were radiolabeled with 32P
and then stimulated with K to induce dephosphorylation of
amphiphysin 1. Then the labeled synaptosomes were washed to
remove K and allow rephosphorylation. Finally, the synapto-
somes were stimulated again with K. Complexes containing
amphiphysin 1 and its associated proteins were isolated from
the labeled synaptosomes and analyzed for phosphorylation
status after each treatment. Amphiphysin 1 was rephosphory-
lated following the removal of K and this was unaffected by
theCdk5-specificinhibitorroscovitine.Incontrast, rephosphory-
lation of dynamin 1 and synaptojanin 1 was blocked by rosco-
vitine. This suggests that rephosphorylation of dynamin 1 and
synaptojanin 1 is dependent on Cdk5/p35, but rephosphoryla-
tion of amphiphysin 1 is not (319). Hence, if Cdk5 does play a
role in amphiphysin 1 phosphorylation in synaptosomes, this
role is redundant with other kinases.
This is reminiscent of yeast Rvs167p, which binds Pcl2p, a
Pho85p cyclin, and is phosphorylated by Pho85p kinase in
vitro. Yeast Pho85p and Pcl2p are functional orthologs of
mammalian Cdk5 and p35/p39, respectively, as shown by the
ability of mammalian Cdk5/p35 to functionally replace Pho85p/
Pcl2p in yeast (129, 225). The central GPA-rich domain of
yeast Rvs167p, which contains the major in vivo phosphoryla-
tion sites for Pho85p/Pcl2p, is equivalent to the central proline-
rich domain of amphiphysin 1 that is phosphorylated by Cdk5/
p35 in vitro. As in the case of amphiphysin 1, Rvs167p
phosphorylation in vivo is only partially dependent on Pho85p/
Pcl2p. Deletion of all five Pcl2p-like cyclins somewhat reduces,
but does not abolish, Rvs167p phosphorylation in vivo (85,
163). This suggests that in yeast as well as in mammalian cells
other kinases act redundantly with Cdk5 family kinases to
phosphorylate amphiphysin family proteins.
Does Cdk5-dependent phosphorylation of amphiphysin 1
affect interaction with its partner proteins dynamin 1, clathrin
heavy chain, and AP-2? In one study in vitro binding assays
showed that phosphorylation of amphiphysin 1 in vitro by
Cdk5/p35 had no effect on binding to dynamin 1, however, it
inhibited binding to AP-2. In the same study phosphorylation
of dynamin 1 in vitro by Cdk5 inhibited its interaction with the
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isolated SH3 domain of amphiphysin 1 (330). In contrast, an-
other report showed that Cdk5/p25 (p25 is a truncated form of
p35) phosphorylation of dynamin 1 in vitro does not affect
dynamin 1 binding to full-length amphiphysin 1 (319). This
study did find, however, that preincubation of dynamin 1 with
the amphiphysin 1 SH3 domain blocked subsequent phosphory-
lation of dynamin 1 by Cdk5. This suggests that phosphoryla-
tion of dynamin 1, instead of regulating binding to amphiphy-
sin 1, may in fact be regulated by binding to amphiphysin 1.
Maybe phosphorylation of dynamin 1 in vivo only occurs at the
termination of synaptic vesicle endocytosis after dynamin 1 and
amphiphysin 1 dissociate.
These studies showing effects of phosphorylation on the
interactions of dynamin 1 and amphiphysin 1 have made use of
proteins that are phosphorylated in vitro by Cdk5. As it is not
yet clear to what extent Cdk5 phosphorylates amphiphysin 1 in
vivo and as other kinases that phosphorylate amphiphysin 1 in
vivo may exist, the physiological relevance of these findings
remains uncertain. In some cases effects on binding were in-
vestigated using protein fragments that represent individual
domains (e.g., SH3 domain). In these cases phosphorylation
may affect the interactions of these domains but not necessarily
affect the interactions of the full-length proteins (which may
interact via multiple domains). Whether interaction per se is
the only aspect that is important (e.g., for holding proteins
together in a complex) or whether the precise way in which the
proteins interact is also important (e.g., in terms of conforma-
tion and activity of the complex) is an interesting area that has
barely been explored. There are examples in which interactions
involving SH3 domains appear to be transient and more im-
portant for regulation than for formation of stable multipro-
tein complexes (260).
As mentioned above, dephosphorylation of amphiphysin 1
and its associated proteins following nerve terminal depolar-
ization induces synaptic vesicle recycling via endocytosis (40,
183). To determine if Cdk5/p35-dependent phosphorylation is
also important for synaptic vesicle recycling, the effect of Cdk5-
specific kinase inhibitors was examined. In the study that found
some Cdk5-dependent phosphorylation of amphiphysin 1 (see
above), Cdk5 inhibitors were also found to increase the num-
ber of synaptic vesicles formed during that round of synaptic
vesicle endocytosis in cultured hippocampal neurons (330).
This suggests that dephosphorylation of amphiphysin 1 favors
synaptic vesicle endocytosis. In contrast, the study that found
Cdk5-dependent phosphorylation of dynamin 1 but not am-
phiphysin 1 also found that addition of Cdk5 inhibitors after
nerve depolarization (to prevent rephosphorylation) actually
inhibited the subsequent rounds of synaptic vesicle endocytosis
(319). This study concluded that rephosphorylation of endo-
cytic proteins (although not amphiphysin 1) by Cdk5/p35 is
required for the maintenance of the synaptic vesicle pool. The
difference between the results of the two studies may be due to
one study’s observing acute and the other study’s observing
long-term effects of Cdk5/p35 inhibition.
When amphiphysin 1 is transiently expressed in CHO cells
that lack p35 or p39 amphiphysin 1 is still phosphorylated,
indicating the existence of other kinases that can potentially
phosphorylate amphiphysin 1 in vivo. Cell cycle synchroniza-
tion reveals that amphiphysin 1 in CHO cells specifically un-
dergoes phosphorylation during mitosis. Moreover, amphiphy-
sin 1 can be phosphorylated in vitro by the major cell cycle
regulatory Cdk Cdc2/cyclin B. The Cdc2/cyclin B kinase sites
mapped to date correspond to the known Cdk5/p35 phosphor-
ylation sites, S272, S276, and S285 (78). While amphiphysin 1
is predominantly expressed in neurons, it is also expressed at
lower levels in some other cell types (see above). In these
nonneuronal cells phosphorylation by Cdc2/cyclin B may have
a physiological role.
Amphiphysin 1 Knockout Mice
The initial evidence for a role of amphiphysin 1 in synaptic
vesicle recycling and endocytosis came from cell-based assays
employing overexpression of dominant negative constructs. Is
amphiphysin 1 essential for synaptic vesicle recycling and en-
docytosis in the context of a whole animal? The amphiphysin 1
(AMPH1) gene has been knocked out in mice and the conse-
quence of amphiphysin 1 deficiency on endocytosis at the syn-
apse examined. Mice homozygous for the amphiphysin 1
knockout are devoid of amphiphysin 1 protein but do not
exhibit developmental or anatomical abnormalities, are phys-
ically robust, and reproduce to yield viable progeny. However,
the amphiphysin 1-deficient mice are more susceptible to sei-
zures that resemble epilepsy upon reaching adulthood than
wild-type mice. The amphiphysin 1 knockout mice also exhibit
severe learning deficiencies. Hence, amphiphysin 1 is impor-
tant for several aspects of brain function (55).
Various endocytic proteins associate in vitro with liposomes
prepared from purified brain lipids. These associations occur
via interaction of endocytic proteins with amphiphysin 1, which
directly binds to membranes. When brain extracts from am-
phiphysin 1-deficient mice and wild-type mice were com-
pared, all endocytic proteins tested except amphiphysin 1 and
Bin16a1213 (see below) were present at similar levels,
showing that endocytic proteins are stable in the absence of
amphiphysin 1. However, the ability of clathrin heavy chain,
AP-2, and synaptojanin 1 present in brain extracts from am-
phiphysin 1-deficient mice to associate in vitro with brain lipid
liposomes was severely reduced. In contrast, association of
dynamin 1 with brain lipid liposomes was unaffected by loss of
amphiphysin 1, presumably because dynamin 1 can bind mem-
branes directly via its pleckstrin homology domain, which is
known to bind phosphoinositides (55).
Is recruitment of dynamin 1 to clathrin coats affected by loss
of amphiphysin 1? The recombinant amphiphysin 1-binding
C-terminal PRD of dynamin 1 forms complexes in vitro with
amphiphysin 1 and also with clathrin heavy chain and AP-2 in
wild-type brain extracts. When amphiphysin 1 knockout brain
extracts were analyzed, the absence of amphiphysin 1 resulted
in reduced association of clathrin heavy chain and AP-2 with
the dynamin 1 PRD in vitro. However, binding of clathrin
heavy chain and AP-2 to the dynamin 1 PRD was restored
when the brain extract was supplemented with physiological
amounts of recombinant amphiphysin 1 (55). Hence, although
dynamin 1 binds liposomes directly in the absence of am-
phiphysin 1, in vivo amphiphysin 1 is important for linking
dynamin 1 to components of clathrin coats on membranes.
Amphiphysin 1 is important but not essential for synaptic
vesicle recycling in vivo. Are there defects in synaptic vesicle
exocytosis or endocytic recycling in the synapses of amphiphy-
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sin 1 knockout mice? Electron micrographs showed that the
synapses of amphiphysin 1 knockout mice, either in situ or
after culturing in vitro, exhibit normal domain organization
and contain the same number of synaptic vesicles as wild-type
synapses. Significantly, there was no significant accumulation
of coated invaginations at the plasmalemma in amphiphysin 1
knockout synapses. This result was surprising since it con-
trasted with the situation in neurons that had been microin-
jected with the recombinant amphiphysin 1 SH3 domain (293).
It also contrasted with what had been observed in neurons of
dynamin mutant (shibire) flies (155). Hence, thorough exami-
nation did not reveal any apparent defect in resting nerve
terminals of amphiphysin 1 knockout mice (55).
Could subtler defects in synaptic vesicle exocytosis or endo-
cytic recycling be revealed under conditions of nerve stimula-
tion? Primary synaptosomes were isolated from the cerebral
cortex of wild-type and amphiphysin 1 knockout mice and
tested for high-K-stimulated release of the neurotransmitter
glutamate. The kinetics of K-stimulated exocytosis and the
quantity of glutamate release are both unaffected in amphiphy-
sin 1 knockout compared to wild-type synaptosomes. Quanti-
tative assays of high-K-stimulation-dependent endocytic in-
ternalization of fluorescent lipophilic dyes were performed and
here it was observed that following stimulation, endocytosis
was 40% less efficient in amphiphysin 1 knockout compared to
wild-type synaptosomes. Moreover, the dye that was internal-
ized after a brief high-K stimulation was less efficiently de-
livered back to the plasmalemma after a second high-K stim-
ulation in amphiphysin 1 knockout compared to wild-type
synaptosomes (55). This indicates that the efficiency of both
endocytic recycling and the subsequent return of endocytosed
synaptic vesicles to an “active exocytic pool” are reduced by
loss of amphiphysin 1.
Cerebral cortex neurons cultured from amphiphysin 1
knockout mice also exhibit a reduced percentage of labeled
synaptic vesicles and endosomes after high-K stimulation in
the presence of the fluid-phase endocytic marker horseradish
peroxidase compared to cultured neurons from wild-type mice.
This difference in the percentage of horseradish peroxidase-
labeled synaptic vesicles and endosomes is dependent on K
stimulation, however. In resting synapses the fraction of syn-
aptic vesicles and endosomes labeled with horseradish perox-
idase is equivalent in amphiphysin 1 knockout and wild-type
neurons. Hence, there are mild defects in synaptic vesicle re-
cycling and exocytosis in amphiphysin 1 knockout mice that
only become apparent under conditions of strong nerve stim-
ulation (55).
Interestingly, while neurons cultured from amphiphysin 1
knockout and wild-type mice have the same total number of
synaptic vesicles, the pool that participates in action potential
stimulated exocytosis differs. Measurements of fluorescent li-
pophilic dye uptake showed that the percentage of the total
pool of synaptic vesicles that undergo exocytosis (and become
labeled with fluorescent dye at the plasma membrane) in-
creases in proportion to the number and duration of stimula-
tory action potentials applied. However, the percentage of the
total pool of vesicles that participate in exocytosis and can be
labeled is 25 to 30% lower for the amphiphysin 1 knockout
neurons than wild-type neurons at each level of stimulation.
Labeled wild-type and amphiphysin 1 knockout neurons lose
their fluorescent dye with comparable efficiency during initial
action potentials, however, after more action potentials the
ability of the mutant neurons to recycle fluorescent dye into
the medium declines compared to that of wild-type neurons
(55). Hence, amphiphysin 1 knockout neurons exhibit a re-
duced active vesicle pool.
Synaptic vesicles that have been reinternalized must be rep-
rimed before they can undergo another round of stimulated
exocytosis. The reduction in fluorescent dye recycling into the
medium observed in the amphiphysin 1 knockout neurons is
consistent with a possible defect in synaptic vesicle repriming.
Repriming is assayed by labeling neurons with a fluorescent
lipophilic dye using an action potential and then examining the
effect of extending the duration of the action potential beyond
the period of dye exposure. The prolonged action potential can
result in immediate recycling of the internalized dye into the
medium if repriming of endocytosed synaptic vesicles is rapid.
If repriming is delayed, the recycling of the internalized dye
into the medium is slower and only apparent if the duration of
the action potential after dye removal is extended. Consistent
with a longer synaptic vesicle repriming time in the amphiphy-
sin 1 knockout synapses, the action potential has to be ex-
tended for longer times after removal of dye before the inter-
nalized dye is reexocytosed compared to wild-type neurons
(55). Defects in repriming may account for the reduced pool of
active synaptic vesicles in amphiphysin 1 knockout neurons.
Essential role for amphiphysin 1 in learning. Particularly
exciting is the finding that amphiphysin 1 knockout mice have
severe learning deficiencies as revealed by standardized behav-
ioral tests (55). Knockout of other genes in mice that encode
synaptic vesicle proteins, e.g., synapsin 1, causes epileptic sei-
zures like those caused by knockout of amphiphysin 1, but in
contrast to amphiphysin 1 knockout these do not affect learn-
ing (294). It may be relevant that a human gene mutated in a
mental retardation disorder encodes a neuronal Rab GDP
dissociation inhibitor (44). In yeast, Rvs167p interacts with a
catalytically active Rab-GAP (Gyp5p) as well as a catalytically
inactive Rab-GAP family member (Gyl1p) (33, 84, 317), rvs167
genetically interacts with a gene encoding an endosomal Rab
protein (Ypt51p/Vps21p) (296), and loss of Rvs161p or
Rvs167p cause accumulation of what appear to be exocytic
vesicles that likely carry the Rab protein Ypt1p (20).
Could amphiphysin 1 in brain function in connection with Rab-
GTPase regulators? Altered Rab-GTPase activity in amphiphysin
1 knockout mice, if it indeed occurs, might explain the delayed
repriming of endocytosed synaptic vesicles, since Rab-GTPases
are key regulators of vesicle exocytosis and their association with
vesicles is regulated by their GTP/GDP status. Indeed, the appar-
ent endocytic defects in amphiphysin 1 knockout synapses may be
a consequence of a failure of vesicles internalized in one round
of endocytosis to undergo exocytosis and thus contribute mem-
branes for the next round of endocytosis. Although there is no
direct evidence for amphiphysin 1–Rab-GAP interactions in
mammals, such interactions may be worth exploring.
Amphiphysin 1 and Molding of Membranes
Dynamin 1 binds membranes and evaginates tubules in
vitro. Binding of clathrin coat components to protein-free li-
posomes results in deformation of the initially spherical lipo-
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FIG. 11. Amphiphysin 1 evaginates liposomes in vitro to generate coated membrane tubules. A, electron micrographs of negatively stained
membrane tubules generated in vitro from spherical liposomes composed of brain lipids a) after incubation with recombinant full-length
amphiphysin 1 (cleaved from a GST fusion protein) or b) after incubation with a recombinant fusion protein comprising GST and the amphiphysin
1 BAR domain only (residues 1 to 286). Bar, 500 nm. B, electron micrographs of negatively stained membrane tubules generated in vitro from
spherical liposomes composed of brain lipids after incubation with clathrin coat components plus: a, recombinant dynamin 1; b, both recombinant
dynamin 1 and recombinant amphiphysin 1; or c, recombinant amphiphysin 1. The insets at the top right of each panel show the ends of tubules
at high magnification (a, negatively stained sample; b and c, positively stained embedded and thin-sectioned samples). For comparison, the bottom
inset in panel a shows clathrin-coated buds at high magnification. Note that the presence of amphiphysin 1 in panels b and c increases the frequency
of clathrin-coated bud formation at tubule ends compared to dynamin 1 alone in panel a. C, electron micrographs showing the appearance of the
tubular coat that forms when spherical liposomes are incubated in vitro with recombinant amphiphysin 1 alone (a and b); recombinant dynamin
1 alone (c and d); both recombinant amphiphysin 1 and recombinant dynamin 1 (e and f), or total brain cytosol with ATP and GTP	S (g). The
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somes to create clathrin-coated buds. Furthermore, binding of
dynamin 1 to protein-free liposomes results in evagination of
the liposomes to form narrow membrane tubules that resemble
the necks of deeply invaginated clathrin-coated pits. These
tubules have a striated appearance and can be immunolabeled
with antiserum to dynamin 1, suggesting that assembly of dy-
namin 1 rings on the liposome drives membrane deformation
to form tubules (314). Dynamin 1 spontaneously assembles
into closed rings and open spirals in vitro even in the absence
of liposomes, and these structures have dimensions similar to
the membrane tubules (121). This suggests dynamin 1 ring and
spiral assembly at the membrane surface may drive membrane
evagination to form tubules (121, 315). Addition of GTP to
dynamin 1-coated tubules causes them to undergo fission to
yield small vesicles (312). This reaction in vitro may mimic dy-
namin 1 function in cleavage of the necks of deeply invaginated
clathrin-coated pits during clathrin-mediated endocytosis.
Amphiphysin 1 binds membranes and evaginates tubules in
vitro. Amphiphysin 1 also binds directly to liposomes and has
membrane-tubulating activity in vitro (Fig. 11A). The lipo-
some-tubulating activity of amphiphysin 1 is even greater than
that of dynamin 1. The tubules formed by amphiphysin 1 dis-
play a striated appearance under electron microscopy, suggest-
ing amphiphysin 1 assembles into rings that surround mem-
brane tubules such as dynamin 1 (Fig. 11B). When clathrin
coat components are also present, the membrane tubules
formed by amphiphysin 1 are almost always associated with
clathrin-coated buds (Fig. 11C). Other clathrin coat compo-
nents (e.g., clathrin and AP-180) are unable to evaginate lipo-
somes into tubules in vitro (316). Similarly, other known lipid-
binding domains such as the pleckstrin homology (PH) domain
of phospholipase C are also unable to evaginate liposomes
into tubules in vitro (73). This suggests the liposome-tubulating
activity of amphiphysin 1 in vitro is specific and requires more
than the ability to bind membranes. Amphiphysin 1 activity in
liposome tubulation in vitro likely reflects an important in vivo
function of amphiphysin 1 in clathrin-dependent endocytosis.
Amphiphysin 1 binding to membranes is dependent on lipid
composition. The membrane tubulation activity of amphiphysin 1
is affected by the lipid composition of the membrane. Liposomes
composed of crude mixtures of brain lipids or of pure phospha-
tidylserine and phosphatidylcholine are efficiently tubulated by
amphiphysin 1, but tubulation activity is proportional to the per-
centage of phosphatidylserine (316). Hence, similar to dynamin 1,
amphiphysin 1 preferentially binds and tubulates membranes
composed of acidic phospholipids.
Amphiphysin 1 and dynamin 1 coassemble into rings on
membrane tubules. Incubation of liposomes with total brain
extract results in very obvious thick striations with regular
spacing along the evaginated membrane tubules. When either
purified dynamin 1 or amphiphysin 1 is used instead, the evagi-
nated tubules display a continuous and tightly spaced arrange-
ment of thin rings. Interestingly, incubation of liposomes with
purified dynamin 1 and amphiphysin 1 in combination results
in thick striations along the evaginated tubules, as seen when
total brain extract is used. This suggests the rings assembled on
evaginated tubules in the presence of total brain extract con-
tain both dynamin 1 and amphiphysin 1. The formation of
these thicker rings requires not only the membrane binding
BAR domain of amphiphysin 1, but also the dynamin 1-inter-
acting amphiphysin 1 SH3 domain. The presence of the iso-
lated amphiphysin 1 SH3 domain does not alter the appear-
ance of coats on tubules evaginated by dynamin 1. Similarly,
the isolated amphiphysin 1 BAR domain did not alter the
appearance of coats on tubules evaginated by dynamin 1.
Hence, the formation of thick rings on evaginated tubules by
dynamin 1 requires full-length amphiphysin 1 (314, 316).
Amphiphysin 1 stimulates assembly of dynamin 1 into thick
rings in solution. Purified amphiphysin 1, unlike purified dy-
namin 1, is unable to assemble into rings in the absence of
liposomes. However, amphiphysin 1 does stimulate the assem-
bly of dynamin 1 into rings in solution. Moreover, the rings
formed by dynamin 1 in the presence of amphiphysin 1 in
solution contain both proteins and resemble the thick rings
formed when liposomes are also present (316). Ring assembly
by amphiphysin 1 and dynamin 1 is influenced by their phos-
phorylation state. Dephosphorylated forms of amphiphysin 1
and dynamin 1 are highly active for assembly and their mixture
results in highly efficient thick-ring assembly in vitro. In con-
trast, phosphorylated amphiphysin 1 and dynamin 1 are less
active for ring assembly and form few thick rings (330).
Amphiphysin 1 coordinates clathrin bud and dynamin 1
tubule formation. It is important that budding and fission be
coordinated during clathrin-mediated endocytosis. However,
when both clathrin coat components and dynamin 1 are incu-
bated with liposomes in vitro, although clathrin-coated buds
and dynamin 1-coated tubules both form on the liposomes,
there is a lack of coordination between the two structures. Few
clathrin-coated buds have tubular dynamin 1-coated necks and
few dynamin 1-coated tubules have clathrin-coated buds. Be-
cause amphiphysin 1 interacts via the central insert domain
with clathrin coat components and via its C-terminal SH3 do-
main with dynamin 1, a key question is whether amphiphysin 1
links clathrin coat components to dynamin 1 and thereby co-
ordinates vesicle budding with vesicle fission. Indeed, if am-
phiphysin 1 is added to liposomes together with clathrin coat
components and dynamin 1, there is an increase in the per-
centage of dynamin 1-coated tubules that are associated with
clathrin-coated buds and vice versa (316).
Amphiphysin 1 stimulates the activity of dynamin 1 in mem-
brane tubule fission. Although amphiphysin 1 alone is unable
to mediate membrane fission in vitro, the addition of purified
amphiphysin 1 substantially increases the extent of liposome
tubulation and subsequent GTP-induced fission mediated by
purified dynamin 1. Under the conditions used in this study the
addition of amphiphysin 1 did not increase dynamin 1 associ-
images in panels a, c, and e represent negatively stained samples, while those in panels b, d, f, and g represent samples embedded, thin sectioned,
and then positively stained. Note that recombinant amphiphysin 1 or dynamin 1 alone forms thin tightly packed rings on membrane tubules while
recombinant amphiphysin 1 and dynamin 1 together or endogenous amphiphysin 1 and dynamin 1 in total brain extract form thick rings with
regular spacing on membrane tubules. (Reprinted from reference 316 with permission of the publisher.)
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ation with membranes or stimulate dynamin 1 GTPase activity
(316). Interestingly, the activity of amphiphysin 1 and dynamin
1 in liposome tubulation and fission is regulated by their phos-
phorylation state. Dephosphorylated forms of both dynamin 1
and amphiphysin 1 were highly active in tubulation and fission,
and incubation with liposomes resulted in dramatic generation
of small vesicles. In contrast, phosphorylation by Cdk5/p35 of
only dynamin 1 or amphiphysin 1 slightly reduced vesicle for-
mation, while phosphorylation of both proteins almost com-
pletely inhibited the generation of small vesicles (330).
In vivo role for amphiphysin 1 in membrane tubule forma-
tion. Is the ability of amphiphysin 1 to bind and tubulate
membranes important in vivo? The first evidence that am-
phiphysin 1 generates membrane tubules in vivo came from
experiments in which a fragment comprising the amphiphysin
1 N-terminal amphipathic -helix and BAR domain (N-BAR)
was overexpressed in COS-7 cells. Overexpression of the N-
BAR fragment induced massive tubulation of the plasma
membrane in vivo (237). The importance of the N-terminal
amphipathic helix for high-affinity liposome binding and tubu-
lation in vitro was first demonstrated for the BAR domain
protein endophilin A1 (see below), but the amphiphysin 1
N-terminal amphipathic helix appears to play a similar role
(73). There is also evidence that amphiphysin 1 plays a physi-
ologically important role in dynamin 1-mediated membrane
fission. Brain cytosol prepared from amphiphysin 1 knockout
mice (and also deficient in Bin16a1213, see below) has
considerably reduced ability to support dynamin 1-dependent
fission of large unilamellar liposomes into small vesicles in
vitro. This deficiency can be rescued by addition of purified
recombinant amphiphysin 1 (380). This shows that the mem-
brane fission defect in these extracts is specifically due to a lack
of amphiphysin 1 (although Bin16a1213 is also deficient,
it appears that amphiphysin 1 alone can stimulate dynamin
1-dependent fission).
Membrane curvature and amphiphysin 1 binding. The N-
terminal amphipathic -helix is critical for high-affinity binding
to liposomes and tubulation, however, the BAR domain alone
retains lower affinity binding to liposomes. A key finding was
that binding of the amphiphysin 1 BAR domain alone to lipo-
somes in vitro is critically dependent on liposome size and
therefore membrane curvature. While the amphiphysin 1 BAR
domain binds poorly to large liposomes (0.8-m diameter) that
have low curvature, it binds strongly to small liposomes
(0.05-m diameter) that have high curvature. This result is
important because it shows the BAR domain not only gener-
ates membrane curvature (in conjunction with the N-terminal
amphipathic -helix), but alone can also act as a sensor of
membrane curvature. An exciting possibility is that amphiphy-
sin 1 may recruit dynamin 1 specifically to high-curvature
membranes such as those at the tubular neck of clathrin-coated
pits. Hence, amphiphysin 1 may potentiate dynamin 1-depen-
dent membrane fission by localizing dynamin 1 within the mem-
brane to sites where fission is most efficient (237, 316, 380).
The effects of membrane curvature on amphiphysin 1- and
dynamin 1-dependent membrane fission were investigated re-
cently. In the presence of large liposomes that can be evagi-
nated into high-curvature tubules, addition of amphiphysin 1
results in a dose-dependent stimulation of both dynamin 1
GTPase activity and recruitment to liposomes. In the presence
of small liposomes that, because of their size, cannot support
evagination of high-curvature tubules, the basal GTPase activ-
ity of dynamin 1 was higher than in the presence of large
liposomes. However, in contrast to what was seen with large
liposomes, addition of amphiphysin 1 in this case led to a
dose-dependent inhibition of dynamin 1 GTPase activity. Small
liposomes contain insufficient membrane material to support
the formation of dynamin 1- and amphiphysin 1-coated high-
curvature tubules, and amphiphysin 1 under these conditions
may engage in inhibitory interactions with dynamin 1. How-
ever, in the case of large liposomes the conversion of low-
curvature membranes into evaginated tubules with high curva-
ture allows extensive coassembly of dynamin 1 and amphiphysin
1 into rings. This promotes a different type of interaction between
amphiphysin 1 and dynamin 1 that in turn stimulates dynamin 1
GTPase activity (380).
Amphiphysin 1 tubulation of membranes is dependent on
lipid composition. The influence of membrane lipid composi-
tion on stimulation of dynamin 1 GTPase activity by amphiphy-
sin 1 was also investigated. In the absence of liposomes dy-
namin 1 GTPase activity was low and only very weakly
stimulated by amphiphysin 1. Large liposomes containing brain
lipids and supplemented with cholesterol and phosphatidylino-
sitol-4,5-phosphatase [PtdIns(4,5)P2]-stimulated dynamin 1
GTPase activity, even in the absence of amphiphysin 1. Addi-
tion of amphiphysin 1 in the presence of these liposomes re-
sulted in further strong stimulation of dynamin 1 GTPase ac-
tivity (380). This is consistent with the view that stimulation of
dynamin 1 GTPase activity by amphiphysin 1 is not due to
direct amphiphysin 1 interaction with dynamin 1 in solution,
but instead related to the ability of these two proteins to
coassemble into rings on high curvature membranes.
PtdIns(4,5)P2 binds the PH domain of dynamin 1 and is
known to not only recruit dynamin 1 to membranes but also
activate dynamin 1 GTPase activity in vitro. If PtdIns(4,5)P2
was substituted with phosphatidylcholine in the large lipo-
somes, dynamin 1 GTPase activity was not as strongly stimu-
lated by liposomes alone, but addition of amphiphysin 1 still
resulted in strong stimulation (380). Perhaps amphiphysin 1 is
especially important for dynamin 1 recruitment to membranes
low in PtdIns(4,5)P2. Dynamin 1 and amphiphysin 1 have been
shown to tubulate liposomes containing high levels of phos-
phatidylserine (314, 316). Furthermore, liposomes containing
phosphatidylserine are subject to GTP-dependent fission by
dynamin 1 in vitro (312, 316). When PtdIns(4,5)P2 was re-
placed with phosphatidylserine, dynamin 1 GTPase activity was
strongly stimulated by liposomes alone and activity was directly
proportional to liposome phosphatidylserine content. More-
over, the addition of amphiphysin 1 led to a very dramatic
further stimulation of dynamin 1 GTPase activity that exhib-
ited positive cooperativity with liposome phosphatidylserine
content (380).
Domains of amphiphysin 1 required for membrane tubula-
tion. Testing of various recombinant fragments of amphiphysin
1 revealed that the N-terminal BAR domain (residues 1 to
286) is sufficient for full liposome tubulation activity and that
an N-terminal piece of the BAR domain (residues 1 to 161)
retains low tubulation activity. In contrast, the C-terminal SH3
domain has no tubulation activity (316). Tubulation activity
correlates with stimulation of dynamin 1 GTPase activity. In
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the presence of large liposomes containing cholesterol and
PtdIns(4,5)P2, the isolated amphiphysin 1 BAR domain stim-
ulates dynamin 1 GTPase activity as efficiently as full-length
amphiphysin 1. This is probably due to the BAR domain’s
promoting high-curvature tubule formation, which in turn fa-
cilitates dynamin 1 binding and assembly into rings. In con-
trast, the isolated amphiphysin 1 SH3 domain was not able to
stimulate dynamin 1 GTPase activity in the presence of large
liposomes (380).
The BAR domain of amphiphysin 1 is predicted to be highly
acidic and hence to bear a strongly negative net charge. That
the BAR domain is the part of amphiphysin 1 that mediates
binding to acidic lipids, including phosphatidylserine and
PtdIns(4,5)P2, initially seemed somewhat puzzling. However,
the three-dimensional structure of the amphiphysin BAR do-
main provides a simple explanation for this apparent paradox
because it reveals that the membrane binding surface of BAR
domains bears a net positive charge (see below).
Interestingly, a construct containing both the BAR and SH3
domains but missing the central insert domain is considerably
more active in stimulation of dynamin 1 GTPase activity than
full-length amphiphysin 1. Hence, full stimulation of dynamin
1 GTPase activity requires both the BAR and SH3 domains,
but not the central insert domain. The central insert domain of
amphiphysin 1 is known to bind the SH3 domain via an in-
tramolecular interaction and this inhibits interaction of the
SH3 domain with dynamin 1 (74). Deletion of the proline-rich
motif in the central insert domain that binds the SH3 domain
enhances the stimulatory effect of amphiphysin 1 on dynamin
1 GTPase activity. The isolated amphiphysin 1 SH3 domain
does not further enhance the ability of the isolated amphiphy-
sin 1 BAR domain to stimulate dynamin 1 GTPase activity in
the presence of large liposomes (380). This shows that the
function of the SH3 domain is to link dynamin 1 to the am-
phiphysin 1 BAR domain and that the SH3 domain does not
independently stimulate dynamin 1 GTPase activity.
The stimulatory effect of these amphiphysin 1 constructs on
dynamin 1 GTPase activity correlates with their ability to re-
cruit dynamin 1 to membranes in vitro, e.g., the amphiphysin 1
construct lacking the central insert domain was more active
than full-length amphiphysin 1 both in recruiting dynamin 1 to
liposomes and in stimulating dynamin 1 GTPase activity (380).
This suggests that coassembly on membranes and stimulation
of dynamin 1 GTPase activity are linked. This is consistent with
results from other studies that show dynamin 1 assembly stim-
ulates its GTPase activity (353). Stimulation is due to intermo-
lecular interactions between the GTPase effector domain of
one dynamin 1 monomer and the GTPase catalytic domain of
the adjacent dynamin 1 monomer that can take place only
within a multimeric assembly (203).
Domains of amphiphysin 1 required for coassembly with
dynamin 1 into rings in solution. The domains of amphiphysin
1 required for coassembly with dynamin 1 into rings in solution
have also been investigated. Visualization of negatively stained
protein samples by electron microscopy reveals that full-length
amphiphysin 1 and amphiphysin 1 constructs lacking either the
proline-rich motif or the entire central insert domain are able
to coassemble with dynamin 1 into rings in solution. In con-
trast, the isolated BAR and SH3 domains lack the ability to
coassemble with dynamin 1 into rings in solution (380). This
requirement for the BAR domain even in the absence of mem-
branes suggests that coassembly of amphiphysin 1 and dynamin
1 in solution may require that amphiphysin 1 make contacts
with dynamin 1 via the BAR domain as well as the SH3 do-
main. However, direct evidence of amphiphysin 1 BAR do-
main-dynamin 1 interaction is lacking.
SECOND ISOFORM OF AMPHIPHYSIN, Bin1
Discovery of Bin1
A number of findings suggested the existence of a second,
more ubiquitously expressed amphiphysin isoform in verte-
brates. These included the ability of the amphiphysin 1 SH3
domain to powerfully inhibit endocytosis in nonneuronal cells
that express only very low levels of amphiphysin 1 (369), the
existence of amphiphysin-related proteins in unicellular eu-
karyotes such as yeast (12, 42, 47, 298), and the finding that
amphiphysin 1-reactive sera from stiff-man syndrome patients
also recognize an additional protein distinct in size from am-
phiphysin 1 (338). Various approaches led to the isolation of
this second isoform of amphiphysin, which has resulted in its
having several names, e.g., amphiphysin 2 (168), amphiphysin
II (23, 256, 338), Amph2 (367), BRAMP2 (168), ALP1 (141),
SH3P9 (306), and Bin1 (278). The Human Genome Organi-
zation-approved designation for this family of amphiphysin-
related proteins is Bin1, so Bin1 is the name that will be used
in this review.
Sequence comparison revealed that Bin1 is the product of a
novel gene and that Bin1 transcripts are subject to extensive
differential splicing, leading to a diversity of Bin1 forms. Table
2 lists all the known splice variants of Bin1 and the various
names that have been assigned to them. Bin1 has a domain
structure similar to that of amphiphysin 1, featuring an N-termi-
nal BAR domain with predicted coiled-coil structure and a C-
terminal SH3 domain (Fig. 1) (23, 141, 168, 256, 278, 306, 367).
The central insert domain of Bin1 is more divergent than
that of amphiphysin 1. Some splice variants include a central
insert domain that is highly homologous to the central insert
domain of amphiphysin 1 and that interacts with clathrin and
AP-2/-adaptin (sometimes referred to as the endocytosis do-
main) (Fig. 1). Other splice variants lack this central insert
domain or have alternative central insert domains that do not
interact with clathrin or AP-2/-adaptin (Fig. 1) (168, 255, 278,
338, 356). The central insert domain contains two proline-rich
motifs (residues 297 to 306 and 340 to 346 in mouse Bin1) that
may bind SH3 domains (168). Although the hydrophobic re-
gion in the central insert domain of human and chicken am-
phiphysin 1 is missing in Bin1, there is a region of hydropho-
bicity near the Bin1 SH3 domain (338). In some brain splice
variants a 31-residue insert (N-terminal insert domain [NTID])
occurs within what was originally predicted to be a coiled-coil
motif in the BAR domain (338). Comparison with the recently
elucidated three-dimensional structure of Drosophila am-
phiphysin now suggests this site of insertion is a disordered
loop between -helices (237).
Four studies identified Bin1 partial sequences simply by
searching expressed sequence tag databases and these were
then used to obtain full-length cDNAs by hybridization screens
(23, 256, 338, 367). In one study, a mouse cDNA expression
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library was screened with a synthetic peptide known to be a
ligand of the Src SH3 domain in an attempt to identify novel
SH3 domain proteins. One of the novel murine SH3 domain
proteins identified was named SH3p9 and is a splice variant of
Bin1 (Table 2) (306). Bin1 was also isolated in two-hybrid
screens for proteins that interact with the oncoproteins c-Myc
(278) and c-Abl (141) (Table 2). Bin1 was independently iden-
tified in a two-hybrid screen for mouse brain proteins that
interact with the proline-rich C-terminal domain of the human
Ras GDP/GTP exchange factor son of sevenless 1 (Sos-1) and
named BRain form of AMPhiphysin 2 (BRAMP2) (Table 2).
Purified recombinant BRAMP2 bound in vitro-translated human
SOS-1 and -2, confirming the yeast two-hybrid interaction and
showing that BRAMP2 binding to SOS-1 and -2 is direct (168).
Characterization of independent Bin1 cDNAs from different
tissues and even from the same tissue revealed complete se-
quence identity over included domains but a high degree of
heterogeneity in domain structure, consistent with the possi-
bility that the Bin1 transcript is subject to differential splicing
(Fig. 1 and Table 2) (23, 168, 256, 278, 338, 356, 367). In two
reports at least 10 different transcripts could be amplified by
PCR from human or rat brain tissue using primers that recog-
nize sequences encoding the N- and C-terminal domains of
Bin1 (338, 367). The longest Bin1 splice variant in human brain
exhibits 71% amino acid sequence similarity and 55% amino
acid sequence identity with human amphiphysin 1 (23). Inter-
estingly, in one study two of the Bin1 cDNAs appeared to
encode splice variants that lacked a C-terminal SH3 domain,
similar to yeast Rvs161p (Table 2) (367).
The intron-exon boundaries of the 54-kb human BIN1 gene
have been mapped by Wechsler-Reya et al. BIN1 encodes at
least 20 exons, of which at least seven are differentially spliced,
giving rise to a vast array of Bin1 splice variants (Fig. 1 and
Table 2). This review will adopt the splice variant nomencla-
ture proposed by Wechsler-Reya et al., but with the addition of
one originally overlooked exon located between exons 6 and 7,
which will be referred to in this review as exon 6a (356). It
should be noted that in the new systematic exon nomenclature
for Bin1, exon 6a is renamed exon 7 and all following exons
have numbers that are n  1 with respect to those assigned by
Wechsler-Reya. The majority of published reports have used
the exon nomenclature of Wechsler-Reya and not the new
systematic exon nomenclature. Our decision to retain the older
nomenclature in this review ensures the exon numbers referred
to here are consistent with those in most of the published
literature.
Although there exist many splice variants, the major forms
vary in four exons: 6a, 10, 12, and 13 (Fig. 1 and Table 2). Exon
6a encodes the 31-residue brain-specific NTID (257). There is
no sequence homologous to the NTID in the reported clones
of amphiphysin 1 (23, 367). Exon 10 is muscle specific and
encodes a 15-residue sequence that contains a putative nuclear
localization sequence and lipid binding sequence (162, 278).
Exon 12 includes a series of alternative brain-specific exons
(12A to -D) that encode the central insert domain. Depending
on the particular exon 12 variant this central insert domain can
interact with -adaptin/AP-2 and/or clathrin heavy chain
and/or endophilin A1 (23, 168, 187, 255, 256, 338, 356, 367).
For simplicity, except in Table 2 this review will not distinguish
which of the exon 12 variants is present, only that an exon 12
is present.
Finally, exon 13 includes part of the Myc binding domain
and is differentially spliced in a tissue-independent manner
(100, 141, 338, 356, 357, 367). Bin16a1213 represents the
neuronal isoforms of Bin1 (amphiphysin 2, amphiphysin II,
Amph2, and BRAMP2), and Bin11013 represents the
muscle isoform of Bin1 (commonly referred to as Bin1).
Bin1101213 represents the widely expressed Bin1 iso-
form known as SH3p9. Finally, Bin1101213 is the most
ubiquitously expressed Bin1 isoform, known as ALP1 or am-
phiphysin IIm.
Different Bin1 splice variants exhibit different tissue distri-
butions. In the rat, every tissue tested expressed transcripts
lacking exons 6a and 10 except the retina (only 6a) and
skeletal muscle (only 10). Exon 6a was present in at least
some transcripts from all nerve tissues, but was not present in
transcripts from any other tissues. In contrast, all skeletal mus-
cle transcripts included exon 10, but exon 10 was not present in
transcripts from any other tissue (Fig. 1 and Table 2). In the
human, rat, and mouse, transcripts containing exon 12 that
encodes the 127-residue central insert domain are expressed
only in the brain (in particular the cerebral cortex and pons),
spinal cord, other neuronal tissue, and neuron-like pheochro-
mocytoma (PC12) cells, similar to amphiphysin 1 (23, 168, 256,
278, 338, 356, 367). Some nonneuronal cells misexpress tran-
scripts containing exon 12 following tumorigenesis (Table 2)
(93, 356). In rat brain Bin1 represents 0.1% of the total pro-
tein, similar to rat brain amphiphysin 1 (367).
In the rat, forms of Bin1 protein lacking the large brain-
specific central insert domain encoded by exon 12 were ex-
pressed at high levels in skeletal muscle and could be detected
(at approximately 10-fold lower levels) in many tissues, includ-
ing heart, brain, lung, liver, skeletal muscle, kidney, ovary, and
thymus (the skeletal muscle forms include the 15-residue mus-
cle-specific domain encoded by exon 10 but the presence of this
domain is difficult to distinguish by electrophoretic mobility)
(367). In the mouse, transcripts lacking exon 12 were expressed
in multiple tissues, including brain, liver, lung, kidney, heart,
ovary, testis, spleen, and skeletal muscle (168, 278). In the
human, transcripts lacking exon 12 were present in the brain,
heart, placenta, lung, liver, kidney, pancreas, spleen, ovary,
testis, and skeletal muscle (23, 141). They were expressed at
equal levels in cultured normal human fibroblasts and in some
cultured human tumor cell lines (e.g., HeLa cervical carcinoma
cells), however, they were absent in other tumor cell lines (e.g.,
HepG2 hepatocarcinoma cells and MCF7 breast carcinoma
cells) (278).
The various Bin1 splice variants exhibit anomolous electro-
phoretic mobilities. In humans the brain isoform of Bin1 mi-
grates at 85 kDa, while in rats it migrates at 92 kDa. Ectopic
expression of the equivalent mouse cDNA gave rise to a dou-
blet at 88 and 96 kDa. In contrast, the longest Bin1 transcript
in human, rat, or mouse brain is predicted to encode a protein
of only 65 kDa (23, 168, 256, 367). The aberrant gel mobility of
brain Bin1 isoforms is similar to what has been observed for
amphiphysin 1. The amino acid sequence encoded by exon 12
corresponds to a sequence that in amphiphysin 1 has been
shown to confer aberrant electrophoretic mobility (47, 175).
Indeed, in the rat the presence of exon 12 in Bin1 has been
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shown to confer aberrant electrophoretic mobility (367). Inter-
estingly, the muscle isoform containing the 15-residue domain
encoded by exon 10 migrates on gels at 60 to 70 kDa although
its predicted size is 50 kDa, so it also exhibits aberrant elec-
trophoretic mobility (278).
Bin16a1213/Amphiphysin 2/Amphiphysin
II/BRAMP2 in the Brain
The function of Bin16a1213 in the brain has been
the topic of an excellent earlier review (368). There are
several brain-specific isoforms of Bin1 that vary in exon 12
subtype (12A to 12D) (encoding the central insert domain)
and the presence of exon 6a (encoding the NTID) (Fig. 1
and Table 2).
Distribution of Bin11213 in the brain. Different local-
izations have been reported for Bin112 in the brain (the
antisera used for these studies could not distinguish between
isoforms containing and lacking exons 6a and 13, so they will
collectively be referred to here as Bin112). In one study
immunocytochemistry revealed a distribution of Bin112 in
the brain similar to that reported for amphiphysin 1. Bin112
was strongly enriched in a subset of nerve terminals within all
three layers of the cerebellum as well as the hippocampus and
pontine nucleus (367). Similarly, in a second study immuno-
fluorescence staining of brain sections showed that Bin112
staining is punctate and colocalizes with known synaptic vesicle
markers and a similar localization to punctate synapses was
seen in spinal cord. The subcellular distribution of Bin112
was cytoplasmic and never nuclear, in contrast to what has
been reported for some other splice variants of Bin1 (see
below) (256). Subcellular fractionation showed that Bin112
cofractionates with isolated nerve terminals. Immunoelectron
microscopy of rat brain sections shows that Bin112 is present
on the surface of synaptic vesicles and also in isolated patches
on the plasma membrane (367).
In contrast, another study found Bin112 distribution in the
brain differs from that of amphiphysin 1. While amphiphysin 1
is enriched at synapses in the cerebral cortex, hippocampus,
and cerebellum, this study found Bin112 enriched at other
sites in the brain. In gray matter, which contains perikarya
(neuronal cell bodies), dendrites, and axons, Bin112 local-
ized to axon initial segments. Axon initial segments are short
unmyelinated tubular segments innervated by basket cells
where the axon is attached to the perikaryon. Bin112 also
localized to the nodes of Ranvier. The nodes of Ranvier are
fine ring-like structures distributed at intervals along the length
of axons. In white matter, which contains mainly axons, the
densely clustered nodes of Ranvier were found to be the main
sites of Bin112 localization (23).
Both axon initial segments and nodes of Ranvier exhibit a
dense submembranous cytoskeletal matrix. This matrix con-
tains actin and a neuron-specific isoform of ankyrin 3 as major
components. In high-magnification images of both axon initial
segments and nodes of Ranvier, Bin112 localizes within the
submembranous cytomatrix (23). This subcellular localization
suggests a role for Bin112 in organization or function of the
cortical actin cytoskeleton and/or in defining these specialized
membrane domains within neurons. In this context it is inter-
esting that in fruit flies (Drosophila melanogaster) amphiphysin
also localizes to actin-rich membrane domains in a variety of
polarized cell types, including the actin-rich apical domain in
intestinal epithelial cells and the actin-rich sensory microvilli of
photoreceptor neurons (386).
Interestingly, axon initial segments and nodes of Ranvier
are active in endocytosis. Within neurons, axon initial seg-
ments and nodes of Ranvier have a higher concentration of
clathrin-coated pits and vesicles than any other site except
the presynaptic terminal. Moreover, they are also enriched
in a variety of integral membrane proteins that mediate ion
flux, including Na channels, Na/K-ATPase, and Na/
Ca2 exchangers (23). This suggests axon initial segments
and nodes of Ranvier are important sites within neurons for
the generation and propagation of action potentials. This
is interesting, as yeast rvs161 and rvs167 mutants exhibit
growth that is severely sensitive to Na. Regulation of ion
channel activity may turn out to be a conserved role of
amphiphysin family proteins.
While the reason for the different subcellular localizations
of Bin112 observed in different studies is not yet clear, it
appears to be related to the antibody used for detection.
Independent monoclonal antibodies raised to the SH3 do-
main of Bin112 preferentially label axon initial segments
and nodes of Ranvier. In contrast, polyclonal antibodies
raised against Bin112 preferentially label presynaptic ter-
mini. One possibility is that the SH3 domain epitopes rec-
ognized by the monoclonal antibodies are masked at syn-
apses due to conformational changes or posttranslational
modification.
Localization of Bin16a12 on purified plasma mem-
branes. Those isoforms of Bin1 in the brain that include the
NTID encoded by exon 6a specifically localize to the plasma
membrane upon transient expression in COS-7 cells. The dis-
tribution of Bin16a12 (this includes isoforms with or lack-
ing sequences encoded by exon 13) on plasma membrane is
punctate, and the puncta partially colocalize with clathrin-
coated pits. Bin16a12 is detected at 62% of plasma mem-
brane clathrin-coated pits. This degree of colocalization with
clathrin-coated pits is similar to that reported for dynamin
1, but less than that reported for other clathrin-coated pit
components, e.g., intersectin (257). There were puncta of
Bin16a12 on the plasma membrane that did not colocalize
with clathrin-coated pits, but the identity of these structures is
not known. Membranes other than plasma membrane were not
examined in this study, so Bin16a12 may also associate with
other intracellular membranes.
Association of Bin1 with membranes. Subcellular fraction-
ation of purified nerve terminals revealed that Bin16a12
(including isoforms with or lacking sequences encoded by exon
13) is present at approximately equal levels in a soluble pool
and in a membrane-associated sedimentable pool (256, 367).
When Bin16a12 is expressed ectopically in COS-7 fibro-
blasts it is also found in association with a sedimentable frac-
tion. Hence, association of Bin16a12 with membranes does
not require brain-specific integral membrane proteins. As
mentioned above, the membrane association of Bin16a12
is very strong and resists washes with 0.5 M Tris-HCl, 1 M KCl,
and 1 M NaCl that strip all clathrin heavy chain and most AP-2
from membranes (257, 367). Tight and salt-resistant associa-
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tion with membranes is also a property of one pool of am-
phiphysin 1 (175).
Recruitment of Bin16a12 to the plasma membrane.
Bin16a12 contains the central insert domain encoded by
exon 12 which, depending on the subtype of exon 12 (A to D),
may bind both clathrin heavy chain and/or AP-2 (Fig. 1). Could
this domain mediate plasma membrane clathrin-coated pit as-
sociation? The discovery that Bin16a12 also localizes to
regions of plasma membrane other than clathrin-coated pits
together with the finding that Bin16a12 remains associated
with isolated plasma membranes after clathrin heavy chain and
AP-2 are both removed by salt washes suggests that other
interactions may play an important role. Consistent with this
view, ectopic expression in COS-7 fibroblasts of four different
splice variants of Bin1 that differ in the presence or absence of
sequences encoded by exons 6a and 12 revealed that some
isoforms that lack the central insert domain encoded by exon
12 (and that therefore lack the ability to bind clathrin heavy
chain or AP-2) are still efficiently targeted to the plasma mem-
brane. Intriguingly, plasma membrane targeting of Bin1 in
neurons correlates with the presence of the NTID. Further-
more, deletion of the NTID from splice variants that include
this sequence completely abolishes plasma membrane localiza-
tion of all Bin1 isoforms examined, including those that also
contain clathrin heavy chain- and AP-2-binding domains (257).
The NTID also plays an important role in general associa-
tion of Bin1 with membranes. When expressed in COS-7 fi-
broblasts the BAR domain alone of each plasma membrane
isoform of Bin1 associates with membranes such as the full-
length protein during subcellular fractionation. Hence, the
SH3 domain is not essential for association of Bin1 with mem-
branes. In contrast, deletion of the BAR domain from plasma
membrane isoforms of Bin1 completely abolishes association
with membranes (257). These data indicate that the BAR
domain of plasma membrane isoforms of Bin1 is both neces-
sary and sufficient for association with membranes. This find-
ing is consistent with the observation that the isolated BAR
domain of yeast Rvs167p retains some ability to localize to
cortical actin patches and to functionally substitute for full-
length Rvs167p (11, 299).
Deletion of the NTID from either full-length Bin16a12 or
its isolated BAR domain significantly reduces, but does not abol-
ish, association with the sedimentable fraction (257). Hence, the
NTID contributes to membrane association but other sequences
in the BAR domain are sufficient to preserve membrane associ-
ation of full-length Bin16a12 or its isolated BAR domain in
the absence of the NTID. Although yeast Rvs161p and Rvs167p
also associate with membranes they lack a BAR domain sequence
that resembles the Bin16a1213 NTID.
Interaction of Bin112 with Other Brain Proteins
Bin112 (with or lacking exons 6a and 13) interacts with
dynamin 1 and synaptojanin 1 in the brain. The first indication
that the brain isoforms of Bin1 may function in endocytosis was
their ability to bind the same set of endocytic proteins as
amphiphysin 1. Bin16a1213 binds several dynamin iso-
forms, including brain dynamin 1 and also brain synaptojanin 1
(23, 168, 187, 256). The interaction of Bin16a1213 with
dynamin 1 is direct and the Kd is 240 nM (168, 187). The Bin1
SH3 domain and the proline-rich motif GPPPQVPSRPNR in
the dynamin 1 PRD appear to mediate the interaction (23,
168). Although both amphiphysin 1 and Bin16a1213 bind
dynamin 1 and synaptojanin 1, peptide competition experi-
ments suggest the two SH3 domains may differ in their affinity
for these proteins (e.g., the Bin16a1213 SH3 domain
binds synaptojanin 1 with much lower affinity than the am-
phiphysin 1 SH3 domain) (23, 302, 367). Interestingly, one
study found that interaction of endogenous Bin16a1213
with dynamin 1 in PC12 cells is regulated by nerve growth
factor (168).
Bin112 (with or lacking exons 6a and 13) interacts with
the -adaptin subunit of AP-2 in the brain. Recombinant
Bin16a1213 binds the -adaptin subunit of AP-2 in
extracts of NIH-3T3 fibroblasts or rat brain (168, 187). The
BAR domain and central insert domain (residues 1–422) of
Bin16a1213 and the appendage domain of -adaptin me-
diated this interaction (187). In contrast, another study found
that -adaptin does not bind to the central insert domain of
Bin16a1213 but rather to the SH3 domain (256). The
difference in -adaptin binding is not due to different exon 12
splice variants because a sequence motif (LFED) similar to the
FFED -adaptin binding motif of amphiphysin 1 is present in
the Bin16a1213 constructs used in all three studies.
Bin112 (with or lacking exons 6a and 13) interacts with
clathrin heavy chain in the brain. Clathrin heavy chain also
binds some splice variants of Bin112 depending on which of
the four exons 12 (A to D) are present in the spliced transcript.
Binding to clathrin heavy chain is direct and mediated by the
Bin112 central insert domain (187, 256). In one study it was
observed that full-length Bin112 is less efficient at binding
clathrin heavy chain than a fragment comprising the BAR and
central insert domains only and that the addition of dynamin 1
inhibits binding of full-length Bin112 to clathrin heavy chain
(187). While the mechanism by which dynamin 1 binding to the
Bin112 SH3 domain inhibits clathrin heavy chain binding to
the central insert domain is not understood, one possibility is
that coassembly of Bin112 and dynamin 1 into rings in solu-
tion reduces the ability of Bin112 to bind clathrin heavy
chain.
Only those central insert domains that contain a 44-residue
domain (residues 378 to 422 in human Bin112) exhibit high-
affinity clathrin heavy-chain binding in vitro. This domain is
located at the C terminus of the central insert domain. Within
this domain there are two motifs highly conserved in the se-
quence of amphiphysin 1 (that also binds clathrin heavy chain),
LLDLDFDP and PWDLW (255). Fragments of Bin112 lack-
ing either LLDLDFDP or PWDLW bind clathrin heavy chain
with approximately equal affinity, but deletion of both motifs
abrogates clathrin heavy-chain binding. Clathrin triskelia bind
to a human Bin112 fragment containing residues 378 to 422
with an affinity of 3 nM, but deletion of either LLDLDFDP or
PWDLW reduces the affinity to 9 nM (255).
Interaction of Bin112 with endophilin A1/SH3p4/SH3GL2
in the brain. In addition to clathrin heavy chain and -adaptin/
AP-2, the central insert domain of Bin112 also binds the
other BAR domain protein endophilin A1 (also called SH3p4
and SH3GL2) (Fig. 1). This interaction is direct and mediated
by the SH3 domain of endophilin A1 and residues 335-378 of
the central insert domain of Bin112. Residues 335 to 378 of
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the central insert domain contain one proline-rich motif that
fits the consensus for SH3 domain binding and may bind the
endophilin A1 SH3 domain (193, 255).
Bin16a12 forms homodimers and heterodimers in the
brain. Bin112 isoforms that contain exon 6a (Bin16a12)
bind amphiphysin 1 and fractionate on density gradients with
amphiphysin 1 during subcellular fractionation. Chemical
cross-linking experiments confirmed the existence of 1:1 het-
erodimers of amphiphysin 1 and Bin16a12 in the brain.
Heterodimer formation is mediated by residues 1 to 150 of the
amphiphysin 1 BAR domain and residues 1 to 328 of the
Bin16a12 BAR domain and the latter also mediate
Bin16a12 homodimer formation. The formation of ho-
modimers or heterodimers by the Bin16a12 BAR domain
was considerably reduced, but not abolished, by deletion of the
NTID. Hence, the NTID contributes to dimer formation but
other sequences in the BAR domain are sufficient to maintain
dimer formation when the NTID is absent (257, 302, 367).
Interaction of amphiphysin 1/Bin16a12 heterodimers
with dynamin 1 in the brain. Amphiphysin 1/Bin16a12
heterodimers associate with dynamin 1 in a 1:2 stoichiometry
in the brain, suggesting that each SH3 domain in the het-
erodimer binds one dynamin 1 molecule (367). The assembly
of dynamin 1 monomers into oligomers in vitro stimulates
dynamin 1 GTPase activity (353). Amphiphysin 1/Bin16a12
heterodimers stimulate dynamin 1 GTPase activity in vitro,
suggesting that their ability to bind two dynamin 1 molecules
via their SH3 domains may promote dynamin 1 assembly into
rings in solution (367). Stimulation of dynamin 1 GTPase ac-
tivity by amphiphysin 1/Bin16a12 heterodimers is likely to
be important in vivo during dynamin 1-mediated severing of
the necks of deeply invaginated clathrin-coated pits.
The three-dimensional crystal structure of the Bin16a12
SH3 domain has been solved to 2.2 Å resolution (232). Unlike
most other SH3 domains, the Bin16a12 SH3 domain has a
highly acidic patch positioned close to the binding cleft. The
existence of this acidic patch explains the curious requirement
for two basic (arginine) residues in the proline-rich motif
within the dynamin PRD recognized by this SH3 domain (168).
The Bin16a12 SH3 domain also has a long insert se-
quence not found in other SH3 domains that is predicted to
form an extended loop near the dynamin-binding site. The
Bin16a12 SH3 domain not only binds dynamin, but also
interferes with dynamin assembly into rings in vitro. Deletion
of the insert loop abolishes the ability of the Bin16a12 SH3
domain to inhibit dynamin assembly in vitro and receptor-
mediated endocytosis of transferrin in vivo. Moreover, transfer
of this insert loop to an unrelated dynamin-binding SH3 do-
main (Grb2) confers the ability to inhibit dynamin assembly in
vitro (232).
Bin16a12 is regulated by phosphorylation and dephos-
phorylation. One study did not observe significant phosphor-
ylation of Bin16a12 in resting synapses, in contrast to am-
phiphysin 1 (193). Subsequent studies, however, showed that
when brain extract is incubated with ATP and protein phos-
phatase inhibitors, Bin16a12, like dynamin 1, synaptojanin
1, clathrin heavy chain, and AP-2, undergoes a shift to lower
electrophoretic mobility suggestive of phosphorylation. As in
the case of the other endocytic proteins, Bin16a12 is rap-
idly dephosphorylated upon nerve terminal depolarization.
Dephosphorylation occurs concomitant with synaptic vesicle
exocytosis, suggesting that Bin16a12 may have to be de-
phosphorylated to become active and that Bin16a12 may
play a role in synaptic vesicle recycling via endocytosis like
amphiphysin 1 and dynamin 1.
The interaction between amphiphysin 1 and Bin16a12 is
not inhibited by phosphorylation of either protein, however, as
observed for amphiphysin 1, association of Bin16a12 with
dynamin 1, synaptojanin 1, clathrin heavy chain, and AP-2 is
inhibited by phosphorylation (of either Bin16a12 or its
partner) (302). Hyperphosphorylation of Bin16a12 occurs
in response to treatment of neurons with the protein kinase C
activator phorbol 12-myristate 13-acetate. This hyperphosphor-
ylation is inhibited by pretreatment with the protein kinase C
inhibitor Ro 31-8220, suggesting that protein kinase C is re-
sponsible for Bin16a12 phosphorylation in synapses (367).
Bin16a12 functions in synaptic vesicle recycling/endocy-
tosis. Does Bin16a12 function in endocytosis? A hint that
it may came from studies that tested the effect of transient
overexpression of amphiphysin 1, Bin16a12, or both pro-
teins on receptor-mediated endocytosis of transferrin in COS-7
cells. Overexpression of either amphiphysin 1 or Bin16a12
had a similar deleterious effect on transferrin endocytosis, but
in contrast coexpression of amphiphysin 1 and Bin16a12
did not. Since amphiphysin 1 and Bin16a12 both bind dy-
namin 1 via their SH3 domains, this result suggests that over-
expression of the individual proteins may lead to sequestration
of dynamin 1 into amphiphysin 1-dynamin 1 or Bin16a12-
dynamin 1 complexes that are inactive for endocytosis. Perhaps
only amphiphysin 1/Bin16a12 heterodimers are able to
functionally interact with dynamin 1 and stimulate endocytosis.
A subsequent study showed an association of other clathrin
coat components, including dynamin 1, synaptojanin 1, Eps15,
and AP-180, with the dynamin 1 PRD in vitro that is depen-
dent on binding of amphiphysin 1/Bin16a12 heterodimers
to the dynamin 1 PRD (302).
Further evidence for a role of Bin16a12 in clathrin-
dependent endocytosis came from studies similar to those of
Shupliakov et al. (293), Wigge et al. (369), and Volchuk et al.
(349) that first showed amphiphysin 1 has a role in endocytosis.
Transient overexpression of the Bin16a12 SH3 domain in-
hibited receptor-mediated endocytosis of transferrin in intact
cells. Moreover, the Bin16a12 SH3 domain caused potent
inhibition of in vitro assays for clathrin-dependent endocytosis
(half-maximal inhibition at 6 M). The Bin16a12 SH3 do-
main inhibited a target present in the membrane fraction and
most potently inhibited the late step of membrane fission and
clathrin-coated vesicle release. The inhibition by the Bin1
6a12 SH3 domain is specific, because control SH3 domains
did not inhibit endocytosis in this in vitro assay even at much
higher concentrations (295).
The role of Bin112 in endocytosis and synaptic vesicle
recycling has also been examined using knockout mice.
Bin112 expression in the brain is critically dependent on
amphiphysin 1 expression. Brain extracts of amphiphysin 1-de-
ficient mice contained normal levels of Bin112 (with or lack-
ing exons 6a and 13) transcript, but were almost devoid of
Bin112 protein. This suggests that in the brain only am-
phiphysin 1/Bin112 heterodimers are stable. It is likely that
Bin112 is subject to proteolysis when amphiphysin 1 is ab-
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sent. The loss of Bin112 expression in the brain of amphiphy-
sin 1 knockout mice is specific. No reduction in expression
level in the brain was observed for other synaptic proteins that
interact with amphiphysin 1. Moreover, the loss of Bin1 ex-
pression is brain specific because Bin110 was expressed nor-
mally in the muscle of amphiphysin 1 knockout mice (am-
phiphysin 1 is not expressed in muscle). Despite the loss of
both amphiphysin 1 and Bin112, amphiphysin 1 knockout
mice exhibit relatively mild defects in synaptic vesicle recycling
that become apparent only under conditions of continuous
nerve stimulation (55).
Mice homozygous for a deletion of the BIN1 gene that
encodes Bin1 exhibit postnatal inviability. Although Bin1
6a12 is highly expressed in the brain, the brains of homozy-
gous Bin1 knockout mice appear to possess normal structures.
Interestingly, amphiphysin 1 expression in the brain is not
dependent on Bin1. Hence, while in yeast each Rvs protein is
unstable in the absence of the other, in mouse brain only
Bin16a1213 is unstable in the absence of its partner. As
expected from analysis of homozygous amphiphysin 1 knock-
out mice that also lack Bin1 in the brain, homozygous Bin1
knockout mice also show no severe endocytic defects in the
brain. Cultured Bin1-deficient neurons exhibit normal neurite
outgrowth and form synapses in vitro. There is no obvious
accumulation of clathrin-coated pits or vesicles at these syn-
apses. Bin1-deficient embryonic fibroblasts express no detect-
able Bin1 isoforms but grow and divide as rapidly in culture as
wild-type embryonic fibroblasts, endocytose fluorescein iso-
thiocyanate-conjugated transferrin with kinetics even more
rapid than that of wild-type embryonic fibroblasts, and exhibit
a normal actin cytoskeleton that includes normal actin stress
fibers (207).
The reason for the apparent discrepancy between the results
obtained by transient overexpression or microinjection exper-
iments in cultured cells and the results obtained by gene
knockout in mice is not yet clear. It is possible that loss of
endocytic function is only observed transiently upon acute per-
turbation of Bin16a12 function. In knockout cells that have
been without Bin1 expression for some time, long-term adap-
tation processes that compensate for loss of Bin1may have
been activated. Alternatively, in the transient overexpression
or microinjection experiments there may have been effects that
were not limited to perturbation of Bin112 alone. These
nonspecific effects, rather than loss of Bin112 interactions,
may have been the cause of the observed endocytic defect.
Bin112 may function in postinternalization transport
through endosomes. While attention has mainly focused on the
possible role of Bin112 isoforms in endocytosis at clathrin-
coated pits on the plasma membrane, one study found that
Bin16a1213 binds sorting nexin 4 (SNX4), a protein that
localizes predominantly to intracellular compartments. Inter-
action is mediated by the C-terminal part of the Bin1
6a1213 BAR domain (BAR-C) and a short sequence at the
extreme C terminusof SNX4 (167). Interestingly, the amino
acid sequence of SNX4 suggests that SNX4 may possess a
C-terminal BAR domain such as SNX1 (25). If so, the
Bin16a1213-interacting sequence would lie within the
SNX4 BAR domain. A pool of Bin16a1213 localizes
to SNX4-containing compartments that contain internalized
transferrin and are therefore a type of early endosome. Hence,
Bin112 isoforms may not only function in the internalization
step, but may also direct postinternalization traffic through
endosomes (167).
Bin11013/Bin1
Identification of Bin11013/Bin1. c-Myc is an important
regulator of cell proliferation versus terminal differentiation
decisions and is mutated in many human cancers. Nondividing
cells do not express c-Myc, but after mitogenic stimulation
c-Myc is one of the first proteins to be induced before cells
enter the cell cycle. The role of c-Myc in cell proliferation is
highlighted by recent studies using Drosophila c-Myc. Overex-
pression of Drosophila c-Myc in select cells in a tissue induces
these cells to proliferate at the expense of surrounding low-
expressor cells in the same tissue, i.e., to become “supercom-
petitors.” Indeed, in these competition experiments the low-
expressor cells are not only overgrown by the high-expressors
but undergo apoptosis (199). However, high c-Myc expression
is not always advantageous. When mammalian cells in culture
are serum starved c-Myc expression is down-regulated and
cells stop dividing and become quiescent. Ectopic c-Myc ex-
pression in serum-starved cells prevents the cells from becom-
ing quiescent. c-Myc-overexpressing cells that continue to divide
under serum-starved conditions eventually undergo c-Myc-de-
pendent apoptosis (278).
c-Myc has been shown to shuttle between the cytoplasm and
the nucleus and can act as a transcriptional activator or repres-
sor. The N-terminal domain of c-Myc is a transcription activa-
tion/repression domain and the C-terminal domain is a DNA
binding domain. The activity of c-Myc both in oncogenic trans-
formation and in apoptosis requires two conserved N-terminal
domains known as Myc boxes 1 (MB1) and 2 (MB2). MB1 is
positioned within the transcriptional activation domain of c-
Myc and is subject to cell cycle-dependent phosphorylation on
residues T58 and S62. MB1 is critically important for control of
cell proliferation since most c-Myc mutations in primary hu-
man tumors and cultured tumor cell lines map to the MB1
domain. The observation that MB1 is mutated in tumors sug-
gests a negative regulator of c-Myc may interact via the MB1
domain and mutation of MB1 may result in loss of this inter-
action and deregulation of c-Myc activity (278).
A Bin1 splice variant (referred to here as Bin11013) was
isolated in a two-hybrid screen with the c-Myc MB1 domain as
the bait and named Box-dependent Myc-interacting protein
(or subsequently bridging integrator) 1 (Bin1) (Fig. 1 and
Table 2) (276, 278). As predicted for a negative regulator of
c-Myc, expression of Bin11013 inhibited the ability of c-
Myc to induce oncogenic transformation in culture (69, 278).
Domain structure of Bin11013. In comparison to Bin1
6a12 (which can either have or lack exon 13), Bin11013
lacks the NTID domain encoded by exon 6a that mediates the
formation of heterodimers with amphiphysin 1 and plasma
membrane targeting (Fig. 1 and Table 2). It also lacks the
central insert domain encoded by exon 12 that in some iso-
forms of Bin112 (with or lacking exons 6a and 13), depending
on the choice of exon 12, binds clathrin heavy chain, -adaptin,
and/or endophilin A1 (Fig. 1 and Table 2). Bin11013 con-
tains, however, an additional 15-residue sequence encoded by
exon 10 that includes a nuclear localization sequence and lipid
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binding sequence that is absent in all variants of Bin112 (with
or lacking exons 6a and 13). Bin11013 and some splice
variants of Bin112 (with or lacking exon 6a) contain a com-
plete c-Myc binding sequence, a third of which is encoded by
exon 13 (Fig. 1 and Table 2). In this way Bin11013 and
Bin16a1213 differ from ALP1/amphiphysin IIm, which
lack the sequences encoded by exon 13 (see below) (Fig. 1 and
Table 2) (23, 168, 256, 257, 278, 338, 356, 357, 367). Hence,
according to the nomenclature of Wechsler-Reya et al., this
original Bin1 isoform is named Bin11013 (356).
Interaction of Bin11013 with c-Myc. The interaction of
Bin11013 with c-Myc was originally identified by two-hy-
brid screens but has been confirmed by protein binding in vitro
and is direct (278). c-Myc interacts with a central domain of
Bin11013 located between the N-terminal BAR domain
and the C-terminal SH3 domain and this domain has been
named the Myc-binding domain (MBD, residues 270 to 377).
A recent study, however, found that the SH3 domain of
Bin11013 mediates binding to c-Myc (245). Bin11013
binding to c-Myc in vitro requires both MB1 and MB2 on
c-Myc, although in the two-hybrid assay MB1 is sufficient
(278).
An initial study did not observe coimmunoprecipitation of
c-Myc and Bin11013 from cell extracts, suggesting these
proteins may not exist in a stable complex in vivo (278). Prior
to differentiation into myotubes, proliferating C2C12 cells ex-
press both c-Myc and Bin11013, however, after differenti-
ation c-Myc expression is lost and Bin11013 expression is
dramatically elevated (357). A subsequent study using prolif-
erating C2C12 cells found endogenous Bin11013 and c-
Myc do coimmunoprecipitate from cell extracts and hence do
form stable complexes in vivo, at least in this cell type.
Bin11013 also coimmunoprecipitates with c-Myc from ex-
tracts prepared from insect Sf9 cells ectopically expressing
both proteins (69).
Bin11013 is a tumor suppressor. Bin11013 is a neg-
ative regulator of cell cycle progression and plays a role in exit
from the cell cycle in response to serum deprivation. The
ability of Bin11013 to suppress oncogenic transformation
by c-Myc demonstrates that Bin11013 has properties char-
acteristic of a tumor suppressor. Moreover, Bin11013 may
be part of an important mechanism preventing oncogenic
transformation and tumorigenesis in vivo, since the domain of
c-Myc that mediates Bin11013 binding (MB1) is frequently
mutated in tumor cells. Moreover, the human and murine
BIN1 genes map to chromosomal loci that are hotspots for
deletion in tumors and Bin11013 expression is absent in a
high percentage of tumor cell lines and primary breast and
other tumors. Furthermore, ectopic expression of Bin1
1013 in tumor cells that have lost endogenous Bin11013
expression causes arrest of cell proliferation. This strongly
supports the idea that loss of Bin11013 expression contrib-
utes significantly to tumorigenesis and is not simply a conse-
quence of genetic instability in tumor cells (278).
This role of Bin11013 as a negative regulator of cell cycle
progression is reminiscent of the role of the yeast Rvs proteins
(12, 42). While Bin11013 plays a role in exit of serum-
starved mammalian cells from the cell cycle (278), the Rvs
proteins play a role in exit of nutrient-starved yeast cells from
the cell cycle (12). Exit from the cell cycle and arrest in G0 are
in turn important for prevention of c-Myc-induced apoptosis in
mammalian cells and for survival under starvation conditions
in yeast cells. Bin11013 and Rvs167p are not functionally
interchangeable, however, as Bin11013 expression in
rvs167 yeast mutants does not rescue the phenotype (278).
Rvs167p also lacks the MBD found in Bin11013 (Rvs167p
has the GPA-rich region in place of the MBD) (Fig. 1). In
addition, yeast does not have an ortholog of mammalian
c-Myc.
Is interaction of Bin11013 with c-Myc important for sup-
pression of oncogenic transformation? Deletion of the MBD
abolishes the ability of Bin11013 to suppress oncogenic
transformation by c-Myc. Moreover, expression of a frag-
ment of Bin11013 comprising only the MBD interferes in
a dominant negative manner with the ability of full-length
Bin11013 to suppress oncogenic transformation by c-Myc.
This suggests binding of Bin11013 to c-Myc is physiologi-
cally important. Interestingly, mutations in MB1 that do not
appear to affect Bin11013 interaction but that prevent
MB1 phosphorylation (e.g., T58M) also abolish suppression
activity. This shows that Bin11013 binding to MB1 is nec-
essary but not sufficient for c-Myc suppression (69, 278).
Another Bin11013 domain essential for suppression of
oncogenic transformation by c-Myc is the C-terminal half of
the BAR domain (BAR-C) (Fig. 1). Deletion of the BAR-C
domain causes partial redistribution of Bin11013 from the
nucleus to the cytoplasm. Moreover, the BAR-C domain con-
tains a nuclear localization sequence. The effect of the BAR-C
deletion shows that this nuclear localization sequence, rather
than that encoded by exon 10, is the critical sequence for
Bin11013 localization to the nucleus. Deletion of Bin1
1013 domains other than the MBD and BAR-C domains had
little or no effect on suppression of c-Myc transformation. The
ability of Bin11013 to inhibit proliferation of tumor cells
that lack endogenous Bin11013 (e.g., HepG2) is critically
dependent on the presence of BAR-C. In contrast, despite the
importance of the MBD in suppression of oncogenic transfor-
mation by c-Myc, Bin11013 lacking the MBD retains signif-
icant ability to inhibit tumor cell proliferation, suggesting this
activity may be partially independent of c-Myc binding (69).
Further insight into the role of Bin11013 in suppression
of oncogenic transformation by c-Myc came from a study of a
Bin1 splice variant that lacks exon 10 but contains neuron-
specific exon 12 (Bin11213) and whose expression in non-
neuronal cells correlates with oncogenesis (93, 245, 356). A
highly sensitive protein interaction assay revealed that many
Bin1 isoforms, including those that lack the MBD encoded in
part by exon 13, do in fact interact with c-Myc. In this study the
isolated MBD was not sufficient to bind c-Myc in vitro. The
novel c-Myc interaction involves the C-terminal SH3 domain
of various Bin1 isoforms interacting with a proline-rich motif
positioned within the MB1 domain of c-Myc. This interaction
is regulated by phosphorylation of S62 within MB1.
Intriguingly, Bin11213 differs from all other Bin1 iso-
forms tested in that its SH3 domain is unable to bind c-Myc.
The explanation comes from the finding that exon 12 contains
a proline-rich motif. When exon 12 is present the SH3 domain
engages in an intramolecular interaction with exon 12 that
prevents its engagement with c-Myc (245).
The effect of Bin11013 may be on the transcriptional
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activity of c-Myc. c-Myc stimulates transcription of various
genes, including those encoding ornithine decarboxylase and
-prothymosin and also stimulates transcription of minimal
viral promoters that have been engineered to include upstream
c-Myc binding elements. The ability of c-Myc to activate tran-
scription from each promoter was inhibited by a construct
expressing Bin11013. Deletion of the Bin11013 MBD
abolished its ability to inhibit c-Myc-dependent activation of
some promoters (e.g., ornithine decarboxylase) but not other
promoters (e.g., -prothymosin). Hence, Bin11013 inhibits
c-Myc-dependent transcriptional activation but does so by dis-
tinct mechanisms, only one of which requires binding of c-Myc
via the MBD.
The effect of Bin11013 on transcriptional activation is
specific to c-Myc. Bin11013 does not inhibit transcriptional
activation by other proteins, e.g., herpesvirus VP16. The N-
terminal domain of c-Myc that contains MB1 and MB2 confers
inhibition of transcriptional activation by Bin11013, as fu-
sion of this domain to the yeast Gal4p transcriptional activator
results in the ability of Bin11013 to inhibit transcriptional
activation of Gal4p-specific promoters (69).
How does Bin11013 inhibit transcriptional activation by
c-Myc? Initially, it was proposed that Bin11013 binding to
MB1 and MB2 acts sterically to inhibit the ability of MB1 and
MB2 to activate transcription at c-Myc-dependent promoters
(278). Subsequently, it was suggested that Bin11013 re-
cruits a transcriptional repressor to c-Myc. Fusion of Bin1
1013 to Gal4p is sufficient to repress transcription at a Gal4p-
dependent promoter and this repression can be relieved by
coexpression of unfused Bin11013, perhaps via titration of
a transcriptional repressor. Interestingly, the Bin11013
MBD is not required either for repression of Gal4p-dependent
transcription or for relief of this repression. Hence, the puta-
tive repressor must bind a domain of Bin11013 distinct
from the MBD. The nature of the repressor recruited by
Bin11013 is not known (69).
Bin11013 activity in tumor suppression is not restricted
to effects on c-Myc. Bin11013 also suppresses oncogenic
transformation by the unrelated adenovirus E1A oncoprotein
and by a dominant negative mutated form of the tumor sup-
pressor p53. The mechanism by which Bin11013 suppresses
transformation by these oncoproteins appears distinct, how-
ever, as neither the MBD nor the BAR-C domain is essential.
Moreover, the Bin11013 MBD does not bind E1A in vitro.
A short sequence (U1) encoded by exon 9 is essential for
suppression of both adenovirus E1A and mutant p53, while the
SH3 domain is also essential for suppression of mutant p53.
Adenovirus E1A and p53 both function in the nucleus, and
hence the partial loss of nuclear localization of Bin11013
caused by deletion of the BAR-C domain may not fully ac-
count for loss of c-Myc suppression. Bin11013 does not
inhibit oncogenic transformation by all oncoproteins, however.
For example, Bin11013 has no effect on oncogenic trans-
formation by the simian virus 40 large T antigen (69, 278).
Hence, the mechanisms by which Bin11013 inhibits onco-
genic transformation and tumorigenesis are specific.
The frequency with which human tumors either lack Bin1
expression or misexpress Bin11213 together with the ability
of ectopic Bin11013 expression in tumor cells lacking en-
dogenous Bin11013 to inhibit proliferation suggests that
Bin1 plays a critical role in tumor suppression in vivo (69, 245,
278). Further support for an important role for Bin11013
in tumor suppression in vivo comes from analysis of the neo-
plastic potential of murine embryonic fibroblasts (MEFs) from
homozygous Bin1 knockout mice. Bin1 knockout MEFs, but
not wild-type MEFs, cotransfected with c-Myc and a mutant
form of Ras exhibited morphological features of oncogenically
transformed cells. Coexpression of c-Myc and mutant Ras in
Bin1 knockout MEFs, but not wild-type MEFs, also led to an
increased ability to form tumors in mice. This effect was spe-
cific to c-Myc, as Bin1 knockout MEFs transfected with viral
oncogenes did not exhibit increased tumor formation (209).
Bin11013 also prevents tumor cells from being recog-
nized and killed by anti-tumor T cells. Bin11013 has re-
cently been shown to be a key regulator of the immunoregula-
tory enzyme indoleamine 2,3-dioxygenase (IDO). Overexpression
of IDO in Bin1 knockout cells may be a major factor in im-
mune escape and accelerated progression of tumor cells, as
treatment of tumor-bearing mice with IDO inhibitors helps
induce tumor regression (208).
Bin11013 induces apoptosis specifically in tumor cells.
One mechanism by which Bin11013 may suppress tumors
is by inducing apoptosis (programmed cell death). Ectopic
expression of Bin11013 in the cultured tumor cell line
HepG2 (which has lost endogenous Bin11013 expression)
induces cell death via activation of an apoptotic pathway. This
apoptotic pathway involves reduction of cell volume, loss of
adherence, accumulation of cytoplasmic vacuoles, and DNA
degradation. This apoptotic role of Bin11013 in tumor cells
requires the BAR-C domain. Apoptosis and DNA degradation
are induced independently of cell cycle stage. This apoptotic
mechanism does not require the tumor suppressor p53 or ret-
inoblastoma protein, caspases, Bcl-2, or Fas-dependent apo-
ptotic signaling. Inhibition of the apoptotic pathway induced by
c-Myc upon serum withdrawal also inhibits DNA degradation
induced by Bin11013, suggesting some apoptotic effects of
Bin11013 are mediated via mechanisms common to c-Myc-
dependent apoptosis (68).
The role of Bin11013 in c-Myc-dependent apoptosis has
been tested in vivo using homozygous Bin1 knockout mice.
Ectopic expression of c-Myc in primary homozygous Bin1
knockout MEFs still induced apoptosis upon serum withdrawal
(207). This is perhaps not unexpected, since Bin11013 has
only been shown to be important for induction of apoptosis in
oncogenically transformed cells (e.g., HepG2) (68). Ectopic
expression of c-Myc in homozygous Bin1 knockout MEFs is
insufficient to induce oncogenic transformation (207).
Subcellular localization of Bin11013. The subcellular
localization of Bin11013 has been an area in which differ-
ent findings have been reported. Bin11013 was initially
reported to exhibit a nuclear localization when ectopically ex-
pressed in HepG2 hepatocarcinoma cells (278). This localiza-
tion is consistent with the ability of Bin11013 to interact
both physically and functionally with the nuclear transcrip-
tional activator c-Myc and the presence of a nuclear localiza-
tion sequence encoded by exon 10 (69, 278). Examination of
endogenous Bin11013 in a collection of human and rodent
Bin11013-expressing tumor cell lines showed again that
Bin11013 localizes to the nucleus and in part to a sub-
nuclear compartment. In some tumor cells Bin11013 local-
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izes entirely to the subnuclear compartment (355). In another
study the expression level and subcellular localization of
Bin11013 in various normal human tissues were compared
and differences were observed between tissues (e.g., bone mar-
row, breast, and intestine). Within intestinal epithelia, an ex-
pression gradient of Bin11013 was observed, with strongest
expression in those cells located at the tips of intestinal pro-
jections (villi) that are committed to undergo apoptosis (61).
Subsequently, two studies found Bin11013 is predomi-
nantly nonnuclear in muscle cells, where this isoform is endo-
genously expressed at high levels (23, 162). When transiently
expressed in COS-7 cells, both brain Bin16a1213 and
muscle Bin11013 were found to localize exclusively to the
cytoplasm. Even when ectopically expressed in HepG2 cells the
localization of Bin11013 was predominantly cytoplasmic.
The reason for the different subcellular localizations reported
for Bin11013 is not known. It has been suggested that
Bin11013 may shuttle between the cytoplasm and the nu-
cleus (23). This process may be regulated in response to some
yet-to-be-identified environmental signal.
During differentiation of C2C12 myoblasts into myotubes in
vitro there is a switch of splice variant from Bin110 to
Bin110 (each with or lacking exon 13) (357). Both the former
(including SH3p9 and ALP1/amphiphysin IIm) and the latter
have been reported to be present strictly in the cytoplasm,
strictly in the nucleus, or distributed between the cytoplasm
and nucleus in different studies (23, 69, 141, 162, 278, 355).
Hence, while exon 10 encodes a predicted nuclear localization
sequence, this exon is not required for nuclear localization of
Bin1. As mentioned above, a second nuclear localization se-
quence that is critical for nuclear localization is present in the
BAR-C domain (69). It is worth noting that the antibodies
used for immunofluorescence localization of Bin110 may not
have distinguished between those splice variants that include
exon 10 sequences and those that lack exon 10 sequences. The
domain encoded by exon 10 is required for the plasma mem-
brane binding and tubulating activity of Bin11013 (see be-
low) (162). Perhaps this property is responsible for a shift from
a nuclear to a cytoplasmic distribution when this exon is incor-
porated.
Stability of Bin11013 in vivo. The in vivo stability of
Bin11013 has been examined by pulse-chase radiolabeling
and Bin11013 is rather unstable in cells, with a half-life of
only about 2 h (355). This is interesting in view of recent
evidence that Rvs167p in yeast interacts with a ubiquitin pro-
tein ligase (Rsp5p, the yeast ortholog of Nedd4) and is subject
to ubiquitination (307), and that Rvs167p is rapidly degraded
in the absence of Rvs161p (180).
Phosphorylation of Bin11013. Like amphiphysin 1 and
other splice variants of Bin1, Bin11013 is phosphorylated
in vivo (355). The role of this phosphorylation, the sites phos-
phorylated, and the kinase(s) responsible are not yet known.
Interestingly, Bin11013 lacks a region of homology to the
proline-rich sequences in the central insert domain of am-
phiphysin 1 and GPA-rich domain of Rvs167p that are subject
to phosphorylation by Cdk5/Pho85p (78, 85, 330). Therefore,
phosphorylation of Bin11013 may have some unique fea-
tures compared to that of amphiphysin 1 or yeast Rvs167p.
Role for Bin11013 in muscle differentiation. Several
findings suggested that Bin11013 may play a role in muscle
differentiation: Bin11013 is a negative regulator of cell
cycle progression, it is encoded by a transcript that undergoes
differential splicing during differentiation of proliferating
C2C12 myoblasts into terminally differentiated myotubes, and
it is highly expressed in adult skeletal muscle. Moreover,
Bin11013 was identified in a large-scale screen of muscle-
specific proteins as a protein required for muscle cell differ-
entiation. The murine skeletal muscle-derived cell line C2C12
can be induced to differentiate into muscle in culture. Conflu-
ent C2C12 myoblasts subjected to serum withdrawal in culture
undergo dramatic elongation and then lateral cell-cell fusion to
form huge multinucleate myotubes similar to those found in
muscle. When Bin11013 is down-regulated differentiation
of C2C12 myoblasts into myotubes upon serum withdrawal is
blocked (172).
To investigate the role of Bin11013 in muscle cell dif-
ferentiation its expression during C2C12 differentiation in cul-
ture was examined. Bin11013 transcript and protein levels
were observed to increase upon serum withdrawal concomitant
with terminal differentiation and cell-cell fusion into myotubes.
c-Myc is a marker of proliferating cells. As expected, c-Myc
expression levels declined after serum withdrawal as cells ex-
ited the cell cycle and became committed to terminal differ-
entiation. Interestingly, higher-molecular-weight Bin1 protein
species appear during differentiation. These forms arise by
altered transcript splicing such that exon 10 is included. Bin1 in
undifferentiated C2C12 cells lacks sequences encoded by exon
10 and localizes predominantly to the nucleus. In contrast, the
form of Bin1 found in terminally differentiated C2C12 myo-
tubes contains sequences encoded by exon 10 and forms a
filamentous network in the cytoplasm (357).
Expression of Bin11013 has also been examined during
embryonic development in mice (182). By embryonic day 10.5
expression of Bin11013 has already been induced in myo-
tomes, which are the precursors of skeletal muscle cells.
Bin11013 appears to regulate cell cycle progression via
induction of the Cdk inhibitor p21WAF1. Down-regulation of
Bin11013 in C2C12 cells prevents induction of p21WAF1
and hence interferes with cell cycle arrest upon serum with-
drawal. Hence, Bin11013 functions at a very early stage in
differentiation of C2C12 myoblasts into myotubes (182).
Overexpression of human Bin11013 slows the prolif-
eration of C2C12 cells in culture and promotes differentia-
tion into myotubes. A decrease in the rate of cell prolifer-
ation is observed even in the presence of serum, however,
differentiation still requires serum withdrawal. Lowering
Bin11013 expression increases the rate of cell prolifer-
ation in the presence of serum and also abolishes differen-
tiation upon serum withdrawal. C2C12 cells in which expres-
sion of Bin11013 is down-regulated do not elongate, nor
do they undergo cell-cell fusion to form multinucleate myo-
tubes. Induction of muscle myosin II is normally observed
in C2C12 cells prior to cell-cell fusion, however, after
Bin11013 down-regulation serum withdrawal no longer
induces myosin II expression. The ability of Bin11013
overexpression to slow cell proliferation is dependent on the
presence of exon 10. In contrast, exon 10 is not essential for
differentiation. Accelerated differentiation of C2C12 myo-
blasts occurs upon serum withdrawal even in cells expressing
a form of Bin11013 in which exon 10 is deleted. Hence,
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increased expression of Bin11013 (although not exon
10) is essential for differentiation of C2C12 myoblasts into
myotubes in culture (162, 357).
A role for Bin11013 in cell differentiation is consistent
with aspects of the function of the Rvs161p and Rvs167p pro-
teins in yeast. In budding yeast two cell differentiation path-
ways have been described, sporulation and pseudohyphal
growth. The sporulation of vegetative diploid cells to produce
haploid spores is dependent on the function of both Rvs161p
and Rvs167p (10, 12, 38, 53). This suggests a possible evolu-
tionarily conserved role in cell differentiation. Furthermore,
the importance of Bin11013 expression for the cell-cell
fusion of myoblasts to form multinucleate myotubes is remi-
niscent of the role of Rvs161p/Fus7p and Rvs167p in fusion of
haploid yeast cells during mating (20, 21, 91). Mating leads
initially to the formation of cells with two haploid nuclei
(multinucleate), however, subsequent nuclear fusion results in
a single diploid nucleus. Fusion of myoblasts requires elevated
expression of type II conventional muscle myosin and this is
dependent on Bin11013 (357). It is interesting that in yeast,
of all the myosins, the strongest genetic interactions of RVS161
and RVS167 are with MYO2, which encodes the sole conven-
tional type II myosin (Myo1p) (19).
Bin11013 localization in adult skeletal muscle. In skel-
etal muscle, Bin11013 localizes to distinctive transverse
bands that appear with regular periodicity along the muscle
fiber. The Bin11013-specific bands were compared with
known bands of muscle fiber and found to be within the broad
actin filament-containing I-band and positioned on either side
of the thinner desmin-containing Z-line. The submembranous
cytoskeletal protein ankyrin 3 localizes to what appear to be
the same bands as Bin11013 within the muscle fiber (23).
Ankyrin 3 is a specific marker for invaginations of the muscle
cell plasmalemma known as transverse (T)-tubules (79). That
Bin11013 localizes to T-tubules in muscle was confirmed by
colocalization with another T-tubule-specific marker, triadin
(108), and immunoelectron microscopy of ultrathin skeletal
muscle frozen sections (23). Interestingly, like axon initial seg-
ments and nodes of Ranvier in the brain, T-tubules in muscle
bear on their cytoplasmic face a dense cytomatrix and it is to
this cytomatrix to which ankyrin 3 localizes. Bin11013 may
function within this cortical cytomatrix to regulate traffic to and
from T-tubules and may play a role in defining these special-
ized membrane subdomains (23, 79, 162).
T-tubules are membrane tubules that extend from the plas-
malemma to form an extensive intracellular membrane retic-
ulum. This T-tubule membrane reticulum is closely associated
with the bundles of muscle fibers within muscle cells. T-tubules
have been proposed to play a key role in passing the Na/K
action potential at the cell surface to each of the muscle fibers
located in the cytoplasm. This propagation of the action po-
tential ensures that the response in muscle fibers is coordi-
nated and synchronous and results in efficient depolarization-
contraction coupling. Moreover, T-tubules are enriched in
integral membrane proteins that function in ion transport,
which suggests a possible role for Bin11013 in regulation of
ion fluxes across membranes. T-tubules may also be sites of
endocytosis in skeletal muscle. Clathrin heavy chain, like
Bin11013, localizes to the I-band. The localizations are not
identical, however, as clathrin heavy chain localizes to a region
between Bin11013 and the Z-line. The insulin-regulated
plasma membrane glucose transporter Glut4 is a protein that
undergoes clathrin-dependent endocytosis. Glut4 localization
in skeletal muscle extensively overlaps that of both clathrin
heavy chain and Bin11013 (23).
Interestingly, in the fruit fly Drosophila melanogaster the
single amphiphysin ortholog is enriched in postsynaptic neu-
romuscular junctions in larvae. In contrast, Drosophila am-
phiphysin expression is low or absent in the central nervous
system. Flies in which the amphiphysin gene is disrupted are
viable and exhibit normal synaptic vesicle recycling and neu-
rotransmission, but display severe locomotory defects in both
larvae and adult flies (e.g., the adults cannot fly). The function
of the neuromuscular junction appears normal. Amphiphysin
localizes to T-tubules in muscle and amphiphysin-deficient flies
have a disorganized T-tubule system. This suggests the loco-
motory defects in amphiphysin-deficient flies result from inef-
ficient excitation-contraction coupling in which the T-tubule
plays a critical role. Moreover, although Drosophila amphiphy-
sin has both an N-terminal BAR domain and C-terminal SH3
domain highly conserved with mammalian amphiphysin 1 and
Bin1 isoforms, the central insert domain of mammalian am-
phiphysin 1 and Bin112 that interacts with clathrin heavy
chain and AP-2 is not well conserved in Drosophila amphiphy-
sin. Indeed, Drosophila amphiphysin does not bind clathrin
heavy chain (169, 258, 259, 386). Hence, Drosophila amphiphy-
sin resembles mammalian Bin11013.
Bin11013 and T-tubule formation in muscle. Although
endogenous amphiphysin 1 and both neuronal Bin16a12
(with or lacking exon 13) and muscle Bin11013 localize to
the cortical cytomatrix, they differ in their ability to localize
to the cortex when ectopically expressed in CHO cells. Am-
phiphysin 1 and neuronal Bin16a1213 both exhibit a pre-
dominantly diffuse localization throughout the cytoplasm. In
contrast, muscle Bin11013 concentrates at the cytoplasmic
face of the plasma membrane (162).
Ectopic expression of muscle Bin11013, but not am-
phiphysin 1 or neuronal Bin16a1213, in CHO cells that
normally lack T-tubules leads to the dramatic appearance of
tubules that resemble T-tubules. These tubules are contiguous
with the plasma membrane and are enriched in PtdIns(4,5)P2.
The ability of Bin11013 to induce membrane tubules in
nonmuscle cells requires the BAR domain and the 15-residue
muscle-specific domain encoded by exon 10 (Fig. 1) (162). This
domain is highly basic with the sequence RKKSKLFSRLR
RKKN and contains a putative nuclear localization sequence
originally thought to confer nuclear localization on
Bin11013 (278). Full-length Bin11013 is able to recruit
a muscle isoform of dynamin (dynamin 2) to the induced tu-
bules in CHO cells. Although the Bin11013 BAR domain
and exon 10-encoded domain are sufficient to induce tubules in
CHO cells, the SH3 domain must also be present for recruit-
ment of dynamin 2 to the tubules. The tubules induced by the
BAR domain and exon 10-encoded domain also appear to lack
surrounding cytomatrix, in contrast to the tubules induced by
full-length Bin11013 (162).
The role of endogenous Bin11013 in T-tubule forma-
tion in muscle cells has been investigated using the myoblast
cell line C2C12. During serum starvation-induced differen-
tiation of C2C12 cells, expression of both Bin11013 and
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caveolin 3 increases and both proteins localize to tubules
that are contiguous with the plasma membrane and enriched
in PtdIns(4,5)P2. Mature T-tubules are narrow tubules con-
taining Bin11013 but not caveolin 3. However, newly
formed T-tubules resemble a series of vesicular structures con-
nected by narrow tubules. Caveolin-3 is concentrated at the
vesicular elements and Bin11013 at the interconnecting
tubular elements. Hence, Bin11013 appears to play an im-
portant in vivo role in deforming membranes to generate nar-
row tubules, consistent with its ability to bind and deform
membranes in vitro (see below) (162).
Further support for a role of Bin11013 in muscle differ-
entiation has come from studies of homozygous Bin1 knockout
mice that lack Bin11013. Homozygous Bin1 knockout mice
appear to undergo normal embryonic development and are
represented at the expected Mendelian frequency at birth
(207). However, the homozygous Bin1 knockout mice do not
feed and die in the first 24 h after birth. Anatomical charac-
terization of homozygous Bin1 knockout mice revealed obvi-
ous cardiac myopathies, in particular a ventricular wall so se-
verely expanded that both ventricular chambers of the heart
were occluded. The ventricular cardiomyocytes are packed
more tightly than those in wild-type mice, but do not appear to
undergo abnormal proliferation. In ventricular cardiomyocytes
of wild-type mice Bin11013 is localized to the nucleus
(207). This is in contrast to skeletal muscle cells, where
Bin11013 localizes to T-tubules that line myofibrils in the
cytoplasm (23, 162).
Ultrastructural examination shows that the myofibrils in the
ventricular cardiomyocytes are not arranged in closely packed
regular arrays in Bin11013-deficient cardiomyocytes as
they are in normal cardiomyocytes. T-tubules are normally
positioned either side of the thin desmin-containing Z-line in
muscle. In Bin11013-deficient ventricular cardiomyocytes
the Z-line is more diffuse than in normal cardiomyocytes, sug-
gesting a possible defect in the T-tubule system. Although
skeletal muscle is present and gross abnormalities are not
apparent in homozygous Bin1 knockout mice, ultrastructural
examination reveals that the myofibrils in skeletal muscle cells
also appear less well organized than in skeletal muscle from
wild-type mice. In addition, the T-tubules appear to be shifted
to the Z-line rather than being aligned on either side of it as in
normal skeletal muscle (207). Hence, Bin11013 is not es-
sential for muscle development, but is important for T-tubule
organization in cardiomyocytes and, to a lesser extent, in skel-
etal muscle.
Bin11013 and lipid rafts. The membranes of T-tubules
have a distinctive lipid composition, being enriched in sterols
and glycosphingolipids (26). Treatment of C2C12 cells with
agents such as amphotericin B and methyl--cyclodextrin,
which deplete cholesterol from membranes, interferes with
Bin11013 distribution and prevents T-tubule formation.
The same treatments also prevent the induction of membrane
tubules in CHO cells upon ectopic expression of Bin11013,
suggesting these tubules are also enriched in cholesterol (162).
During muscle differentiation the lipid raft marker caveolin-3
localizes to T-tubules (26). Caveolins are a family of proteins
that localize to flask-shaped, lipid-raft-enriched cell surface
invaginations known as caveolae. Caveolae have been shown to
function in endocytosis and in signal transduction (113, 159).
As caveolae and T-tubules are both lipid-raft-enriched invagi-
nations of the plasma membrane and newly forming T-tubules
contain caveolin-3, it has been proposed that T-tubules may
form in the same way as caveolae (26). Interestingly, in CHO
cells the endogenous isoform of caveolin (caveolin 1) localizes
to Bin11013-induced tubules (162). The localization of
Bin11013 to lipid-raft-enriched T-tubules in muscle is in-
teresting in light of the observation that Rvs161p and Rvs167p
in yeast fractionate with detergent-insoluble lipid rafts (10, 97).
Bin11013 binds and tubulates liposomes in vitro. Re-
combinant Bin11013 has been shown to bind liposomes
in vitro via direct interaction with lipids. When incubated in
vitro with liposomes recombinant Bin11013 generates
narrow membrane tubules by a process of evagination (162).
This is similar to what was shown earlier for recombinant
amphiphysin 1 in vitro (316). The lipid composition of the
liposomes influences the efficiency of binding of Bin11013.
The presence of PtdIns(4,5)P2 strongly enhances binding and
PtdIns(4)P has a similar but slightly weaker effect. While the
Bin11013 N-terminal amphipathic -helix and BAR do-
main are sufficient for binding to liposomes in vitro, enhance-
ment of binding by PtdIns(4,5)P2 or PtdIns(4)P is dependent
on the domain encoded by exon 10. Neither PtdIns(4,5)P2 nor
PtdIns(4)P affect binding of fragments comprising the N-ter-
minal amphipathic -helix and BAR domains of either am-
phiphysin 1 or Bin16a1213 to liposomes (162). Drosoph-
ila amphiphysin also has the ability to evaginate tubules from
liposomes composed of brain lipids in vitro, showing that this
property has been conserved during evolution (258).
The importance of the Bin11013 BAR domain for lipo-
some binding in vitro is consistent with the results of in vivo
studies. The Bin11013 BAR domain and the sequence en-
coded by exon 10 are both essential for ectopically expressed
Bin11013 to localize to the plasma membrane in CHO
cells. The plasma membrane is the major site of PtdIns(4,5)P2
in cells. Hence, PtdIns(4,5)P2 binding may be important for
Bin11013 localization and membrane tubulation in vivo
(162).
Bin1101213/SH3p9
A splice variant of Bin1 that lacks the putative nuclear lo-
calization sequence and sequences required for lipid binding
encoded by exon 10 compared to muscle Bin11013 but that
still retains the central third of the MBD encoded by exon 13
was identified in a screen for novel SH3 domain proteins and
named SH3p9 (Fig. 1) (306). SH3p9 is referred to here as
Bin1101213. This Bin1 isoform is expressed in many tis-
sues, although it may be absent in some specialized cell types
such as macrophages (100) (see below). The function of
Bin1101213 remains unknown.
Bin1101213/ALP1/Amphiphysin IIm
While Bin1 was identified as a c-Myc-interacting protein, a
distinct splice variant was identified by its ability to bind an-
other oncoprotein, c-Abl, and named Amphiphysin-Like Pro-
tein 1 (ALP1) (141). The same splice variant was identified as
the sole amphiphysin and Bin1 isoform in macrophages and
named amphiphysin IIm (100). Bin1101213 is the most
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ubiquitous splice variant of Bin1. This splice variant is distinct
from the original Bin1 isoform (Bin11013) because it lacks
the 15-residue sequence containing the putative nuclear local-
ization sequence and sequences required for lipid binding en-
coded by exon 10 and furthermore is distinct from both
Bin1101213 (SH3p9) and Bin11013 in that it lacks
exon 13, which encodes the central third of the MBD (note
that although the initial report by Kadlec et al. [141] described
ALP1 as essentially identical to SH3p9 in lacking exon 13,
ALP1 in fact differs from SH3p9 in lacking exon 13) (100, 141,
278, 306, 338, 357).
Despite lacking the putative nuclear localization sequence
encoded by exon 10, when transiently expressed in NIH 3T3
fibroblasts Bin1101213 localizes to the nucleus in a high
percentage of cells. However, in some transfected NIH 3T3
cells Bin1101213 is found predominantly in the cyto-
plasm (141). Nuclear import of Bin1101213 is presum-
ably mediated by the alternative nuclear localization sequence
present in the BAR-C domain, which is common to all Bin1
splice variants (69). What cellular mechanism regulates the
nuclear/cytoplasmic distribution of Bin1101213 is un-
known.
c-Abl is a nonreceptor tyrosine kinase that localizes to both
the nucleus and the actin cytoskeleton, and mutations in c-Abl
have the ability to transform cells. c-Abl and ALP1 coimmu-
noprecipitate from cotransfected cells, showing they associate
in vivo. Moreover, in vitro protein binding experiments showed
that the C-terminal SH3 domain of ALP1 mediates interaction
and binds at least two distinct proline-rich motifs within the
c-Abl C-terminal domain. The c-Abl SH3 does not bind ALP1.
Unlike Bin11013, Bin1101213 does not bind c-Myc in
vitro, presumably due to the absence of MBD sequences en-
coded by exon 13 (141).
Bin1101213 in regulation of the actin cytoskeleton.
Transient coexpression of c-Abl and Bin1101213 induces
a dramatic change in cell morphology in which actin stress
fibers are lost and the cells adopt a more rounded and “spin-
dly” appearance. High-level expression of c-Abl inhibits cell
proliferation and coexpression of Bin1101213 does not
reverse this inhibition. Bin1101213 expression does not
activate c-Abl tyrosine kinase activity, however, induction of
the morphological change by coexpression requires an intact
c-Abl kinase domain as well as the Bin1101213 SH3
domain and the proline-rich motifs in c-Abl with which it
interacts. The change in cell morphology induced by coexpres-
sion of c-Abl and Bin1101213 resembles those that ac-
company oncogenic transformation, but is not accompanied by
oncogenic transformation. The altered BCR-Abl form of c-Abl
is associated with leukemia. Expression of Bin1101213
somewhat increases the ability of BCR-Abl to oncogenically
transform cells in culture (141). This is in contrast to
Bin11013, whose high-level expression suppresses onco-
genic transformation by the oncoprotein c-Myc (278).
Bin1101213 functions in phagocytosis in macro-
phages. Murine macrophages express Bin1101213 as
their only Bin1 splice variant and this has been named am-
phiphysin IIm but is identical to ALP1 (100, 141). Like am-
phiphysin 1 and other splice variants of Bin1, Bin1101213
binds dynamin (dynamin 2 in macrophages) via its C-terminal
SH3 domain. The mutant form of Bin1101213 that lacks
an SH3 domain has dominant negative effects on receptor-
mediated endocytosis of low-density lipoprotein (100).
Is Bin1101213 also required for phagocytosis of parti-
cles? Phagocytosis of large particles (0.5 m) does not utilize
clathrin-coated pits regulated by clathrin, AP-2, and dynamin.
Instead, phagocytosis (literally, “cell eating”) involves the
spreading of plasma membrane projections around a particle
to be internalized in a process dependent on the cortical actin
cytoskeleton. Macrophages function in phagocytosis of patho-
gens and other particles and express cell surface receptors that
specifically recognize particles to be phagocytosed (1). Binding
of particles to phagocytic receptors is followed by recruitment
of actin, Bin1101213, and dynamin 2 to the site of par-
ticle binding. Actin filament assembly then generates an “actin
pedestal” beneath the bound particles. Finally, membrane ruf-
fles and projections form that eventually engulf the receptor-
bound particles. Both actin and Bin1101213 are gradu-
ally shed from the surface of phagosomes during maturation of
phagosomes into digestive compartments (100).
Expression of a dominant negative mutant form of
Bin1101213 lacking the C-terminal SH3 domain
(Bin1101213SH3) prevents recruitment of dynamin 2
to the site of particle binding and formation of membrane
ruffles and projections, and as a consequence results in a severe
block in particle engulfment and internalization (Fig. 12).
However, expression of Bin1101213SH3 does not affect
cell viability, expression of the phagocytic receptors, particle
binding, cell spreading, actin pedestal formation, or secretion
to the cell surface (100). Interestingly, in these experiments the
recruitment of Bin1101213 to the site of particle binding
was not affected by deletion of the SH3 domain. This suggests
that the BAR domain mediates the subcellular localization of
Bin1101213. This is consistent with the finding that in
yeast the BAR domain mediates subcellular localization of
Rvs167p and that Rvs161p localizes similarly despite compris-
ing only a BAR domain (11, 144). Subcellular localization of
Bin1101213 may be achieved by binding specific mem-
brane lipids. In support of this, treatment of macrophages
with the phosphatidylinositol 3-kinase inhibitor wortmannin
to deplete PtdIns(3)P abolishes the recruitment of Bin110
1213 to the site of particle binding (100). Interestingly,
Bin1101213 lacks exon 10 that encodes the PtdIns(4,5)P2
binding domain of Bin11013, so other domains in Bin1
101213 may bind phosphoinositides (162).
In these experiments an acute perturbation of Bin1101213
function was achieved using a dominant negative construct. Interest-
ingly, however, macrophages derived from homozygous Bin1
knockout mice do not exhibit obvious defects in phagocytosis
(207). The reason for the difference between the results ob-
tained by dominant negative constructs and gene knockout is
not yet clear. Expression of a mutant construct can have off-
target effects, so it is not certain that the defects in phagocy-
tosis seen using the Bin1101213SH3 construct arise
from a role of amphiphysin IIm in phagocytosis. Another pos-
sibility is that Bin1101213 function is critical for phago-
cytosis but long-term compensatory mechanisms are induced
during the development of homozygous knockout mice lacking
Bin1101213 that bypass the normal requirement for
Bin1101213 in phagocytosis. Further experiments will be
102 REN ET AL. MICROBIOL. MOL. BIOL. REV.
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
m
br.asm
.org/
D
ow
nloaded from
 
necessary to distinguish between these possibilities. A possible
endocytic or phagocytic role is supported by the finding that
Bin1101213 interacts via its BAR-C domain with SNX4,
such as neuronal Bin16a1213. SNX4 plays a key role in
membrane traffic through early endosomes (167).
Originally, it was assumed that the membrane that engulfs
bound particles during phagocytosis is derived from the plasma
membrane and that the process is one of plasma membrane
invagination. However, both in the slime mold Dictyostelium
discoideum and in murine macrophages a role for the endo-
plasmic reticulum in phagocytosis has recently emerged. Dictyo-
stelium mutations that affect the ER-resident proteins calnexin
and calreticulin severely compromise phagocytosis (211). In
murine macrophages, direct fusion between the ER and the
plasma membrane occurs at sites of particle engulfment and
the membrane that surrounds the particles being phagocy-
tosed is largely derived from the ER (14, 88). The role of
Bin1101213 in phagocytosis is not yet well understood.
Bin1101213 lacks an NTID that has been shown to be
critical for plasma membrane targeting of Bin16a1213
(257). Perhaps Bin1101213 localizes to an intracellular
compartment such as the ER that moves to the plasma mem-
brane only after engagement of phagocytic receptors.
A potential role for Bin1101213 in phagocytosis is par-
ticularly interesting in light of parallels between endocytosis in
yeast and phagocytosis in mammalian cells. Important parallels
include the dependence on a functional cortical actin cytoskel-
eton and the lack of strict dependence on cytoplasmic coat
proteins such as clathrin and AP-2 (95, 213, 266). A role for the
ER in yeast endocytosis is possible, but has not been fully
explored. Some mutations that block the secretory pathway at
the step of ER exit also compromise endocytosis (118, 265).
However, it has been difficult to assess how direct these effects
on endocytosis are (118).
Rvs161p and Rvs167p have recently been shown to physi-
cally interact with proteins involved in both membrane traffic
from the ER and also post-Golgi apparatus membrane traffic
to the cell surface (e.g., Gyp5p and Gyl1p) (33, 84, 317). Gyp5p
and Gyl1p regulate the Rab GTPase Ypt1p, which has been
implicated in export of lipid rafts from the ER as well as vesicle
targeting (202). In mammals, the Ypt1p ortholog Rab1 has
also been implicated in export from the ER as well as vesicle
targeting (227, 238, 239, 248). It would be interesting if these
Rab proteins have additional functions in endocytosis in yeast
and phagocytosis in mammalian cells.
AMPHIPHYSIN-RELATED PROTEIN Bin2
Bin2 is perhaps the most enigmatic of the amphiphysin-
related proteins. It was identified as a protein in cells not
FIG. 12. Bin1101213 functions in phagocytosis in macrophages. RAW-TT10 (murine macrophage-derived) cells were transiently cotrans-
fected with a construct that expresses GFP and with either an empty vector (Control) or a construct that expresses a dominant negative form of
Bin1101213 lacking the C-terminal SH3 domain (AmphIImSH3). The cells expressing the highest levels of GFP were recovered by flow
cytometry and incubated with immunoglobulin G-coated sheep red blood cells for 10 min (panels A and B) or for 1 h (panels C and D) before
visualization by scanning electron microscopy. The control cells formed actin pedestals beneath the bound sheep red blood cells, then formed
membrane ruffles (A), and then phagocytosed the bound sheep red blood cells (C). In contrast, cells expressing the dominant negative mutant
Bin1101213 lacking the C-terminal SH3 domain formed actin pedestals beneath the bound sheep red blood cells (B), but did not form
membrane ruffles, and did not phagocytose the bound sheep red blood cells which remained on the cell surface (D). The scale bar in panel B applies
to each panel. (Reprinted from reference 100 with permission from Elsevier.)
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expressing amphiphysin 1 that is also distinct from Bin1 but
cross-reacts with polyclonal antisera to Bin11013. The
cross-reactive antibodies specifically recognize the BAR-C re-
gion of Bin11013. A homology search of the expressed
sequence tag database identified a B-lymphocyte cDNA en-
coding a protein with high sequence identity to Bin11013 in
the BAR-C region and this protein was named Bridging INte-
grator 2 (Bin2). Bin2 is the product of a distinct gene known as
BIN2. Both a major 2.6-kb and a minor 3.5-kb transcript are
encoded by the BIN2 gene, suggesting that Bin2, like am-
phiphysins 1 and Bin1, is differentially spliced (94).
Bin2 has a predicted N-terminal amphipathic helix (residues
23 to 45) (see below) and BAR domain (residues 45 to 249)
homologous to those in amphiphysin 1 and Bin1 (residues 1 to
249 of Bin2 exhibit 61% amino acid sequence identity to Bin1)
(Fig. 1). Bin2 has a large C-terminal acidic domain enriched in
serine and proline residues, but lacks a central insert domain
homologous to those in amphiphysins 1 and Bin112 that
bind clathrin heavy chain and AP-2/-adaptin or to that in
Bin11013 that binds c-Myc. Bin2 also lacks an SH3 domain.
As found for other amphiphysin-like proteins it migrates
anomalously during electrophoresis, giving an apparent size of
80 kDa, while its sequence predicts a size of 61.7 kDa. When
transiently expressed at high levels in COS-7 fibroblasts, Bin2
was found to be cytosolic (94). It is possible that endogenous
Bin2 associates with membranes in lymphoid cells.
Bin2 is highly expressed in lymphoid cells and its expression
increases during induced differentiation of a granulocyte pre-
cursor cell line (HL60) in vitro (granulocytes are a class of
lymphoid cell that includes neutrophils, basophils, and eosin-
ophils). Bin2 transcripts are abundant in cultured lymphoid
cell lines, but are not found in cell lines derived from brain,
liver, lung, breast, prostate, connective tissue (fibroblast), or
colon, suggesting that Bin2 may be lymphoid cell specific (94).
Bin2 forms 1:1 heterodimers in vitro with Bin11013. The
association is specific because Bin2 cannot form heterodimers
in vitro with amphiphysin 1. Bin2 coimmunoprecipitates with
Bin11013 (or with the neuron-specific isoform Bin16a
1213) from extracts of COS-7 cells transiently expressing
both proteins, suggesting that Bin2 may also form het-
erodimers in vivo. Association requires the N-terminal part of
the Bin11013 BAR domain (residues 1 to 122), but not the
BAR-C part (residues 124 to 207). Heterodimer formation
does not require the Bin11013 MBD or C-terminal SH3
domain (94). However, heterodimer formation has not yet
been demonstrated for endogenous Bin2 in lymphoid cells.
Unlike amphiphysin 1 and Bin1, Bin2 is not implicated in
endocytosis. Transient high-level expression of Bin2 in COS-7
cells, unlike high-level expression of neuronal Bin16a1213,
does not inhibit receptor-mediated endocytosis of transferrin.
BIN2 knockout mice have not yet been reported, so the effect
of loss of Bin2 expression on endocytosis is not yet known.
High-level expression of Bin2, unlike that of Bin11013,
does not inhibit growth of the tumor cell lines HepG2 (hepa-
toma), MCF-7 (breast carcinoma), A549 (lung carcinoma), or
DU145 and PC3 (prostate carcinoma), nor does Bin2 affect the
ability of Bin11013 to inhibit growth of these tumor cells in
coexpression experiments (94). The physiological role of Bin2
remains to be determined.
AMPHIPHYSIN-RELATED PROTEIN Bin3
For a time it appeared that proteins comprising a BAR
domain only are unique to yeast (42). However, a human
protein containing only a BAR domain was eventually identi-
fied by homology search of the expressed sequence tag data-
base using the amino acid sequence of S. cerevisiae Rvs161p as
the query and named Bin3 (Fig. 1). Bin3 is encoded by a gene
distinct from those that encode amphiphysin 1 (AMPH1), Bin1
(BIN1), and Bin2 (BIN2) and has been named BIN3. Human
Bin3 exhibits 28 and 29% amino acid sequence identity to S.
cerevisiae Rvs161p and S. pombe Hob3p, respectively, but ex-
hibits significantly lower homology to the BAR domains of S.
cerevisiae Rvs167p, S. pombe Hob1p, and human Bin1. Unlike
Bin1, which generates a large number of distinct transcripts,
there appears to be only a single major Bin3 transcript. This
Bin3 transcript is expressed ubiquitously in embryos and all
adult tissues tested with the sole exception of the brain. Unlike
Bin1, whose expression is lost in a significant percentage of
cultured cancer cell lines and primary tumors, all tumor cell
lines tested to date retain Bin3 expression, suggesting that Bin3
is not a tumor suppressor (276). There has not yet been a
thorough characterization of Bin3 and its cellular functions
remain to be identified.
ENDOPHILIN FAMILY OF PROTEINS
Identification of Endophilin A1/SH3p4/SH3GL2
Endophilin A1 (also called SH3p4 and SH3GL2) is a 40-kDa
BAR domain protein identified as a major synaptojanin 1
binding protein in the brain (28, 51, 192, 269, 270), as a novel
SH3 domain protein (SH3p4) that binds a synthetic peptide
known to be a ligand of the Src SH3 domain (306), as a protein
containing a GRB2-like SH3 domain (SH3GL2) (99), and as
an SH3 domain protein that binds a proline-rich motif in the
1-adrenergic receptor cytoplasmic tail (323) (Fig. 1 and Table
2). The name endophilin derives from the affinity this protein
displays for several different endocytic proteins (51, 192, 193).
Endophilin A1 possesses an N-terminal amphipathic -helix,
a BAR domain that mediates homodimer formation, and a
C-terminal SH3 domain that binds dynamin 1, synaptojanin 1,
amphiphysin 1, and Bin112 (Fig. 1). Although the endophilin
A1 SH3 domain binds the C-terminal PRDs of both synapto-
janin 1 and dynamin 1, its affinity for the former is considerably
greater (51, 192, 270). Unlike amphiphysin 1, endophilin A1
has only a short central domain and does not bind clathrin
heavy chain or AP-2/-adaptin (28, 51, 73, 192, 193, 255, 269)
(note: Cestra et al. [28] refer to endophilin A1/SH3p4 as en-
dophilin 2). Endophilin A1 has been reported to exhibit lyso-
phosphatidic acid acyltransferase activity in vitro (284). How-
ever, a very recent study found this activity is due to a
contaminant (89).
The endophilin A1 SH3 domain binds the PRD of dynamin
1 at a site distinct from the amphiphysin 1 SH3 domain (302).
Similarly, the endophilin A1 SH3 domain binds a motif in the
synaptojanin 1 PRD (PKRPPPPR) distinct from the two mo-
tifs recognized by the amphiphysin 1 SH3 domain (PIRPSR
and PTIPPR) (28, 269). The endophilin A1 SH3 domain also
binds germinal center kinase-like kinase (GLK). Endophilin
A1 binding to GLK is implicated in Jun N-terminal kinase
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(Jnk) activation (254). This interaction is interesting, as fission
yeast Hob1p also interacts via its SH3 domain with a kinase of
the GLK family (Nak1p) (131).
Like amphiphysin 1, endophilin A1 is highly enriched in the
brain, where it colocalizes with synaptojanin 1 in presynaptic
nerve terminals. Endophilin A1 does not stably associate with
the plasmalemma or with synaptic vesicles but is predomi-
nantly soluble in the nerve terminal cytoplasm. Endophilin A1
and synaptojanin 1 coimmunoprecipitate from brain extract,
indicating that they form a stable complex in vivo. Synaptoja-
nin 1 in the brain also forms complexes with amphiphysin
1/Bin16a1213 heterodimers that do not contain endophi-
lin A1. Hence, synaptojanin 1 in the brain is present in two
separate complexes, one containing endophilin A1 and the
other containing amphiphysin 1 and Bin16a1213. Inter-
estingly, while amphiphysin 1, dynamin 1, and synaptojanin 1
are all phosphorylated in resting neurons and rapidly dephos-
phorylated upon neuron depolarization, endophilin A1 is not
phosphorylated in resting neurons (51, 192, 193).
Two very closely related proteins with the same domain
structure as endophilin A1 that are also enriched in the brain
are endophilin A2 (also called SH3p8, SH3GL1, and EEN)
and endophilin A3 (also called SH3p13 and SH3GL3) (Fig. 1
and Table 2) (28, 34, 99, 133, 269, 270, 306, 323). Endophilin
A2 is a 45-kDa protein that localizes to presynaptic nerve
terminals and forms heterodimers via BAR domain interac-
tions with endophilin A1 (269). The endophilin A2 SH3 do-
main, like the endophilin A1 SH3 domain, binds the PRD of
dynamin 1 via a site distinct from that recognized by the am-
phiphysin 1 SH3 domain and also binds the synaptojanin 1
PRD (270, 302). The endophilin A2 SH3 domain also binds the
short central domain of endophilin A2 and this homotypic
interaction may also occur in the case of endophilin A1 (31).
The endophilin 2 SH3 domain also binds a proline-rich motif
in the 1-adrenergic receptor cytoplasmic tail (323). Although
enriched in the brain, endophilin A3 is also expressed at low
levels in the cervical carcinoma HeLa cells, where it localizes to
the cytoplasm and also the nucleus (133). The endophilin A3
SH3 domain, like those of endophilins A1 and A2, binds the
C-terminal PRDs of dynamin 1 and synaptojanin 1 (270) and a
proline-rich motif in the 1-adrenergic receptor cytoplasmic
tail (323). Endophilins A1, A2, and A3 are each encoded by a
distinct gene (99).
A second subfamily of endophilins comprises endophilins B1
(also called SH3GLB1) and B2 (SH3GLB2), which are also
encoded by distinct genes (196, 244) (Fig. 1 and Table 2).
Endophilins B1 and B2 have a domain structure similar to that
of endophilin A family members, with an N-terminal BAR
domain and C-terminal SH3 domain (Fig. 1). Endophilins B1
and B2 form homo- and heterodimers via BAR domain inter-
actions (244). Endophilin B1 interacts with amphiphysin 1,
Bin11213, and dynamin 1, but not synaptojanin 1. En-
dophilin B1 was reported to possess lysophosphatidic acid acyl-
transferase activity (196), but as with endophilin A1 this is
probably due to a contaminant (89). Endophilins B1 and B2
colocalize to structures in the cytoplasm and are not found in
the nucleus (244). Endophilin B1 has three known splice vari-
ants, of which one is ubiquitously expressed and two are ex-
pressed mainly in the brain (196).
Endophilin A and B Family Proteins Bind
and Tubulate Membranes
Recombinant endophilin A1 can bind directly to liposomes
in vitro. Binding results in evagination of membrane tubules 20
to 100 nm in diameter similar to those formed by dynamin 1 or
amphiphysin 1. The tubules formed by endophilin A1 display a
pattern of fine tightly packed transverse striations that resem-
bles that seen on the tubules formed by amphiphysin 1. Mem-
brane binding and tubule formation by endophilin A1 are not
dependent on the presence of the substrates for its reported
lysophosphatidic acid acyltransferase activity, consistent with a
recent report that this activity is due to a contaminant enzyme
(89). Indeed, liposome evagination appears to be nonenzy-
matic. When clathrin coat proteins are also present, most of
the endophilin A1-coated tubules that form terminate in a
clathrin-coated bud (73). This is similar to what is observed for
incubation of liposomes with clathrin coat proteins and am-
phiphysin 1 (316).
Structure-function analysis reveals that the N-terminal do-
main (residues 1 to 125) of endophilin A1 is both necessary
and sufficient for in vitro liposome binding and tubulation
activity. This domain is predicted to have a high content of
-helices and to form coiled coils. One endophilin A1 se-
quence in particular (residues 1 to 35) exhibits particularly high
sequence homology to residues 1 to 41 of the BAR domain of
amphiphysin 1. Deletion of this sequence in either endophilin
A1 or amphiphysin 1 abolishes binding to liposomes and mem-
brane tubulation. This sequence is predicted to contain an
amphipathic helix with a hydrophobic face and a highly basic
face and may interact with the phospholipid headgroups as
well as the hydrophobic interior of the bilayer. Consistent with
this idea, replacement of hydrophobic residues with charged
residues within the hydrophobic face of this predicted helix
abolishes liposome binding and tubulation activity (73).
Chemical cross-linking shows that endophilin A1 assembles
into high-molecular-weight oligomers in the presence of lipo-
somes in vitro. Moreover, endophilin A1 assembles with dy-
namin 1 to form a coat on membrane tubules that has a dif-
ferent physical appearance from those coats formed by
endophilin A1 alone. The coat formed by endophilin A1 and
dynamin 1 has thicker and more widely spaced striations and
resembles the coat formed by brain cytosol or by a mixture of
purified dynamin 1 and amphiphysin 1. To form this distinctive
coat requires not only the BAR domain but also the C-terminal
SH3 domain of endophilin A1 that binds dynamin 1. Unex-
pectedly, coated membrane tubules formed by dynamin 1 and
endophilin A1 do not vesiculate in vitro upon addition of GTP
(73). This is in contrast to tubules that are coated by dynamin
1 and amphiphysin 1, which do vesiculate efficiently upon GTP
addition (316). Endophilin A1 may therefore prevent dynamin
1-mediated vesiculation of membrane tubules. Both endophi-
lin A1 and amphiphysin 1 have been reported to inhibit dy-
namin 1 GTPase activity in vitro (73). However, stimulation of
dynamin 1 GTPase activity was subsequently shown in the case
of amphiphysin 1 and this stimulation is dependent on lipo-
some size (380). Perhaps this will also be the case for endophi-
lin A1, but this is not known.
Interestingly, an amphipathic membrane binding and tubu-
lating domain homologous to that in endophilin A1 is also
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found in endophilin B1. In neurons a small pool of endophilin
B1 localizes to presynaptic termini, similar to endophilin A1,
but there is also a large pool that localizes to the Golgi appa-
ratus. Recombinant endophilin B1 binds liposomes in vitro and
evaginates membrane tubules such as endophilin A1. More-
over, deletion of the short amphipathic -helix in the N-ter-
minal BAR domain abolishes membrane tubulation activity,
suggesting that endophilin B1 binds and tubulates membranes
in a manner similar to endophilin A1 (73).
Endophilin A Family Proteins Function in
Receptor-Mediated Endocytosis
Evidence in support of an endocytic role for endophilin A1
has come from studies similar to those that first implicated
amphiphysin 1 in endocytosis (293, 369). In permeabilized neu-
rons treated with nonhydrolyzable guanosine 5-O-(3-thio-
triphosphate) (GTP	S) to inhibit dynamin 1 GTPase activity
and induce the accumulation of deeply invaginated clathrin-
coated pits, endophilin A1 colocalizes with amphiphysin 1 and
dynamin 1 in the electron-dense rings at the neck of each
clathrin-coated pit (270). Transient overexpression of the en-
dophilin A1 SH3 domain inhibits receptor-mediated endocy-
tosis of transferrin in intact cells (295). In the case of the
endophilin A1 SH3 domain the target is more likely to be
synaptojanin 1 than dynamin 1 due to the higher affinity for
synaptojanin 1. These results from SH3 domain overexpression
experiments should be interpreted with caution, however, due
to the possibility of off-target interactions and nonspecific ef-
fects. As yet, there are no reports of endophilin A1 knockout
mice. It will be interesting to see how similar the phenotype
associated with loss of endophilin A1 is to the phenotype
reported for amphiphysin 1 knockout mice (55).
The endophilin A1 SH3 domain also inhibits transferrin
internalization in in vitro receptor-mediated endocytosis assays
that utilize either permeabilized 3T3-L1 adipocytes or A431
adenocarcinoma cells (half-maximal inhibition in 3T3-L1 adi-
pocytes occurs at 11 M) (295). The endophilin A1 SH3 do-
main is therefore somewhat less potent an inhibitor than the
Bin1 SH3 domain. The inhibition may be specific because the
c-Abl SH3 domain (which does not bind dynamin 1 or synap-
tojanin 1) does not inhibit transferrin internalization in this in
vitro assay, even at high concentrations. Treatment of perme-
abilized cells with the endophilin A1 SH3 domain prior to
assay gave stronger inhibition than treatment of the cytosol
(120, 295). This suggests that the endophilin A1 SH3 domain
target relevant to endocytosis is membrane associated. Unex-
pectedly, addition of neither dynamin 1 nor synaptojanin 1 to
the assay relieved inhibition by the endophilin A1 SH3 domain.
This suggests that these known endophilin A1 SH3 domain
interactors may not be the targets whose inhibition blocks
endocytosis (120). These results with SH3 domain inhibition
should be considered suggestive rather than conclusive due to
possible off-target interactions and nonspecific effects.
At what stage of endocytosis does endophilin A1 function?
Endophilin A1 may have multiple roles in clathrin-dependent
endocytosis. Microinjection into living synapses of a peptide
that binds the endophilin A1 SH3 domain and inhibits its
interaction with dynamin 1 and synaptojanin 1 induces the
accumulation of both clathrin-coated vesicles and deeply in-
vaginated clathrin-coated pits, suggesting a dual role in mem-
brane fission and in uncoating of clathrin-coated vesicles. Ac-
cumulation of deeply invaginated clathrin-coated pits was also
induced by microinjection of the endophilin A1 SH3 domain
(87). Microinjection of antibodies to endophilin A1 into syn-
apses has been reported to block the conversion of flat clathrin
lattices to invaginated clathrin-coated pits, suggesting a role for
endophilin A1 in the earliest steps of clathrin-coated vesicle
formation (268).
Using in vitro assays that reconstitute the sequential steps of
clathrin-dependent endocytosis in permeabilized 3T3-L1 adi-
pocytes and A431 adenocarcinoma cells, one study found that
the endophilin A1 SH3 domain specifically inhibits the late
step of membrane fission and clathrin-coated vesicle release
(295). In contrast, in another study using permeabilized A431
cells, the endophilin A1 SH3 domain was observed to inhibit
the formation of deeply invaginated and constricted clathrin-
coated pits as well as inhibiting clathrin-coated vesicle fission
(120). Immunoelectron microscopy of synaptic membranes af-
ter incubation with brain extract, ATP, and GTP	S in vitro
revealed that endophilin A1 is not a stoichiometric component
of clathrin coats. Instead, endophilin A1 specifically localizes
to dynamin 1-coated tubules. Consistent with this (and in con-
trast to treatment with the endophilin A1 SH3 domain) immu-
nodepletion of endophilin A1 from brain extract does not
affect the formation of deeply invaginated clathrin-coated pits
on synaptic membranes incubated with ATP and GTP	S in
vitro, but does reduce dynamin 1-coated tubule formation
(268).
Interestingly, in Drosophila flies endophilin A is highly ex-
pressed in neurons and localizes to the presynaptic side of
neuromuscular junctions. Like mammalian endophilin A1,
Drosophila endophilin A was reported to possess lysophospha-
tidic acid acyltransferase activity in vitro (106), although, as
recently shown for mammalian endophilin A1, this activity may
be due to a contaminant (89). Drosophila endophilin A colo-
calizes with dynamin, suggesting that it may function in endo-
cytosis (267). Mutation of endophilin A perturbs endocytosis
of membrane-soluble endocytic dyes and blocks synaptic vesi-
cle recycling in neurons, resulting in lethality at an early larval
stage (106, 267, 347). As in mammalian cells, Drosophila en-
dophilin A appears to function in early stages of clathrin-
coated pit invagination as well as fission of invaginated pits
(106). Drosophila endophilin A also functions in concert with
synaptojanin in uncoating of clathrin-coated vesicles (348).
Hence, in Drosophila flies amphiphysin is specialized in
muscle function, while endophilin A is specialized in neu-
ronal function.
Ubiquitination plays an important role in the sorting of
plasma membrane proteins for endocytosis in yeast (117, 327).
More recently it has become apparent that ubiquitination is
also critical for the sorting of plasma membrane receptors into
clathrin-coated pits and endocytosis in mammalian cells (103,
308, 310, 345). Endophilins A1, A2, and A3 form complexes
with CIN85 (an SH3 domain adaptor protein similar to yeast
Sla1p) and function with the RING domain ubiquitin ligase
Cbl in ubiquitin-dependent sorting during endocytosis of
growth factor receptors in mammalian cells (240, 305, 313).
A further role of endophilins A1 and A2 in synaptic vesicle
endocytosis is in regulating Ca2 influx into neurons. Both
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endophilin A1 and A2 exhibit direct binding to voltage-gated
Ca2 channels (VGCCs). This interaction is regulated by Ca2
binding to a site in the central domain of endophilins A1 and
A2. The endophilin A1 and A2 SH3 domains interact with a
proline-rich motif in the central domain adjacent to the Ca2-
binding site. Ca2 binding to the central domain of endophilins
A1 and A2 breaks this intramolecular SH3 interaction and
allows interaction of the central domain with VGCCs. En-
dophilin A2 association with VGCCs is important in vivo since
transient expression in hippocampal neurons of a mutant en-
dophilin A2 construct that constitutively binds VGCCs inhibits
endocytosis (possibly by preventing Ca2 influx) (31). This
regulation of Ca2 influx is somewhat reminiscent of the role
of Rvs161p in low-affinity Ca2 influx during mating in yeast
(210).
In yeast, Rvs161p and Rvs167p are implicated in de novo
actin filament assembly. Rvs167p interacts via its SH3 domain
with the WASp-related protein Las17p and with Abp1p, both
of which are activators of the Arp2/3p actin filament nucleation
complex (18, 38, 101, 176, 181, 372). The neuronal isoform of
mammalian WASp (N-WASp) is a key activator of the mam-
malian Arp2/3 actin filament nucleation complex and has been
implicated in clathrin-dependent endocytosis (119, 151, 280).
Yet evidence of a direct role for amphiphysin 1 or Bin1 in actin
polymerization in vertebrate cells is lacking.
Interestingly, there is evidence that endophilin A3 may reg-
ulate Arp2/3-dependent actin filament assembly during endo-
cytosis in mammalian cells. The endophilin A3 SH3 domain
directly binds proline-rich motifs in N-WASp. Moreover, en-
dophilin A3 enhances the ability of N-WASp to activate the
Arp2/3 complex for actin polymerization in vitro. Endophilin
A3 and N-WASp coimmunoprecipitate from cell extracts,
showing that they form complexes in vivo. Complex formation
and accumulation of F-actin at intracellular sites where en-
dophilin A3 and N-WASp colocalize are both enhanced by
treatment of cells with epidermal growth factor (230). En-
dophilin A family members may therefore have a role in actin-
dependent movement during endocytosis potentially analo-
gous to that of Rvs161p and Rvs167p (which have been
proposed to bear more resemblance to mammalian endophil-
ins than to amphiphysins (307).
These studies show that endophilin A family members have
multiple roles in endocytosis. They not only have the ability to
tubulate membranes, but also function in Ca2 influx to trigger
dephosphorylation and activation of the endocytic machinery,
in ubiquitin-dependent sorting of plasma membrane proteins
into forming vesicles, in actin filament assembly which may
propel endocytic vesicles from the plasma membrane, and in
uncoating of clathrin-coated vesicles for fusion with endo-
somes in concert with synaptojanin family proteins.
OTHER BAR DOMAIN PROTEINS
Rich-1/Nadrin 1
The RhoGAP Interacting with CIP4 Homologs (RICH, sub-
sequently renamed RICH-1) protein was identified in a screen
for proteins that interact with the SH3 domain-containing
adaptor protein CDC42-Interacting Protein 4 (CIP4) and
found to have GTPase-activating protein activity on Rho fam-
ily GTPases (263). RICH-1 is also known as nadrin 1. RICH-1
possesses an N-terminal amphipathic -helix homologous to
that in endophilin A1 and B1 that mediates high-affinity lipo-
some binding and tubulation as well as a BAR domain and has
been confirmed to have liposome-binding and tubulating ac-
tivity in vitro (73, 237, 264). RICH-1 localizes to the ER: in
contrast to amphiphysin 1 and Bin1 isoforms, RICH-1 does not
localize to either the plasma membrane or endosomes. An
interesting feature of RICH-1 is the ability of its isolated BAR
domain to directly bind phosphoinositides in vitro, including
PtdIns, PtdIns(3)P, PtdIns(4)P, PtdIns(5)P, PtdIns(3,5)P2, and
PtdIns(4,5)P2 as well as other phospholipids, including phos-
phatidylserine and phosphatidic acid on a solid support (264).
The specificity of binding to these lipids has not yet been tested
using more physiological assays such as liposome binding, and
it is possible that the BAR domain is recognizing predomi-
nantly negative charge rather than these specific lipids.
SNX1
Sorting nexin 1 (SNX1) also has a BAR domain which has
the ability to sense membrane curvature and mediate the for-
mation of SNX1 dimers. SNX1 functions in membrane traffic
of the cation-independent mannose 6-phosphate receptor
from the early endosome to the trans-Golgi network. SNX1
has been shown to drive tubulation of the early endosome in
vivo and the purified protein also efficiently tubulates lipo-
somes in vitro (25).
Other BAR Domain Proteins
Other BAR domain proteins recently shown to tubulate
liposomes in vitro include arfaptin2, RICH-2/nadrin 2, cen-
taurin 2, and oligophrenin (237). Other proteins have been
predicted on the basis of sequence homology to possess BAR
domains, e.g., Tuba (279), SNX2, SNX4-9, and SNX18 (25,
325a), Insulin Receptor Substrate protein of 53 kDa (IRSp53),
and Adaptor protein containing PH domain, PTB domain, and
Leucine zipper motif 1 (APPL1) and 2 (APPL2) (109). These
proteins are predicted to have liposome binding and tubulating
activity in vitro, but this has not yet been experimentally veri-
fied. Liposome binding and tubulation appear to be common
features of BAR domain proteins.
CRYSTAL STRUCTURE OF THE AMPHIPHYSIN
BAR DOMAIN
Structure of the BAR Domain
The crystal structure of the BAR domain of Drosophila am-
phiphysin was solved by Peter et al. (237) and the structure has
been the topic of several excellent recent reviews (90, 109, 164,
390). Using the structural data together with liposome-binding
and tubulation experiments with wild-type and mutant BAR
domain proteins, the authors propose a general mechanism for
membrane binding and/or bending by BAR domains in differ-
ent proteins. Structural analysis revealed a banana-shaped
dimer formed by monomers, each comprising three -helices
in a coiled-coil arrangement (Fig. 13). The kinks in two of the
-helices together with the angled arrangement of the mono-
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mers generate the curved shape of the dimer. Basic residues in
the concave face of the dimer (K137 and R140) as well as basic
residues at each end of the dimer (K161 and K163) were shown
to be critical for membrane binding and tubulation.
The electrostatic interactions between the dimer and mem-
brane coupled with the rigidity of the BAR domain are pre-
dicted to be sufficient for membrane bending (390). However,
the BAR domain alone does not tubulate liposomes as effi-
ciently as the full-length protein, which also contains the N-
terminal amphipathic helix (residues 1 to 41). Also, binding of
the BAR domain alone to liposomes is dependent on liposome
size, displaying enhanced binding to smaller liposomes with
more curvature. In contrast, the full-length protein binds effi-
ciently to liposomes independently of their size. Based on these
two observations, Peter et al. propose that the BAR domain
itself is primarily a sensor of membrane curvature (237).
More recently, the crystal structure of the endophilin A1
BAR domain was solved (359). This BAR domain also forms a
banana-shaped dimer. However, a striking difference between
this structure and that of the Drosophila amphiphysin BAR
FIG. 13. Three-dimensional crystal structure of the Drosophila amphiphysin BAR domain. A, Two amphiphysin monomers (depicted in purple
and green) associate in antiparallel orientation to form a banana-shaped homodimer represented here in ribbon format. The residues that form
the basic patches on the concave membrane-binding surface of the dimer are highlighted. The Protein Data Bank identifier is 1URU. Note that
the Drosophila amphiphysin BAR domain lacks an NTID, but sequence alignment with mammalian Bin1 suggests the NTID would be positioned
within the unstructured loop between helices 2 and 3 as seen in the Drosophila BAR domain. This loop is positively charged and two conserved
lysine residues have been shown to be important for membrane association of both Drosophila amphiphysin and rat amphiphysins 1 and 2 (237).
The presence of the NTID would contribute extra positive charges to the unstructured loop and may further strengthen membrane association.
B, The homodimer represented in electrostatic surface format and viewed with the same orientation as in A. Electrostatic potential is indicated:
10 kTe1 in red; 10 kTe1 in blue). C, The homodimer represented in ribbon format but viewed at an angle perpendicular to that in panel
A to highlight details of the concave face. D, The homodimer represented in electrostatic surface format and viewed with the same orientation
as in panel C. (Reprinted from reference 237 with permission of the publisher. Copyright 2004 American Association for the Advancement of
Science.)
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domain is the presence of a disordered region (amino acids 60
to 88), within helix 1. The disordered regions in each monomer
are adjacent and in the middle of the dimer, where they extend
out of the concave face of the dimer. It is not clear whether
they extend perpendicularly out of the concave face of the
dimer or to the side of the dimer or whether they become
ordered upon membrane binding. The role of these regions
and their effect on the membrane binding properties of the
BAR domain have not been determined. In addition, the en-
dophilin A1 BAR domain was bound to 11 cadmium ions and
is proposed to bind to Ca2 in vivo and provide a basis for the
role of intracellular Ca2 in endocytosis.
Coupling of the BAR Domain with Additional
Lipid-Binding Sequences
BAR domains frequently exist together with a second mem-
brane binding sequence such as an amphipathic -helix, a
pleckstrin homology (PH) domain, or a phox homology (PX)
domain (109, 237). The N-terminal amphipathic -helix found
in amphiphysin 1, arfaptin, and RICH-1/nadrin 1 increases the
ability of the BAR domain protein to bend membranes. These
proteins are efficient at tubulation, and binding of the N-ter-
minal amphipathic -helix and BAR domain of these proteins
to liposomes is independent of membrane curvature (237).
This may be due to deformation of the membrane by the
amphipathic -helix in a manner similar to the amphipathic
-helix of epsin (81). In amphiphysin 1 the BAR domain and
N-terminal amphipathic -helix are thought to mediate mem-
brane invagination upon recruitment of the protein to the
membrane. The BAR domain then drives accumulation of the
protein at the neck of the invagination, where the curvature is
optimal for binding. This is followed by recruitment of dy-
namin to the neck of the invagination, where it oligomerizes
and allows fission of the vesicle from the membrane (380).
BAR domain proteins with adjacent PH domains, which lack
the N-terminal amphipathic -helix, tubulate liposomes less
efficiently and binding of these BAR domains and their adja-
cent PH domains to liposomes is sensitive to membrane cur-
vature (237). The PH and PX domains, which bind to specific
phosphoinositides, are thought to increase the specificity of
membrane targeting of BAR domain proteins since the BAR
domain together with the PH/PX domain would allow target-
ing to a membrane subdomain with a specific membrane cur-
vature and lipid composition.
Several members of the sorting nexin family of proteins,
which are characterized by the presence of PX domains, are
predicted to contain BAR domains adjacent to PX domains.
The BAR and PX domains of SNX1 have been shown to target
SNX1 to a highly curved microdomain in early endosomes that
contains PtdIns(3)P (25). SNX1 mediates tubulation of the
early endosome and via association with the retromer complex
(107) drives transport from the early endosome to the trans-
Golgi network. A PtdIns(4,5)P2 binding site encoded by exon
10 is thought to recruit Bin11013 to plasma membrane sites
enriched in this phosphoinositide in muscle cells. The BAR
domain and N-terminal amphipathic -helix then bend the
membrane and drive the formation of T-tubules (162).
Membrane Binding and GTPase Binding of BAR Domains:
Independent or Associated?
The structure of the BAR domain is highly homologous to
the structure of a fragment of Arfaptin2 GTPase, which binds
to Rac (341), and Arf GTPase (147). Arfaptin2 is proposed to
modulate membrane ruffling through interactions with these
GTPases (324). Arfaptin2 is now recognized to possess a BAR
domain and the concave face of the Arfaptin2 BAR domain
dimer contains the binding site for Rac. APPL1 and APPL2
bind the Rab5 endosomal GTPase via sequences predicted to
form BAR domains. APPL1 and APPL2 colocalize and are
associated with tubular and vesicular elements of a membrane
compartment that is likely to be an endosome. The binding of
these proteins to GTPases via their BAR domains has raised
the question of whether membrane binding and GTPase bind-
ing are mutually exclusive or common functions of the BAR
domain (109). The BAR domain of Arfaptin2 is also able to
tubulate liposomes in vitro, suggesting that it retains the mem-
brane-binding function. However, an in vivo role for arfaptin2
in membrane binding or bending has not yet been demon-
strated. Further studies are required to establish whether other
BAR domain proteins bind small GTPases and whether mem-
brane binding and GTPase binding are mutually exclusive or
common features of BAR domains.
BAR Domain and IMD Structure
IRSp53 is a Rac GTPase binding protein that was also pre-
dicted to contain a BAR domain (109). The N-terminal 250
amino acids form a domain that is homologous to the B iso-
form of Missing In Metastasis (MIM). Thus, this region, which
resembles a BAR domain, has been independently defined as
an IMD (IRSp53 MIM homology Domain) (374). The IMD
alone has been shown to play a role in actin bundling and
contains the Rac1 binding site. The recent crystal structure of
the IRSp53 IMD revealed that it is a cylindrically shaped dimer
with tapered ends (195). Nevertheless, there is a striking ho-
mology between the IMD and BAR domain. The IMD mono-
mer is composed of a coiled-coil arrangement of -helices
similar to that of the BAR domain monomers, however, an
additional shorter fourth -helix is present and the resulting
dimer is flat, unlike the curved BAR domain. Basic residues
present at the ends of the IMD dimer have been shown to be
critical for the function of the IMD in actin filament bundling.
The structures of the BAR domain and IMD illustrate how the
coiled-coil motif can be used to build protein domains with
diverse functions, including membrane binding, binding to
small GTPases, and actin filament bundling.
MEMBRANE TUBULATION AND BAR DOMAIN
PROTEIN FUNCTION IN VIVO
We now know that BAR domains bind and tubulate mem-
branes both in vitro and also in vivo (73, 264, 316, 380). Fur-
thermore, crystallography has revealed that BAR domains are
banana-shaped dimers able to sense and (depending on the
presence of other membrane-binding domains) create mem-
brane curvature (237). The challenge now is to use this new
knowledge to gain insight into the diverse roles of BAR do-
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main proteins in vivo. Can a role in membrane binding and
tubulation help explain the roles of BAR domain proteins in
clathrin-dependent endocytosis, muscle development, sporula-
tion, tumor suppression, phagocytosis, mitochondrial function,
transmembrane ion flux, cell-cell fusion, and viability upon
starvation?
The ability of BAR domain proteins to tubulate the plasma
membrane readily fits with current understanding of clathrin-
dependent endocytosis. In clathrin-dependent endocytosis in-
vagination of the clathrin-coated pit leads to the formation of
a deeply invaginated pit in which the formed vesicle is still
attached to the plasma membrane by a narrow neck comprising
a membrane tubule (121, 283, 290, 293, 315). Formation of the
tubular neck by amphiphysin 1/Bin112 heterodimers com-
bined with SH3 domain interactions may facilitate the recruit-
ment of dynamin 1 to the neck of deeply invaginated pits.
Curvature sensing by amphiphysin 1/Bin112 dimers may also
play an important role in positioning the associated dynamin 1
correctly at the neck, which has the highest membrane curva-
ture (380). Dynamin 1 mediates GTP-dependent fission of
membrane tubules in vitro (312). Moreover, dynamin 1 is im-
plicated in fission of the necks of deeply invaginated clathrin-
coated pits and release of clathrin-coated vesicles in vivo (45,
116, 121, 155, 344).
The ability of Bin11013 to bind and tubulate membranes
via its BAR domain and PtdIns(4,5)P2-binding domain en-
coded by exon 10 also readily explains the role of this protein
in T-tubule biogenesis. T-tubules are believed to form by pro-
gressive invagination of the plasma membrane (26, 162). In this
case dynamin-dependent fission does not occur and the tubules
remain as a type of extensive network of deeply invaginated
plasma membrane pits.
Membrane tubulation by BAR domain proteins is not a
phenomenon specific to the plasma membrane. For example,
RICH-1 has been shown to localize to the ER and to play a
role in tubule formation at this organelle (73, 264). Endophilin
B1 tubulates Golgi apparatus membranes (73) while SNX1
plays a role in tubule formation at the early endosome (25).
Bin16a1213 and Bin1101213 both interact with
SNX4 and may therefore function with SNX4 in membrane
tubulation events in endosomes (167). Endophilin A3 has been
shown to localize to a fine network of cytoplasmic tubules as
well as to sites of endocytosis at the plasma membrane (133).
Hence, the phenomenon of membrane tubulation by BAR
domain proteins may not be specific to clathrin-coated pits or
T-tubules.
Is membrane tubulation a process that also occurs in the
nucleus? The observation that Bin110 and Bin11012
(each isoform with or lacking exon 13) localize to the nucleus
in at least some cell types suggests a possible role for BAR
domain proteins in nuclear events (69, 141, 278, 355). A role
for BAR domain proteins in the nucleus is further supported
by studies of APPL1 and APPL2 (191). APPL1 and APPL2 are
predicted BAR domain proteins that bind the endosomal Rab5
GTPase and localize with Rab5 to a subset of early endosomes
(109, 191). APPL1 and APPL2 play a role in signaling to the
nucleus in response to changes in the extracellular environ-
ment. Upon exposure of cells to epidermal growth factor or
oxidative stress, APPL1 has been shown to dissociate from
the early endosome and to be imported into the nucleus. In
the nucleus APPL1 interacts with the multisubunit histone
deacetylase complex NuRD/MeCP1. NuRD/MeCP1 is a key
factor in chromatin remodeling and regulation of gene expres-
sion. Both APPL1 and APPL2 are known to be important for
cell proliferation. Hence, APPL1 and APPL2 have been pro-
posed to link events occurring at the cell surface to nuclear
changes in gene expression required for cell proliferation
(191).
The role of Bin11013 in the nucleus (if this splice variant
is indeed found in the nucleus) is still unclear. Bin11013
regulates c-Myc function, but whether this regulation is im-
posed in the cytoplasm or nucleus is a question that remains
unresolved. A recent study suggests the role of Bin11013
may be related to that of APPL1. As mentioned above, over-
expression of Drosophila c-Myc in select cells within a tissue
induces the high-expressor cells to become supercompetitors
and to proliferate at the expense of their neighboring cells in
the tissues that express lower levels of Drosophila c-Myc (199).
Intriguingly, the same study showed that overexpression of
Rab5 also induces a supercompetitor state. This finding sup-
ports the existence of links between Rab5 function in early
endosomes and c-Myc signaling pathways that regulate cell
proliferation and survival. Moreover, Bin1 has been shown to
interact via its C-terminal SH3 domain with Rin3 (142). Rin3
displays Rab5-specific GTP/GDP exchange factor activity (i.e.,
is a Rab5-GEF) and colocalizes with Rab5 to a subset of early
endosomes (142). This study implicates Bin1 in Rab5 GTPase
activation via interaction with Rin3.
An intriguing possibility is that the tumor suppression and
apoptotic functions of Bin11013 reflect an involvement in
the process known as autophagy, in which membranes form
around internal organelles as a prelude to their degradation (see
below). There are strong emerging links between autophagy in
mammalian cells and tumor suppression and apoptosis (66).
The picture that is emerging for the BAR domain proteins in
some ways resembles that which has emerged for dynamin. The
classical dynamin (dynamin 1) was first implicated in endocy-
tosis via clathrin-coated pits (45, 116, 121, 155, 290, 344). How-
ever, the discovery and characterization of diverse dynamin-
like proteins has revealed that the membrane fission activity of
this family of proteins extends to other membrane compart-
ments, including the ER, mitochondria, and peroxisomes (154,
174, 246, 378, 379). Different BAR domain proteins may func-
tion in different organelles in processes related to membrane
binding, tubulation, fission, and fusion. It is also possible that
the same BAR domain protein may function in more than one
cellular location and process. This possibility is especially likely
in the case of Rvs161p and Rvs167p, since these are the only
BAR domain proteins in yeast and therefore expected to pro-
vide a more diverse range of functions than the vertebrate
BAR domain proteins, of which there are many.
How can a role in membrane tubule formation explain the
phenotypes of yeast rvs mutants? Loss of Rvs161p or Rvs167p
reduces the efficiency of endocytic internalization in yeast (21,
38, 180, 215). This endocytic defect may be explained by an
inability of the rvs mutants to tubulate the plasma membrane
to form deeply invaginated endocytic pits or to form endocytic
vesicles by membrane fission. Rvs161p and Rvs167p het-
erodimers may be sufficient for plasma membrane tubulation
during endocytosis, since clathrin, AP-2, and dynamin are not
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strictly required for endocytosis in yeast (37, 92, 130, 226, 235,
318, 377, 383). Alternatively, by analogy to the putative role of
amphiphysin IIm in phagocytosis in macrophages, Rvs161p
and Rvs167p may be required for fusion of the cortical ER
with sites of endocytosis at the plasma membrane in order to
provide additional membrane material (14, 88, 100, 211). In-
deed, some mutations that block traffic from the ER also lower
the efficiency of endocytosis, although the molecular basis for
this link remains unclear (118, 265).
Three lines of evidence suggest that a model in which Rvs
proteins regulate direct fusion of cortical ER with plasma
membrane is worth consideration. First, electron microscopy
studies reveal regions of contact between the cortical ER and
plasma membrane in yeast known as plasma membrane-asso-
ciated membranes (named by analogy to mitochondrion-asso-
ciated membranes [MAMs]) (see below) (243). Second,
Rvs161p and Rvs167p physically and genetically interact with
proteins involved in membrane traffic from the ER (Gyp5p,
Gyl1p, Rud3p, Sec22p, Sec21p, and Sec27p) (84, 123, 317, 332)
and with proteins that function in vesicle fusion with the
plasma membrane (Exo70p, Sec8p, Sur4p, Fen1p/Sur5p, and
possibly also Gyp5p and Gyl1p) (10, 18, 33, 48, 53, 262). Third,
a very recent study found that at least one yeast integral mem-
brane protein (Ist2p) is transported directly from the cortical
ER to the plasma membrane without passing through inter-
mediate membrane compartments, suggesting the ER and
plasma membrane are able to undergo localized fusion (140).
Can a role in membrane tubulation provide an explanation
for why loss of Rvs161p and Rvs167p perturbs the polarized
distribution of cortical actin patches (12, 215, 298)? Cortical
actin patches are associated with plasma membrane invagina-
tions (205). Electron microscopy studies suggested that these
invaginations are distinct from the invaginations associated
with receptor-mediated endocytosis (204). However, several
subsequent real-time imaging studies have shown that mem-
brane structures containing endocytosed material colocalize
with cortical actin patches and that actin filament nucleation
correlates with movement of endocytic cargo (71, 132, 139,
143). Therefore, a defect in plasma membrane tubulation
might directly impact on the formation, movement, and distri-
bution of cortical actin patches. Alternatively, defects in lipid
delivery to the plasma membrane from the ER may perturb the
membrane dynamics of the plasma membrane or perturb sig-
nal transduction pathways involving lipid second messengers.
These changes in rvs mutants may then affect plasma mem-
brane tubulation and cortical actin patch formation, move-
ment, and distribution.
Although the role of Rvs161p and Rvs167p in mitochondrial
function is poorly understood it is intriguing that some Rvs-
interacting proteins are implicated directly or indirectly in mi-
tochondrial import of hydrophobic proteins, e.g., Pse1p/
Kap121p (18, 39). Moreover, it is interesting that the dynamin-
like protein 1 (DLP1) in mammalian cells has been shown to
localize to sites of contact between the ER and mitochondria
known as MAMs and to play a role in regulation of mitochon-
drial morphology (378). MAMs are thought to play a role in
lipid transfer from the site of lipid synthesis in the ER to
mitochondria, in particular the transfer of phosphatidylserine
(291, 342, 343, 378). The current view is that transfer is
achieved by lipid flipping at a site of contact. Perhaps mem-
brane tubule formation also plays a role in transfer of lipids to
mitochondria and defects in this process may perturb mito-
chondrial function. Consistent with a role for BAR domain
proteins in lipid transfer to mitochondria, overexpression or
down-regulation of endophilin B1 in mammalian cells has se-
vere consequences for mitochondrial morphology (148).
It is interesting that the lipid transferred from the ER to
mitochondria by the MAM, phosphatidylserine, is also a lipid
enriched in yeast plasma membrane-associated membranes
(see above) (243). Moreover, phosphatidylserine strongly stim-
ulates dynamin GTPase activity and is essential for dynamin-
dependent liposome fission in vitro (312, 380). Finally, given
the roles of some Bin1 splice isoforms in caspase-independent
apoptosis, it is interesting that elevated phosphatidylserine in
the outer leaflet of the plasma membrane is a hallmark of
apoptosis (342). It is possible that BAR domain proteins will
be found to play a role in delivery of phosphatidylserine to the
outer leaflet of the plasma membrane during Myc-induced
apoptosis and in phosphatidylserine delivery from the ER to
mitochondria via MAMs in concert with dynamin family pro-
teins, although this is conjecture and experimental evidence for
such postulated roles is lacking.
A role for membrane tubulation in lipid transfer between
the ER and other organelles might also contribute to sporula-
tion. After sporulation of a diploid cell to form four haploid
spores, the spores are held together in a cluster (ascus) by the
surrounding plasma membrane contributed by the diploid par-
ent. Each haploid nucleus formed during meiosis requires de
novo membrane biogenesis to construct a membrane (pros-
pore membrane) that will become the plasma membrane of the
spore (198). The process of membrane assembly around hap-
loid nuclei is not well understood but involves recruitment of
membrane material from elsewhere in the cell. A role for
another cortical actin patch component (End3p) in membrane
traffic to the prospore membrane has very recently been dem-
onstrated (201). Perhaps the Rvs proteins play a role in mem-
brane recruitment via in vivo tubule formation. Mutations in
the ER-to-Golgi apparatus Rab GTPase Ypt1p that confer
reduced viability upon starvation and block sporulation as rvs
mutations do have been isolated (288). Rvs161p and Rvs167p
both interact with proteins that regulate Ypt1p, suggesting
Rvs161p and Rvs167p may regulate Ypt1p function in sporu-
lation (18, 33, 49, 84, 85, 317).
Finally, it is interesting to consider the phenotype of reduced
viability upon starvation exhibited by rvs mutants. During nu-
trient starvation, cells induce a process known as autophagy in
which nonessential internal structures and organelles are de-
graded (145, 351). Autophagy is a way of providing nutrients
for use in essential cellular processes when external nutrients
are no longer available. A classic phenotype of mutants defec-
tive in autophagy is reduced viability upon starvation. Like
sporulation, autophagy is a process that relies on de novo
membrane biogenesis. During autophagy, internal structures
and organelles are surrounded by a double-layer membrane
derived, at least in part, from the ER. The newly formed
compartment is known as the autophagosome. The autopha-
gosome eventually fuses with the vacuole, and its contents are
degraded by resident hydrolases.
The formation of an autophagosome requires the recruit-
ment of membrane material from donor compartments such as
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the ER. This process is still very poorly understood. One pos-
sibility is that membrane is recruited via membrane tubules
that connect the donor compartment (e.g., the ER) to the
autophagosome. If this is correct then BAR domain proteins
such as Rvs161p and Rvs167p may play a crucial role in gen-
erating the membrane tubules that connect the donor com-
partment to the nascent autophagosome. According to this
model, loss of Rvs161p or Rvs167p would block the formation
of the autophagosome and thereby prevent efficient turnover
of nonessential structures and organelles. This would result in
an acute shortage of nutrients for essential processes and re-
duced viability upon starvation. Intriguingly, elements of the
ER itself are turned over by autophagy in yeast. Although it is
not known if Rvs161p and Rvs167p specifically are required for
this process, the actin cytoskeleton has recently been demon-
strated to play a critical role (110). Mutations that affect GTP
hydrolysis by Ypt1p and lock it in the active GTP-bound state
appear to induce cellular changes characteristic of autophagy
(49). The Rvs161p and Rvs167p interactors Gyp5p/Ypl249cp
and Gyl1p/Ymr192wp are important regulators of Ypt1p (18,
33, 49, 84, 85, 317).
CONCLUSIONS AND FUTURE PERSPECTIVES
The BAR domain proteins provide a function so fundamen-
tal and important it has been used repeatedly in different
contexts, including synaptic vesicle recycling in neurons, fusion
of myoblasts into myotubes in developing muscle, tumor sup-
pression, and possibly regulation of ion flux across membranes.
Genetic studies in yeast have shown that even in a simple
unicellular eukaryote BAR domain proteins are important for
a bewildering range of processes, including regulation of cell
cycle progression, cell polarity, endocytosis, mitochondrial
function, response to nutrient starvation, sensitivity to Na,
cell-cell fusion during mating, actin cytoskeletal organization,
exocytosis, and differentiation into spores. The underlying mo-
lecular function of the BAR domain as a generator and a
sensor of membrane curvature has been demonstrated. The
structure of the BAR domain has revealed the structural basis
for this molecular function. The major challenge now is to
define how the fundamental processes of membrane curvature
generation and sensing are adapted in vivo to support such a
tremendous range of important physiological processes from
yeast to humans.
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